United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others

1 Table of Contents 2

1.1 List of Tables 62

1.2 List of Figures 78

2 Introduction 81

2.1 What Is This Report About? 81

2.2 In Vitro Diagnostics Market Segmentation 81

2.3 Definitions of Markets Covered in the Report 85

3 In Vitro Diagnostics Market, United States 114

3.1 In Vitro Diagnostics Market, United States, Revenue ($m), 2015-2025 114

3.2 In Vitro Diagnostics Market, United States, Revenue Mix ($m), 2018 116

3.3 In Vitro Diagnostics Market, United States, Category Contribution by Revenue ($m), 2018 117

3.4 In Vitro Diagnostics Market, United States, Revenue ($m), 2015-2025 119

3.5 In Vitro Diagnostics Market, United States, Volume (Units), 2015-2025 122

3.6 In Vitro Diagnostics Market, United States, Volume (Units), 2015-2025 124

3.7 In Vitro Diagnostics Market, United States, Company Share by Revenue ($m), 2018 127

4 Cardiac Disease Market, United States 129

4.1 Cardiac Disease Market, United States, Revenue ($m), 2015-2025 129

4.1.1 Cardiac Marker Tests Market, United States, Revenue ($m), by Segment, 2015-2025 131

4.2 Cardiac Disease Market, United States, Volume (Units), 2015-2025 134

4.2.1 Cardiac Marker Tests Market, United States, Volume (Units), by Segment, 2015-2025 136

4.3 Cardiac Disease Market, United States, Average Price ($), 2015-2025 139

4.4 Cardiac Disease Market, United States, Distribution Share by Revenue ($m), 2018 141

4.5 Cardiac Disease Market, United States, Company Share by Revenue ($m), 2018 142

5 Clinical Chemistry Market, United States 144

5.1 Clinical Chemistry Market, United States, Revenue ($m), 2015-2025 144

5.1.1 Substrates Market, United States, Revenue ($m), by Segment, 2015-2025 146

5.2 Clinical Chemistry Market, United States, Volume (Units), 2015-2025 149

5.2.1 Substrates Market, United States, Volume (Units), by Segment, 2015-2025 151

5.3 Clinical Chemistry Market, United States, Average Price ($), 2015-2025 154

5.4 Clinical Chemistry Market, United States, Distribution Share by Revenue ($m), 2018 156

5.5 Clinical Chemistry Market, United States, Company Share by Revenue ($m), 2018 157

6 Hematological Disorders Market, United States 159

6.1 Hematological Disorders Market, United States, Revenue Mix ($m), 2018 159

6.2 Hematological Disorders Market, United States, Segment Contribution (%), 2018 160

6.3 Hematological Disorders Market, United States, Revenue ($m), 2015-2025 161

6.3.1 Hematology Tests Market, United States, Revenue ($m), by Segment, 2015-2025 163

6.3.2 Hemostasis Tests Market, United States, Revenue ($m), by Segment, 2015-2025 166

6.4 Hematological Disorders Market, United States, Volume (Units), 2015-2025 169

6.4.1 Hematology Tests Market, United States, Volume (Units), by Segment, 2015-2025 171

6.4.2 Hemostasis Tests Market, United States, Volume (Units), by Segment, 2015-2025 174

6.5 Hematological Disorders Market, United States, Average Price ($), 2015-2025 177

6.6 Hematological Disorders Market, United States, Distribution Share by Revenue ($m), 2018 181

6.7 Hematological Disorders Market, United States, Company Share by Revenue ($m), 2018 182

7 Hormonal Disorders Market, United States 184

7.1 Hormonal Disorders Market, United States, Revenue ($m), 2015-2025 184

7.1.1 Thyroid Function Tests Market, United States, Revenue ($m), by Segment, 2015-2025 186

7.2 Hormonal Disorders Market, United States, Volume (Units), 2015-2025 189

7.2.1 Thyroid Function Tests Market, United States, Volume (Units), by Segment, 2015-2025 191

7.3 Hormonal Disorders Market, United States, Average Price ($), 2015-2025 194

7.4 Hormonal Disorders Market, United States, Distribution Share by Revenue ($m), 2018 196

7.5 Hormonal Disorders Market, United States, Company Share by Revenue ($m), 2018 197

8 Infectious Disease Market, United States 199

8.1 Infectious Disease Market, United States, Revenue Mix ($m), 2018 199

8.2 Infectious Disease Market, United States, Segment Contribution (%), 2018 200

8.3 Infectious Disease Market, United States, Revenue ($m), 2015-2025 202

8.3.1 Chlamydia Trachomatis Tests Market, United States, Revenue ($m), by Segment, 2015-2025 206

8.3.2 Clostridium difficile Tests Market, United States, Revenue ($m), by Segment, 2015-2025 208

8.3.3 Cytomegalovirus (CMV) Tests Market, United States, Revenue ($m), by Segment, 2015-2025 211

8.3.4 Hepatitis Tests Market, United States, Revenue ($m), by Segment, 2015-2025 214

8.3.5 Human Immunodeficiency Virus (HIV) Tests Market, United States, Revenue ($m), by Segment, 2015-2025 216

8.3.6 Human Papilloma Virus (HPV) Tests Market, United States, Revenue ($m), by Segment, 2015-2025 219

8.3.7 Human T-Lymphotropic Virus (HTLV) Tests Market, United States, Revenue ($m), by Segment, 2015-2025 221

8.3.8 Mycobacterium Tuberculosis Tests Market, United States, Revenue ($m), by Segment, 2015-2025 223

8.3.9 Neisseria Gonorrhoeae Tests Market, United States, Revenue ($m), by Segment, 2015-2025 225

8.3.10 Treponema pallidum Tests Market, United States, Revenue ($m), by Segment, 2015-2025 227

8.4 Infectious Disease Market, United States, Volume (Units), 2015-2025 230

8.4.1 Chlamydia Trachomatis Tests Market, United States, Volume (Units), by Segment, 2015-2025 235

8.4.2 Clostridium difficile Tests Market, United States, Volume (Units), by Segment, 2015-2025 237

8.4.3 Cytomegalovirus (CMV) Tests Market, United States, Volume (Units), by Segment, 2015-2025 240

8.4.4 Hepatitis Tests Market, United States, Volume (Units), by Segment, 2015-2025 243

8.4.5 Human Immunodeficiency Virus (HIV) Tests Market, United States, Volume (Units), by Segment, 2015-2025 245

8.4.6 Human Papilloma Virus (HPV) Tests Market, United States, Volume (Units), by Segment, 2015-2025 248

8.4.7 Human T-Lymphotropic Virus (HTLV) Tests Market, United States, Volume (Units), by Segment, 2015-2025 250

8.4.8 Mycobacterium Tuberculosis Tests Market, United States, Volume (Units), by Segment, 2015-2025 252

8.4.9 Neisseria Gonorrhoeae Tests Market, United States, Volume (Units), by Segment, 2015-2025 254

8.4.10 Treponema pallidum Tests Market, United States, Volume (Units), by Segment, 2015-2025 256

8.5 Infectious Disease Market, United States, Average Price ($), 2015-2025 259

8.6 Infectious Disease Market, United States, Distribution Share by Revenue ($m), 2018 265

8.7 Infectious Disease Market, United States, Company Share by Revenue ($m), 2018 266

9 IVD Analyzers and Reagents Market, United States 268

9.1 IVD Analyzers and Reagents Market, United States, Revenue Mix ($m), 2018 268

9.2 IVD Analyzers and Reagents Market, United States, Segment Contribution (%), 2018 269

9.3 IVD Analyzers and Reagents Market, United States, Revenue ($m), 2015-2025 270

9.3.1 Clinical Chemistry Analyzers Market, United States, Revenue ($m), by Segment, 2015-2025 273

9.3.2 Hematology Analyzers Market, United States, Revenue ($m), by Segment, 2015-2025 275

9.3.3 Immunochemistry Analyzers Market, United States, Revenue ($m), by Segment, 2015-2025 278

9.3.4 Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), by Segment, 2015-2025 281

9.4 IVD Analyzers and Reagents Market, United States, Volume (Units), 2015-2025 284

9.4.1 Clinical Chemistry Analyzers Market, United States, Volume (Units), by Segment, 2015-2025 287

9.4.2 Hematology Analyzers Market, United States, Volume (Units), by Segment, 2015-2025 289

9.4.3 Immunochemistry Analyzers Market, United States, Volume (Units), by Segment, 2015-2025 292

9.4.4 Polymerase Chain Reaction (PCR) Systems Market, United States, Volume (Units), by Segment, 2015-2025 295

9.5 IVD Analyzers and Reagents Market, United States, Average Price ($), 2015-2025 298

9.6 IVD Analyzers and Reagents Market, United States, Distribution Share by Revenue ($m), 2018 302

9.7 IVD Analyzers and Reagents Market, United States, Company Share by Revenue ($m), 2018 303

10 Metabolic Disorder Market, United States 305

10.1 Metabolic Disorder Market, United States, Revenue ($m), 2015-2025 305

10.1.1 Diabetes Assays Market, United States, Revenue ($m), by Segment, 2015-2025 307

10.2 Metabolic Disorder Market, United States, Volume (Units), 2015-2025 310

10.2.1 Diabetes Assays Market, United States, Volume (Units), by Segment, 2015-2025 312

10.3 Metabolic Disorder Market, United States, Average Price ($), 2015-2025 315

10.4 Metabolic Disorder Market, United States, Distribution Share by Revenue ($m), 2018 316

10.5 Metabolic Disorder Market, United States, Company Share by Revenue ($m), 2018 317

11 Oncology Market, United States 319

11.1 Oncology Market, United States, Revenue Mix ($m), 2018 319

11.2 Oncology Market, United States, Segment Contribution (%), 2018 320

11.3 Oncology Market, United States, Revenue ($m), 2015-2025 322

11.3.1 ALK Tests Market, United States, Revenue ($m), by Segment, 2015-2025 325

11.3.2 BRCA Tests Market, United States, Revenue ($m), by Segment, 2015-2025 327

11.3.3 Colorectal Cancer Screening Tests Market, United States, Revenue ($m), by Segment, 2015-2025 329

11.3.4 EGFR Tests Market, United States, Revenue ($m), by Segment, 2015-2025 332

11.3.5 HER2 Amplification Tests Market, United States, Revenue ($m), by Segment, 2015-2025 335

11.3.6 KRAS Tests Market, United States, Revenue ($m), by Segment, 2015-2025 337

11.4 Oncology Market, United States, Volume (Units), 2015-2025 339

11.4.1 ALK Tests Market, United States, Volume (Units), by Segment, 2015-2025 342

11.4.2 BRCA Tests Market, United States, Volume (Units), by Segment, 2015-2025 344

11.4.3 Colorectal Cancer Screening Tests Market, United States, Volume (Units), by Segment, 2015-2025 346

11.4.4 EGFR Tests Market, United States, Volume (Units), by Segment, 2015-2025 349

11.4.5 HER2 Amplification Tests Market, United States, Volume (Units), by Segment, 2015-2025 352

11.4.6 KRAS Tests Market, United States, Volume (Units), by Segment, 2015-2025 354

11.5 Oncology Market, United States, Average Price ($), 2015-2025 356

11.6 Oncology Market, United States, Distribution Share by Revenue ($m), 2018 360

11.7 Oncology Market, United States, Company Share by Revenue ($m), 2018 361

12 Women’s Health Market, United States 363

12.1 Women’s Health Market, United States, Revenue Mix ($m), 2018 363

12.2 Women’s Health Market, United States, Segment Contribution (%), 2018 364

12.3 Women’s Health Market, United States, Revenue ($m), 2015-2025 365

12.3.1 Prenatal Screening Market, United States, Revenue ($m), by Segment, 2015-2025 367

12.3.2 Reproductive Hormones and Proteins Tests Market, United States, Revenue ($m), by Segment, 2015-2025 370

12.4 Women’s Health Market, United States, Volume (Units), 2015-2025 373

12.4.1 Prenatal Screening Market, United States, Volume (Units), by Segment, 2015-2025 375

12.4.2 Reproductive Hormones and Proteins Tests Market, United States, Volume (Units), by Segment, 2015-2025 378

12.5 Women’s Health Market, United States, Average Price ($), 2015-2025 381

12.6 Women’s Health Market, United States, Distribution Share by Revenue ($m), 2018 385

12.7 Women’s Health Market, United States, Company Share by Revenue ($m), 2018 386

13 Overview of Key Companies in United States, In Vitro Diagnostics Market 388

13.1 F. Hoffmann-La Roche Ltd 388

13.1.1 Company Overview 388

13.2 Abbott Laboratories 388

13.2.1 Company Overview 388

13.3 Siemens Healthineers AG 388

13.3.1 Company Overview 388

13.4 Exact Sciences Corp 389

13.4.1 Company Overview 389

13.5 Danaher Corp 389

13.5.1 Company Overview 389

13.6 Ortho-Clinical Diagnostics Inc 389

13.6.1 Company Overview 389

13.7 Beckman Coulter Inc 390

13.7.1 Company Overview 390

13.8 Sysmex Corp 390

13.8.1 Company Overview 390

13.9 Bio-Rad Laboratories Inc 390

13.9.1 Company Overview 390

13.1 Merck KGaA 391

13.10.1 Company Overview 391

13.11 Hologic Inc 391

13.11.1 Company Overview 391

13.12 Quidel Corp 391

13.12.1 Company Overview 391

13.13 Thermo Fisher Scientific Inc 392

13.13.1 Company Overview 392

13.14 Qiagen NV 392

13.14.1 Company Overview 392

14 In Vitro Diagnostics Market Pipeline Products 393

15 Financial Deals Landscape 398

15.1 Acquisition 398

15.1.1 Oncology Venture Acquires Oncology Venture US (2X Oncology) 398

15.1.2 Smiths Detection to Acquire PathSensors 400

15.1.3 Healthy.io Acquires Inui Health 401

15.1.4 Invitae to Acquire ArcherDX 402

15.1.5 Foundation Medicine Acquires Lexent Bio 404

15.1.6 MEDNAX Plans to Sell MEDNAX Radiology Solutions 405

15.1.7 Predictive Oncology Acquires BioDtech 406

15.1.8 OraSure Technologies to Acquire UrSure for up to USD31 Million 408

15.1.9 Premier and 15 Health Systems Acquires Minority Stake in Prestige Ameritech 410

15.1.10 Moncef Slaoui to Divest Stake in Moderna for USD12.4 Million 414

15.1.11 OncBioMune Pharma Acquires Avant Diagnostics 415

15.1.12 Bio-Rad Labs Acquires Celsee 417

15.1.13 Daniel Alain Acquires Stake in Applied Biology 418

15.1.14 Maravai Life Sciences Acquires MockV Solutions 419

15.1.15 Document Security Systems to Acquire Impact Biomedical from Global BioMedical 420

15.1.16 Invitae to Acquire Genelex 422

15.1.17 Abcam Acquires Marker Gene Technologies 424

15.1.18 Nexelis to Acquire ImmunXperts 425

15.1.19 Genovis Acquires QED Bioscience for USD2 Million 426

15.1.20 Exact Sciences Acquires Paradigm Diagnostics and Viomics 428

15.1.21 Conatus Pharma Acquires Histogen 430

15.1.22 Alpha Holdings Revises offer to Acquire OncoSec Medical 432

15.1.23 BioNTech Acquires Neon Therapeutics 433

15.1.24 OncoCyte Acquires Insight Genetics 435

15.1.25 Todos Medical Enters into Option Agreement to Acquire Provista Diagnostics 437

15.1.26 Axim Biotechnologies Acquires Sapphire Biotech 438

15.1.27 Illumina Terminates Acquisition of Pacific Biosciences of California 439

15.1.28 Becton Dickinson Acquires NAT Diagnostics 441

15.1.29 KNOW Bio Acquires Clinical Sensors 442

15.1.30 Charles River Labs Acquires HemaCare 443

15.1.31 Oncology Pharma Plans to Acquire Minority Stakes in Diagnomics and Eone Diagnomics Genome 445

15.1.32 Canopy Biosciences Acquires Core Diagnostics 446

15.1.33 Dare Bioscience Acquires Microchips Biotech 447

15.1.34 Accumen Acquires 3DR Laboratories 449

15.1.35 China Grand Pharma and Sirtex Medical Acquire

52.8% Stake in OncoSec Medical for USD30 Million 450

15.1.36 OncoCyte Acquires Razor Genomics 452

15.1.37 Bio-Rad Lab Acquires Exact Diagnostics 454

15.1.38 Amgen May Acquire Alexion Pharma 455

15.1.39 BioIVT Acquires Keystone Biologicals 456

15.1.40 Exact Sciences Acquires Genomic Health for USD2.8 Billion 457

15.2 Asset Transactions 459

15.2.1 P4 Diagnostix Acquires Assets of Strand Diagnostics 459

15.2.2 Ligand Pharma Acquires Core Assets from Icagen 460

15.2.3 Abcam Acquires Gene Editing Platform and Oncology Product Portfolio of Applied StemCell 462

15.2.4 Haemonetics Acquires TEG 6s Hemostasis Analyzer System from CoraMed Technologies 464

15.2.5 Gold Standard Diagnostics Acquires Assets from Diamedix for USD2.2 Million 465

15.2.6 Psomagen Acquires Microbiome Patents and Data from uBiome for USD7 Million 467

15.2.7 Phenomics Health Acquires Pharmacometabolomic Technology from Precera Bioscience 469

15.2.8 Envigo RMS Acquires In Vivo Business Unit from Horizon Discovery 470

15.2.9 Edan Diagnostics to Acquire ClariLight Molecular Diagnostic Platform from LGC 472

15.2.10 Cleveland HeartLab Acquires Certain Assets from True Health Diagnostics for USD8.5 Million 473

15.2.11 LineaRx Acquires Assets and Intellectual Property of Vitatex 474

15.2.12 LabCorp Acquires Diagnostic Clinical Laboratory Assets from South Bend Medical Foundation 476

15.3 Debt Offerings 478

15.3.1 Abbott Laboratories Raises USD650 Million in Public Offering of

1.4% Notes Due 2030 478

15.3.2 Abbott Laboratories Raises USD650 Million in Public Offering of

1.15% Notes Due 2028 480

15.3.3 Merck Raises USD1 Billion in Public Offering of

0.750% Notes Due 2026 482

15.3.4 Merck Raises USD1.25 Billion in Public Offering of

1.450% Notes Due 2030 484

15.3.5 Merck Raise USD1 Billion in Public Offering of

2.350% Notes Due 2040 486

15.3.6 Merck Raises USD1.25 Billion in Public Offering of

2.450% Notes Due 2050 488

15.3.7 Agilent Technologies Prices Public Offering of

2.1% Notes Due 2030 for USD500 Million 490

15.3.8 ProLung Raises USD3 Million in Private Placement of Notes 492

15.3.9 BioMarin Pharma Raises USD600 Million in Private Placement of

1.25% Notes Due 2027 493

15.3.10 Quest Diagnostics Prices Public Offering of

2.800% Notes Due 2031 for USD550 Million 495

15.3.11 Becton Dickinson Raises USD750 Million in Public Offering of

2.823% Notes Due 2030 497

15.3.12 Becton Dickinson Raises USD750 Million in Public Offering of

3.794% Notes Due 2050 499

15.3.13 Luminex Prices Private Placement of

3.00% Notes Due 2025 for USD260 Million 501

15.3.14 Amgen Raises USD1 Billion in Public Offering of

2.2% Notes Due 2027 503

15.3.15 Amgen Raises USD1.2 Billion in Public Offering of

2.3% Notes Due 2031 505

15.3.16 Amgen Raises USD1 Billion in Public Offering of

3.375% Notes Due 2050 507

15.3.17 Amgen Raises USD750 Million in Public Offering of

3.15% Notes Due 2040 509

15.3.18 NeoGenomics Prices Public Offering of

1.25% Convertible Senior Notes Due 2025 for USD175 Million 511

15.3.19 Eli Lilly Raises USD1.08 Billion in Public Offering of

2.25% Notes Due 2050 513

15.3.20 Natera Prices Private Placement of

2.25% Notes Due 2027 for USD250 Million 515

15.3.21 Danaher Raises USD163.4 Million in Public Offering of

1.7% Senior Notes Due 2024 517

15.3.22 Danaher Raises USD327 Million in Public Offering of

2.1% Senior Notes Due 2026 519

15.3.23 Danaher Raises USD327 Million in Public Offering of

2.5% Senior Notes Due 2030 521

15.3.24 CytoDyn Raises USD15 Million in Private Placement of 10% Notes Due 2022 523

15.3.25 Thermo Fisher Scientific Raises USD668 Million in Public Offering of

2.375% Notes Due 2032 524

15.3.26 Thermo Fisher Scientific Raises USD668 Million in Public Offering of

1.750% Notes Due 2027 526

15.3.27 Baxter International Raises USD500 Million in Private Placement of

3.95% Senior Notes Due 2030 528

15.3.28 Baxter International Raises USD750 Million in Private Placement of

3.75% Senior Notes Due 2025 529

15.3.29 Danaher Raises USD810.2 Million in Public Offering of

1.700% Senior Notes Due 2024 530

15.3.30 Danaher Raises USD540 Million in Public Offering of

2.100% Senior Notes Due 2026 532

15.3.31 Danaher Raises USD540 Million in Public Offering of

2.500% Senior Notes Due 2030 534

15.3.32 Pfizer Raises USD1.25 Billion in Public Offering of

2.625% Notes Due 2030 536

15.3.33 Thermo Fisher Scientific Raises USD1.1 Billion in Public Offering of

4.133% Notes Due 2025 538

15.3.34 Thermo Fisher Scientific Raises USD1.1 Billion in Public Offering of

4.497% Notes Due 2030 541

15.3.35 NanoString Technologies Prices Private Placement of

2.625% Notes Due 2025 for USD200 Million 544

15.3.36 Exact Sciences Prices Public Offering of

0.3750% Notes Due 2028 for USD1 Billion 546

15.3.37 Amgen Raises USD1.25 Billion in Offering of

3.150% Senior Unsecured Notes Due 2040 548

15.3.38 Amgen Raises USD1.25 Billion in Debt Offering of

3.375% Senior Unsecured Notes Due 2050 550

15.3.39 Amgen Raises USD750 Million in Debt Offering of

2.200% Senior Unsecured Notes Due 2027 552

15.3.40 Amgen Raises USD1.25 Billion in Debt Offering of

2.450% Senior Unsecured Notes Due 2030 554

15.3.41 Amgen Raises USD500 Million in Debt Offering of

1.900% Senior Unsecured Notes Due 2025 556

15.3.42 Promis Diagnostics Raises USD10.8 Million in Private Placement of Convertible Notes 558

15.3.43 Verastem Raises USD0.8 Million in Debt Financing 559

15.3.44 Bruker Raises USD301.6 Million in Private Placement of Senior Notes 560

15.3.45 Quest Diagnostics Prices Public Offering of

2.95% Notes Due 2030 for USD800 Million 561

15.3.46 Fluidigm to Raise USD45 Million in Private Placement of Notes Due 2024 563

15.3.47 LabCorp Raises USD400 Million in Public Offering of

2.3% Notes Due 2024 565

15.3.48 LabCorp Raises USD650 Million in Public Offering of

2.95% Notes Due 2029 568

15.3.49 Halozyme Therapeutics Raises USD460 Million in Public Offering of

1.25% Convertible Senior Notes Due 2024 571

15.3.50 AbbVie Raises USD750 Million in Private Placement of Floating Rate Notes Due 2021 573

15.3.51 AbbVie Raises USD750 Million in Private Placement of Floating Rate Notes Due 2022 574

15.3.52 AbbVie Raises USD1.75 Billion in Private Placement of

2.150% Notes Due 2021 575

15.3.53 AbbVie Raises USD3 Billion in Private Placement of

2.300% Notes Due 2022 576

15.3.54 AbbVie Raises USD3.75 Billion in Private Placement of

2.600% Notes Due 2024 577

15.3.55 AbbVie Raises USD4 Billion in Private Placement of

2.95% Notes Due 2026 578

15.3.56 AbbVie Raises USD5.5 Billion in Private Placement of

3.2% Notes Due 2029 580

15.3.57 AbbVie Raises USD4 Billion in Private Placement of

4.050% Notes Due 2039 581

15.3.58 AbbVie Raises USD5.75 Billion in Private Placement of

4.250% Notes Due 2049 582

15.3.59 AbbVie Raises USD750 Million in Private Placement of Senior Floating Rate Notes Due 2021 583

15.3.60 Danaher Raises USD700 Million in Public Offering of

2.05% Senior Notes Due 2022 584

15.3.61 Danaher Raises USD700 Million in Public Offering of

2.2% Senior Notes Due 2024 586

15.3.62 Danaher Raises USD900 Million in Public Offering of

3.25% Senior Notes Due 2039 588

15.3.63 Danaher Raises USD900 Million in Public Offering of

3.4% Senior Notes Due 2049 590

15.3.64 Eli Lilly Prices Public Offering of

0.625% Notes Due 2031 for USD665.5 Million 592

15.3.65 Eli Lilly Prices Public Offering of

1.7% Notes Due 2049 for USD1.1 Billion 594

15.3.66 Danaher Raises USD800 Million in Public Offering of

2.6% Senior Notes Due 2029 596

15.3.67 Charles River Labs Raises USD500 Million in Private Placement of

4.25% Notes Due 2028 598

15.3.68 Thermo Fisher Scientific Raises USD990 Million in Public Offering of

1.500% Notes Due 2039 600

15.3.69 Thermo Fisher Scientific Raises USD900 Million in Public Offering of

2.600% Notes Due 2029 603

15.3.70 Thermo Fisher Scientific Raises USD1.1 Billion in Public Offering of

1.875% Notes Due 2049 606

15.3.71 Thermo Fisher Scientific Raises USD880 Million in Public Offering of

0.500% Notes Due 2028 609

15.3.72 Thermo Fisher Scientific Raises USD990 Million in Public Offering of

0.875% Notes Due 2031 612

15.3.73 Thermo Fisher Scientific Raises USD880 Million in Public Offering of

0.125% Notes Due 2025 615

15.3.74 AbbVie Raises USD719.6 Million in Public Offering of

1.25% Notes Due 2031 618

15.3.75 AbbVie Raises USD830.3 Million in Public Offering of

0.75% Notes Due 2027 620

15.3.76 PerkinElmer Raises USD850 Million in Public Offering of

3.3% Notes Due 2029 622

15.3.77 Agilent Technologies Raises USD500 Million in Public Offering of

2.75% Senior Notes Due 2029 624

15.3.78 Invitae to Raise USD200 Million in Private Placement of Notes Due 2024 626

15.3.79 Danaher Raises USD1.37 Billion in Public Offering of

1.35% Notes Due 2039 627

15.3.80 Danaher Raises USD1.92 Billion in Public Offering of

0.75% Notes Due 2031 629

15.3.81 Danaher Raises USD823 Million in Public Offering of

1.8% Notes Due 2049 631

15.3.82 Danaher Raises USD1.37 Billion in Public Offering of

0.2% Notes Due 2026 633

15.3.83 Danaher Raises USD1.37 Billion in Public Offering of

0.45% Notes Due 2028 635

15.3.84 Clovis Oncology Raises USD250 Million in Private Placement of

4.50% Notes Due 2024 637

15.3.85 Mateon Therapeutics Raises USD0.2 Million in Private Placement of 8% Note 639

15.4 Equity Offerings 640

15.4.1 Daxor Prices Private Placement of Shares and Warrants for USD7 Million 640

15.4.2 SINTX Technologies Prices Private Placement of Shares for USD3 Million 642

15.4.3 Adaptive Biotechnologies Prices Public Offering of Shares for USD320 Million 643

15.4.4 ARCA biopharma to Raise up to USD7.3 Million in Public Offering of Shares 645

15.4.5 Bio-Path Holdings to Raise USD7 Million in Public Offering of Common Stock 646

15.4.6 Vaxart Files Registration Statement for Public Offering of Securities 647

15.4.7 Personalis Files Registration Statement for Public Offering of Securities for up to USD250 Million 648

15.4.8 Aeterna Zentaris Raises USD12 Million in Public Offering of Units 649

15.4.9 Aspira Womens Health to Raise USD11 Million in Private Placement of Shares 651

15.4.10 Cancer Genetics Files Registration Statement for Public Offering of Securities for up to USD100 Million 652

15.4.11 SINTX Technologies to Raise USD41.3 Million in Public offering of Shares 653

15.4.12 SINTX Technologies Prices Private Placement of Shares for USD5.6 Million 655

15.4.13 Castle Biosciences Raises USD85.1 Million in Public Offering of Shares 656

15.4.14 Akouos Raises USD244.4 Million in IPO of Shares 658

15.4.15 Progenity Prices IPO of Shares for USD100 Million 660

15.4.16 Constellation Pharma Prices Public Offering of Shares for USD192.5 Million 662

15.4.17 Celldex Therapeutics Raises USD150 Million in Public Offering of Shares 664

15.4.18 Medibio to Raise USD0.3 Million in Private Placement of Shares 666

15.4.19 Medibio Raises USD0.4 Million in Rights Offering of Shares 667

15.4.20 CareDx Raises USD143.8 Million in Public Offering of Shares 669

15.4.21 ArcherDX Files Registration Statement for IPO of Shares for up to USD100 Million 671

15.4.22 Celcuity to Raise up to USD10 Million in Public Offering of Shares 673

15.4.23 Twist Bioscience Raises USD115 Million in Public Offering of Shares 675

15.4.24 Aileron Therapeutics Raises USD11.2 Million in Public Offering of Shares 677

15.4.25 ARCA biopharma Raises USD6.1 Million in Private Placement of Shares and Warrants 679

15.4.26 Guardant Health Raises USD362.3 Million in Public Offering of Shares 681

15.4.27 Cleveland BioLabs Raises USD3.2 Million in Private Placement of Shares 683

15.4.28 SurModics Plans to Raise up to USD200 Millon in Public Offering of Securities 685

15.4.29 Geron Raises USD150 Million in Public Offering of Shares and Warrants 686

15.4.30 Cardiff Oncology Raises USD0.8 Million in Private Placement of Shares 688

15.4.31 Becton Dickinson Raises USD1.5 Public Offering of Shares 689

15.4.32 Becton Dickinson Raises USD1.5 Billion in Public Offering of Depositary Shares 692

15.4.33 ThermoGenesis to Raise USD15 Million in Public Offering of Common Stock 695

15.4.34 Turning Point Therapeutics Announces Full Exercise of Underwriters’ Option to Purchase Shares for USD373.8 Million 697

15.4.35 Clovis Oncology Prices Public Offering of Shares for USD89.3 Million 699

15.4.36 Moderna Prices USD1.34 Billion in Public Offering of Shares 701

15.4.37 Akers Biosciences Raises USD4.8 Million in Private Placement of Shares 703

15.4.38 Danaher Raises USD1.55 Billion in Public Offering of Shares 704

15.4.39 Danaher Raises USD1.71 Billion in Public Offering of Series B Convertible Preferred Stock 706

15.4.40 Aspirar Medical Lab Raises Funds through Equity Financing 708

15.4.41 GenMark Diagnostics Raises USD80.5 Million in Public Offering of Shares 709

15.4.42 Kura Oncology Raises USD143.9 Million in Public Offering of Shares 711

15.4.43 Insmed Raises USD259.4 Million in Public Offering of Shares 713

15.4.44 Lineage Cell Therapeutics Files Registered Statement for Public Offering of Securities up to USD75 Million 715

15.4.45 Lineage Cell Therapeutics Files Registered Statement for Public Offering of Securities up to USD25 Million 717

15.4.46 VistaGen Therapeutics to Raise up to USD5.75 Million in Public Offering of Shares 719

15.4.47 NeoGenomics Prices Public Offering of Shares for USD125.4 Million 721

15.4.48 Syndax Pharma Raises USD115 Million in Public Offering of Shares 723

15.4.49 Immunomedics Raises USD483 Million in Public Offering of Shares 725

15.4.50 Biocept Files Registered Statement for Public Offering of Securities up to USD100 Million 727

15.4.51 Heat Biologics Plans to Raise up to USD150 Million in Public Offering of Securities 728

15.4.52 Heat Biologics to Raise up to USD50 Million in Public Offering of Shares 729

15.4.53 H-CYTE Raises USD2.9 Million in Equity Financing 731

15.4.54 Biocept Prices Private Placement of Shares for USD10.3 Million 732

15.4.55 ProtoKinetix Raises USD0.07 Million in Private Placement of Shares 733

15.4.56 ProtoKinetix Raises Additional USD0.13 Million in Private Placement of Shares 734

15.4.57 Entasis Therapeutics Raises USD3.3 Million in Private Placement 735

15.4.58 Dascena Raises Funds through Private Placement 737

15.4.59 Akers Biosciences Prices Private Placement of Shares for USD4.6 Million 738

15.4.60 Invitae Raises USD184 Million in Public Offering of Shares 739

15.4.61 Trovagene Raises USD2 Million in Equity Offering 741

15.4.62 Celldex Therapeutics Files Registration Statement for Public Offering of Shares up to USD18 Million 742

15.4.63 Precipio Files Registration Statement for Public Offering of Securities up to USD50 Million 743

15.4.64 Cassava Sciences Files Registration Statement for Public Offering of Shares up to USD100 Million 745

15.4.65 miRagen Therapeutics Files Registration Statement for Public Offering of Securities up to USD175 Million 747

15.4.66 miRagen Therapeutics Files Registration Statement for Public Offering of Securities up to USD14.9 Million 748

15.4.67 miRagen Therapeutics Files Registration Statement for Public Offering of Securities up to USD37.9 Million 750

15.4.68 Novus Therapeutics Plans to Raise up to USD2.3 Million in Public Offering of Shares 752

15.4.69 ThermoGenesis Holdings Raises USD3.5 Million in Registered Direct Offering 753

15.4.70 Verastem Plans to Raise up to USD78.6 Million in Public Offeirng of Shares 754

15.4.71 Akers Biosciences Raises USD1.2 Million in Equity Offering 755

15.4.72 OncoCyte to Raise upto USD25 Million in Public Offering of Shares 756

15.4.73 Biomerica Plans to Raise USD12.5 Million in Public Offering of Shares 758

15.4.74 Aethlon Medical Plans to Raise up to USD25 Million in Public Offering of Securities 760

15.4.75 Aethlon Medical to Raise up to USD7.5 Million in Public Offering of Shares 761

15.4.76 OpGen to Raise up to USD15.7 Million in Private Placement of Common Stock 763

15.4.77 CytoDyn Raises USD0.9 Million in Equity Offering 765

15.4.78 Bionano Genomics to Raise USD30 Million in Public Offering of Shares 766

15.4.79 Bionano Genomics Plans to Raise up to USD0.9 Million in Public Offering of Shares 768

15.4.80 AIM ImmunoTech to Raise USD18 Million in Public Offering of Common Stock 769

15.4.81 Seres Therapeutics Files Registration Statement for Public Offering of Securities for up to USD125 Million 771

15.4.82 Corvus Pharma Files Prospectus for Public Offering of Securities for up to USD200 Million 772

15.4.83 Corvus Pharma Plans to Raise up to USD50 Million in Public Offering of Shares 773

15.4.84 T2 Biosystems Plans to Raise up to USD95 Million in Public Offering of Shares 774

15.4.85 Titan Pharma Raises USD5.9 Million in Private Placement of Shares upon Exercise of Warrants 776

15.4.86 Biocept Prices Private Placement of Shares for USD6.6 Million 777

15.4.87 Fluidigm to Raise USD50 Million in Public Offering of Shares 778

15.4.88 Daxor Raises USD2 Million in Private Placement of Shares 780

15.4.89 AIM ImmunoTech Raises USD10.4 Million in Public Offering of Common Stock 781

15.4.90 DermTech to Raise USD65 Million in Private Placement of Shares 783

15.4.91 Biocept Prices Registered Direct Offering of Shares for USD9.2 Million 785

15.4.92 Vaxart Prices Private Placement of Shares and Warrants for USD10 Million 787

15.4.93 Tracon Pharma Plans Public Offering of Shares for up to USD2 Million 788

15.4.94 iBio Files Registration Statement for Public Offering of Securities for up to USD100 Million 790

15.4.95 ARCA biopharma Files Registration Statement for Public Offering of Securities for up to USD15 Million 791

15.4.96 Aeterna Zentaris Raises USD4.5 Million in Private Placement of Shares and Warrants 793

15.4.97 Blueprint Medicines Plans to Raise Funds through Public Offering of Securities 795

15.4.98 Deciphera Pharma Raises USD175 Million in Public Offering of Shares 796

15.4.99 DiaMedica Therapeutics Raises USD8.5 Million in Public Offering of Shares 798

15.4.100 Atossa Therapeutics to Raise up to USD5 Million in Public Offering of Shares 800

15.4.101 miRagen Therapeutics Prices Public Offering of Shares and Warrants for USD15 Million 801

15.4.102 CytoDyn Plans to Raise up to USD18 Million in Public Offering of Shares 803

15.4.103 CytoDyn Raises USD7.57 Million in Equity Offering 804

15.4.104 Trovagene Raises USD1.5 Million in Private Placement upon Exercise of Warrants 805

15.4.105 Synedgen Raises USD2.6 Million in Financing 806

15.4.106 VistaGen Therapeutics to Raise USD2.8 Million in Private Placement of Shares and Warrants 807

15.4.107 Adaptive Biotech Prices Public Offering of Common Stock for USD212 Million 808

15.4.108 Sintx Technologies to Raise USD8.8 million in Rights Offering 810

15.4.109 Regulus Therapeutics Files Registration Statement for Public Offering of Securities for up to USD82.2 Million 812

15.4.110 Blueprint Medicines Prices USD324 Million Public Offering of Common Stock 814

15.4.111 ImmunoGen Raises USD104.2 Million in Public Offering of Shares 816

15.4.112 SI-Bone Prices USD92.45 Million Public Offeirng of Shares 818

15.4.113 Aethlon Medical Raises USD3.8 Million in Private Placement of Shares and Warrants 820

15.4.114 Precipio Plans to Raise up to USD1.7 Million in Public Offering of Shares 822

15.4.115 Titan Pharma Prices Private Placement of Shares and Warrants for USD2.2 Million 823

15.4.116 OncoCyte Prices Private Placement of Shares for USD5 Million 824

15.4.117 ProtoKinetix Raises Additional USD0.05 Million in Private Placement of Units 825

15.4.118 ProtoKinetix Raises Additional USD0.12 Million in Private Placement of Units 826

15.4.119 Clovis Oncology Files Prospectus for Public Offering of Securities for up to USD250 Million 827

15.4.120 ThermoGenesis Files Registration Statement for Public Offering of Shares for up to USD30 Million 829

15.4.121 CytoDyn Raises USD0.7 Million in Private Placement of Shares 830

15.4.122 Constellation Pharma Raises USD257.9 Million in Public Offering of Shares 832

15.4.123 Celldex Therapeutics Files Registration Statement for Public Offering of Securities for USD150 Million 834

15.4.124 Immunomedics Raises USD287.5 Million in Public Offering of Shares 835

15.4.125 Akers Biosciences to Raise Funds through Public Offering of Units 837

15.4.126 Seres Therapeutics Plans to Raise up to USD25 Million in Public Offering of Shares 838

15.4.127 Molecular Templates Prices USD50 Million Public Offering of Shares and Series A Convertible Preferred Stock 839

15.4.128 Bio-Path Holdings Raises USD8 Million in Registered Direct Offering of Shares and Warrants 841

15.4.129 Molecular Templates Raises USD15 Million in Private Placement 842

15.4.130 H-CYTE Raises USD6 Million in Private Placement of Preferred Shares 843

15.4.131 HTG Molecular Diagnostics to Raise up to USD20 Million in Public Offering of Shares 844

15.4.132 SI-Bone Plans to Raise up to USD200 Million in Public Offering of Securities 846

15.4.133 Fulgent Genetics Prices Public Offering of Shares for USD26.2 Million 847

15.4.134 Agios Pharma Raises USD294.09 Million in Public Offering of Shares 849

15.4.135 PAVmed to Raise USD14 Million in Private Placement 851

15.4.136 Akers Biosciences Raises USD8 Million in Public Offering of Shares 852

15.4.137 Biocept Raises USD10 Million Public Offering of Common Stock 854

15.4.138 Miragen Therapeutics Raises Additional USD0.5 Million in Private Placement of Shares 856

15.4.139 VistaGen Therapeutics Raises USD0.7 Million in Financing 857

15.4.140 Trovagene Raises USD5 Million in Private Placement of Shares and Warrants 858

15.4.141 iBio Prices Public Offering of Shares for USD5 Million 860

15.4.142 OPKO Health Raises USD75 Million in Public Offering of Shares 862

15.4.143 ProtoKinetix Raises USD0.1 Million in Private Placement of Securities 864

15.4.144 Natera Prices Public Offering of Shares for USD200 Million 865

15.4.145 OpGen Raises USD9.4 Million in Public Offering of Units 867

15.4.146 HTG Molecular Diagnostics Plans to Raise up to USD4.5 Million in Public Offering of Shares 869

15.4.147 Titan Pharma Raises USD9.06 Million in Public Offering of Units 871

15.4.148 Nabsys Raises USD21 Million in Equity Financing 873

15.4.149 Entasis Therapeutics to Raise up to USD20 Million in Public Offering of Shares 874

15.4.150 Constellation Pharma to Raise USD65 Million in Private Placement of Shares 875

15.4.151 Vaxart Prices Public Offering of Shares and Warrants for USD8 Million 877

15.4.152 AIM ImmunoTech Prices Public Offering of Shares for USD8 Million 879

15.4.153 LexaGene Holdings Raises USD5 Million in Public Offering of Units 881

15.4.154 EDP Biotech Raises USD5 Million in Equity Financing 883

15.4.155 Aeterna Zentaris Raises USD5 Million in Registered Direct Offering of Shares 884

15.4.156 Interpace Diagnostics Plans to Raise up to USD4.8 Million in Public Offering of Shares 886

15.4.157 HTG Molecular Diagnostics Raises USD3.5 Million in Private Placement of Shares Upon Exercise of Warrants 888

15.4.158 Bionano Genomics Raises USD18 Million in Public Offering of Shares and Warrants 889

15.4.159 HTG Molecular Diagnostics Raises USD19 Million in Public Offering of Shares 891

15.4.160 Catalyst Pharma to Raise Funds through Public Offering of Shares 893

15.4.161 OncoCyte Prices Private Placement of Shares for USD6.6 Million 895

15.4.162 Syndax Pharma to Raise USD50 Million in Public Offering of Shares 896

15.4.163 Turning Point Therapeutics Prices Public Offering of Shares for USD202.5 Million 897

15.4.164 PRA Health Sciences Raises USD650 Million in Public Offering of Shares 899

15.4.165 Aridis Pharma Plans to Raise up to USD100 Million in Public Offering of Securities 901

15.4.166 Aridis Pharma Decreases Size of Public Offering of Shares to Raise up to USD22 Million 903

15.4.167 CytoDyn Files Registration Statement for Public Offering of Shares for up to USD7.5 Million 905

15.4.168 CytoDyn Raises USD2.3 Million in Private Placement of Shares and Warrants 906

15.4.169 Exagen (Exagen Diagnostics) Raises USD57.96 Million in Initial Public Offering 908

15.4.170 OncoSec Medical Plans to Raise up to USD50 Million in Public Offering of Securities 910

15.4.171 Trovagene Raises USD1.5 Million in Financing 911

15.4.172 Accelerate Diagnostics Raises USD1 Million in Financing 912

15.4.173 Quanterix Raises USD60 Million in Public Offering of Shares 913

15.4.174 Titan Pharma Prices USD2.1 Million in Offering of Common Stock 915

15.4.175 GenMark Diagnostics to Raise up to USD35 Million in Public Offering of Shares 916

15.4.176 Constellation Pharma Plans to Raise up to USD200 Million in Public Offering of Securities 917

15.4.177 Constellation Pharma Plans to Raise up to USD50 Million in Public Offering of Shares 919

15.4.178 Sera Prognostics Raises USD25.77 Million in Equity Offering 921

15.4.179 T2 Biosystems to Raise up to USD30 Million in Public offering of Shares 922

15.4.180 OncoGenesis to Raise USD5.5 Million in Private Placement of Preferred Shares 923

15.4.181 Castle Biosciences Raises USD73.6 Million in IPO of Shares 924

15.4.182 Seattle Genetics Raises USD575 Million in Public Offering of Shares 926

15.5 Grants 928

15.5.1 A Dried Blood Spot Companion Diagnostic to Measure Neuroendocrine Changes in ADHD. 928

15.5.2 Analytical validation of a biochemical test for alpha-synuclein aggregates in biological fluids for the diagnosis of Parkinson’s Disease 929

15.5.3 Development of Immune Mediator Based Blood Tests that Inform Concurrent and Future Clinical Disease Activity in Systemic Lupus Erythematosus (SLE) 930

15.5.4 Low-Cost Instrument-free Point-of-Care Test for Chlamydia and Gonorrhea 931

15.5.5 Rapid and Simple Paper Strip Test for the Multiplexed Detection of Gastrointestinal Pathogens at the Point-of-Need 932

15.5.6 Low Cost, Rapid Molecular Diagnostic for Chlamydia and Gonorrhea at the Point-of-Care 933

15.5.7 Development of a Highly Sensitive Quantitative Rapid Digital LSPR Diagnostic for Acute Dengue and Zika Virus Infection 934

15.5.8 Diagnostics via Rapid Enrichment, Identification, and Phenotypic Antibiotic Susceptibility Testing of Pathogens from Blood. 935

15.5.9 Digital Microfluidics – Minimizing Blood Volume for Pediatric Coagulation Screening 936

15.5.10 A Molecular Diagnostic Assay for Accurately Differentiating Melanoma from Benign Lesions 937

15.5.11 Dual Electron-Based Fragmentation with Ion Mobility to Advance Native Top-Down Proteomics 938

15.5.12 Immunoassay for early diagnosis of mucormycosis 939

15.5.13 Nanostructured Magnetic Disks for Wide Range Size Selection in NGS Library Preparation and PCR Purification 940

15.5.14 An Innovative Unbound Bilirubin Assay to Identify Bilirubin-Induced Neurological Dysfunction (BIND) Risk as Part of a Comprehensive and Novel Point-of-Care Newborn Screening Panel 941

15.5.15 Long non-coding RNA signatures to track treatment responses in multiple sclerosis 942

15.5.16 Sensitive and Portable Physician Office-Based Urine Analyzer to Tackle Prescription Drug Abuse 943

15.5.17 Reducing the incidence of febrile neutropenia in cancer patients treated with chemotherapy with PointCheck: a portable non-invasive neutropenia analyzer 944

15.5.18 Development of Molecular Diagnostic Test for Early Onset of Lyme disease 945

15.5.19 Hybrid ELISA: Simple and specific one-tier assay for Lyme disease 946

15.5.20 Bloodstream infection detection directly on whole blood 947

15.5.21 Multiplex nucleosome-based profiling for the development of next-generation chromatin labeling reagents 948

15.5.22 Multiplex nucleosome-based profiling for the development of next-generation chromatin labeling reagents 949

15.5.23 Saliva biomarkers for noninvasive diagnostics of acute mTBI in children 950

15.5.24 Sinu-Test, A Multiplexed Device for Rapid Diagnosis of Acute Bacterial Sinusitis 951

15.5.25 Super-sensitive detection of universal markers of allograft rejection 952

15.5.26 Rapid Point-of-Care Assay for Diagnosis of Neurocysticercosis in Seizure Patients 953

15.5.27 Feasibility and validation of an integrated newborn screening algorithm with targeted Next Generation Sequencing (tNGS) technology as part of a 2nd-tier test for Pompe and MPS I 954

15.5.28 Feasibility and validation of an integrated newborn screening algorithm with targeted Next Generation Sequencing (tNGS) technology as part of a 2nd-tier test for Pompe and MPS I 955

15.5.29 Development of a Universal Assay for Minimal Residual Disease in Acute Myeloid Leukemia using Duplex Sequencing 956

15.5.30 Rapid and Simple Paper Strip Test for the Multiplexed Detection of Gastrointestinal Pathogens at the Point-of-Need 957

15.5.31 Near Patient Acute Kidney Injury Biomarker Analysis in Critically Ill Neonates 958

15.5.32 Multiplexed Bioassay for Checkpoint Inhibitor Autoimmunity 959

15.5.33 Smokescreen Translational (TL) Analysis Platform 960

15.5.34 GMP Production of a Tau Oligomer Inhibitor to Enable Clinical Development for ADRD 961

15.5.35 Noninvasive biomarkers for gastrointestinal disease in preterm infants 962

15.5.36 Molecular Biomarkers of Dangerous Intracranial Aneurysms 963

15.5.37 A Low Blood Volume Platform for Global Newborn Screening of Common, Treatable Conditions 964

15.5.38 A Rapid HIV RNA Detection without Sample Preparation 965

15.5.39 Rapid, Point-of-Care Nucleic Acid Test for HCV 966

15.5.40 An automated test for gestational diabetes based on glycated CD59 967

15.5.41 Early Detection of Ovarian Cancer Using Uterine Lavage and Duplex Sequencing 968

15.5.42 Smokescreen Translational (TL) Analysis Platform 969

15.5.43 Development of a urine test for the early detection of liver cancer 970

15.5.44 Improved detection of bladder cancer recurrence using a biophysical biomarker 971

15.5.45 A Point of Care Test to Monitor and Improve Adherence to Dolutegravir for HIV Treatment 972

15.5.46 Validation of a salivary miRNA diagnostic test for autism spectrum disorder 973

15.5.47 Development of a JBS HI-LO Urine DNA Kit 974

15.5.48 Project isoPTE: isothermic post-traumatic epilepsy miRNA biomarker detection 975

15.5.49 Cytology-Free POC Cervical Cancer Diagnostics for Global Health 976

15.5.50 Highly selective detection of tau oligomers in biological fluids for the diagnosis of Alzheimer’s Disease 977

15.5.51 Seromic Mucin Signature for the Early Diagnosis of Pancreatic Cancer 978

15.5.52 Lateral flow immunoassay for rapid diagnosis of tinea capitis and onychomycosis 979

15.5.53 Silicon Photonic Blood Typing 980

15.5.54 Multiplex Platform for Point-of-Care Newborn Screening of Hyperbilirubinemia 981

15.5.55 Long non-coding RNA signatures to track treatment responses in multiple sclerosis 982

15.5.56 CapioCyte circulating tumor cell assay as a biomarker for cancer immunotherapy response 983

15.5.57 A Dried Blood Spot Companion Diagnostic to Measure Neuroendocrine Changes in ADHD. 984

15.5.58 Comprehensive, Near Patient Assessment of Severe Hypoglycemia in Newborns Using Low Blood Volume 985

15.5.59 Detecting species-specific bacterial meningitis markers with iDDS probes 986

15.5.60 Development of a Clinical Screening Platform for Type 1 Diabetes 987

15.5.61 Point-of-care HIV viral load system using RPA and MXR 988

15.5.62 Optimization and Validation of an indicator cell assay for blood-based diagnosis of lung cancer 989

15.5.63 Low-cost, portable and automated semen analysis using computational microscopy for home-based testing of male wellness and fertility 990

15.5.64 Expanding thyroid testing in high risk newborns: total T3, free T4, TSH and TRAB 991

15.5.65 Improving Anticoagulation Monitoring in Pediatric Patients: Use of a Microfluidic Platform to Test Low Volume Blood Samples Obtained by Heel-Stick Collection 992

15.6 Merger 993

15.6.1 AstraZeneca Reportedly Drops Interest in Merging with Gilead Sciences 993

15.6.2 Icare USA Merges with CenterVue 994

15.6.3 Organovo Holdings Terminates Merger with Tarveda Therapeutics 995

15.6.4 International Display Advertising to Merge with IR Med 997

15.6.5 Tocagen Merges with Forte Biosciences 998

15.6.6 Qualigen Therapeutics (Ritter Pharma) Merge with Qualigen in Reverse Merger Transaction 1000

15.6.7 NuProbe Merges with CarrierGene Biotech 1002

15.6.8 Organovo Holdings Receives Merger Proposal from Viscient Biosciences 1003

15.6.9 OpGen and Curetis Complete Merger 1004

15.6.10 PointR Data to Merge with Mateon Therapeutics 1006

15.6.11 Progentec Diagnostics and Karate Health Merge 1008

15.7 Partnerships 1009

15.7.1 3M Company Enters into Co-Development Agreement with Massachusetts Institute of Technology 1009

15.7.2 Menarini Silicon Biosystems Enters into Co-Promotion Partnership with OpGen for CELLSEARCH Platform and Other COVID-19 Related Products 1010

15.7.3 Todos Medical Enters into Distribution Agreement with Meridian Health Services Network for Covid-19 Testing 1011

15.7.4 Biocare Medical Enters into Partnership with Bethyl Labs 1012

15.7.5 Thermo Fisher Scientific and Daiichi Sankyo Enter into Co-Development Agreement 1013

15.7.6 NuProbe Global and Weigao Group Enter into Co-Development Agreement 1014

15.7.7 Metabolon and DNA Genotek Enter into Agreement 1015

15.7.8 Epredia and Lunaphore Technologies Enter into Distribution Agreement 1016

15.7.9 Microbix Biosystems Enters into Distribution Agreement with Alpha-Tec Systems for Covid-19 Tests 1017

15.7.10 Codexis Enters into Co-Marketing Agreement with Alphazyme 1018

15.7.11 ArcherDX Enters into Collaboration with AstraZeneca 1019

15.7.12 Inivata Enters into Collaboration with NeoGenomics 1020

15.7.13 BioGX and Bosch Healthcare Solutions Enter into Co-Development Agreement 1022

15.7.14 Prevencio Enters into Research Collaboration with Seattle Children’s Research Institute 1023

15.7.15 Oncimmune Holdings Enters into Drug Development Agreement with US Biopharmaceutical Company 1024

15.7.16 Sime Diagnostics Enters into Agreement for Commercialisation of Respiratory Diagnostic Platform 1025

15.7.17 Berg Enters into Research Collaboration with Boehringer Ingelheim 1026

15.7.18 Meridian Bioscience Enters into Partnership with QuantuMDx for COVID-19 Assay 1027

15.7.19 Nimble Therapeutics Enters into Agreement with Roche Diagnostics for COVID-19 Diagnostics Assays 1028

15.7.20 AIkido Pharma Enters into Research Agreement with Cogia Biotech (Cogia) 1029

15.7.21 Roswell Biotechnologies and Imec Enter into Partnership 1030

15.7.22 CareDx Enters into Agreement with Weill Cornell Medical College 1031

15.7.23 Alveo Technologies Enters into Research Collaboration with Janssen Pharma 1032

15.7.24 Applied BioMath Enters into Agreement with Xilio Therapeutics 1033

15.7.25 Veracyte Enters into Licensing Agreement with Yale University 1034

15.7.26 Elysium Health Enters into Licensing Agreement with Yale University 1036

15.7.27 Mission Bio Enters into Co-Marketing Agreement with Agilent Technologies 1037

15.7.28 Roswell Park Enters into Agreement with Catholic Health and University at Buffalo for Covid-19 1038

15.7.29 Opentrons Labworks and Zymo Research Enter into Agreement for Covid-19 1039

15.7.30 OpGen Enters into Agreement with Karolinska Institutet for Covid-19 1040

15.7.31 Envisagenics Enters into Research Agreement with Lung Cancer Initiative at Johnson & Johnson 1042

15.7.32 Entopsis Enters into Commercialization Agreement with Genetics Institute of America 1043

15.7.33 RedHill Biopharma Enters into Agreement with National Institute of Allergy and Infectious Diseases for Covid-19 1044

15.7.34 Hememics Biotechnologies Enters into Co-Development Agreement with Biomedical Advanced Research and Development Authority for Covid-19 1045

15.7.35 Nimble Therapeutics and Svar Life Science Enter into Collaboration 1046

15.7.36 Sino Biological Enters into Co-Development Agreement with Nanommune for COVID-19 Assay 1047

15.7.37 Accelerate Diagnostics and BioCheck Enter into Collaboration Agreement to Distribute MS-FAST Chemiluminescence Immunoassay Analyzer and SARS-CoV-2 Antibody Tests 1048

15.7.38 NanoMosaic Enters into Licensing Agreement with Harvard University Office for Technology Development for Infectious Disease Monitoring Including COVID-19 1049

15.7.39 Q2 Solutions Enters into Co-Development Agreement with University of Texas Medical Branch to Help Accelerate Development of COVID-19 Vaccines 1050

15.7.40 Todos Medical and 3DMed Enter Into Coronavirus (COVID-19) and Influenza A/B Testing Kit Distribution Agreement 1051

15.7.41 NuProbe Enters into Agreement with Qiagen 1052

15.7.42 Veravas Enters into Licensing Agreement with MIP Diagnostics 1053

15.7.43 Invicro Enters into Research Partnership with Yale University School of Medicine 1054

15.7.44 Fluidigm and Next Gen Diagnostics Enter into Agreement 1055

15.7.45 Spherix Enters into Research Agreement with University of Texas Southwestern Medical Center 1056

15.7.46 Pinpoint Science Enters into Collaboration with Analog Devices to Advance Novel Nanosensors for Pathogen Detection 1057

15.7.47 Resolution Bioscience to Enter into Agreement with LabCorp 1058

15.7.48 Thermo Fisher Scientific and NanoPin Technologies Enter into Partnership 1059

15.7.49 Q-linea Enters into Commercialization Agreement with Thermo Fisher Scientific 1060

15.7.50 Becton Dickinson (BD) and Babson Diagnostics Enter into Agreement 1061

15.7.51 ProSciento and Nordic Bioscience Enter into Partnership 1062

15.7.52 Baxter International and Spectral Medical Enter into Distribution Agreement 1063

15.7.53 Predictive Technology and Atrin Pharma Enter into Co-Development Agreement 1064

15.7.54 Twist Bioscience Enters into Agreement with Schrodinger 1065

15.7.55 Horizon Discovery Exercises its Option with Rutgers University to License Base Editing Technology 1066

15.7.56 Genomic Testing Co-Operative (GTC) and C2i Genomics Enter into Partnership 1067

15.7.57 Roche Enters into Partnership with Illumina 1068

15.7.58 Veravas and Tymora Analytical Enter into Partnership 1069

15.7.59 Curis and DarwinHealth Enter into Research Collaboration 1070

15.7.60 Horizon Discovery Enters into Licensing Agreement with Mammoth Biosciences 1071

15.7.61 Personal Genome Diagnostics and Mayo Clinic Enter into Collaboration 1072

15.7.62 Veracyte Enters into Partnership with Acerta Pharma 1073

15.7.63 NuProbe Global Enters into Partnership with Illumina 1074

15.7.64 IncellDx Enters into Distribution Agreement with Biolidics 1075

15.7.65 Prescient Metabiomics and CoreBiome Enter into Collaboration 1076

15.7.66 Novoheart Enters into Agreement with Harvard University 1077

15.7.67 Horizon Discovery Enters into Licensing Agreement with Mammoth Biosciences 1078

15.7.68 Ontera and QuantuMDx Enter into Partnership 1079

15.7.69 NeuMoDx Molecular Enters into Partnership with Sentinel Diagnostics 1080

15.7.70 Royal Philips and Paige Form Partnership 1081

15.7.71 ArcherDX Expands Co-Development Agreement with Illumina 1082

15.7.72 Cyrus Biotech and Broad Institute Enter into Partnership 1084

15.7.73 LG Chem Enters into Licensing Agreement with Kryptos Biotechnologies 1085

15.7.74 Asuragen Enters into Agreement with Wave Life Sciences 1086

15.7.75 Navrogen Enters into Licensing Agreement with Lonza Pharma 1087

15.7.76 Personalis Enters into Agreement With Merck 1088

15.7.77 Ikonisys Enters into Partnership with Sheba Medical Center 1089

15.7.78 Baystate Health and Life Image Enter into Development Partnership 1090

15.7.79 Galectin Therapeutics Enters into Agreement with Siemens Healthineers 1091

15.7.80 Abcam Enters into Partnership Agreement with BrickBio 1092

15.7.81 Lexent Bio Enters into Partnership Agreement with Illumina 1093

15.7.82 Owlstone Medical Enters into Partnership with Thermo Fisher Scientific 1094

15.7.83 Bio Techne Enters into Licensing Agreement with C4 Therapeutics 1095

15.7.84 Akoya Biosciences Enters into Agreement with Precision for Medicine 1096

15.7.85 Sonic Healthcare Enters into Licensing Agreement with University of Pittsburgh Medical (UPMC) 1097

15.7.86 Siemens Healthineers Enters into Licensing Agreement with Quanterix 1098

15.7.87 Beam Therapeutics Enters into Licensing Agreement with Prime Medicine 1099

15.7.88 Thermo Fisher Scientific and Genialis Enter into Co-Marketing Agreement 1100

15.7.89 Sherlock Biosciences and Mologic Enter into Partnership 1101

15.7.90 PredictImmune Enters into Partnership with KSL Biomedical 1102

15.7.91 Novigenix Enters into Agreement with RadioMedix 1103

15.7.92 PExA Enters into Research Agreement with Janssen and University of Gothenburg 1104

15.7.93 Adaptive Biotechnologies Enters into Partnership with Illumina 1105

15.7.94 CareDx and NanoString Technologies Enter into Partnership 1107

15.7.95 Natera and Foundation Medicine Enter into Partnership 1108

15.7.96 Thermo Fisher Scientific Enters into Agreement with Eli Lilly 1110

15.7.97 Genmab and Tempus Labs Enter into Agreement 1112

15.7.98 Thermo Fisher Scientific and Cedars-Sinai Medical Center Enter into Partnership 1113

15.7.99 True Diagnostics and Veravas Enter into Commercialization Agreement 1115

15.7.100 NanoString Technologies and Mayo Clinic Labs Enter into Development Agreement 1116

15.7.101 Biodesix and Immodulon Therapeutics Enter into Research Collaboration 1117

15.7.102 Bio-Techne Enters into Licensing Agreement with UmanDiagnostics 1118

15.8 Private Equity 1119

15.8.1 Molecular Templates Raises USD43 Million in Private Placement of Shares 1119

15.8.2 Vaxart Raises USD89.4 Million in Public Offering of Common Stock 1120

15.8.3 Cardiff Oncology to Raise USD13.5 Million in Private Placement of Shares and Warrants 1122

15.8.4 DNAnexus Raises USD100 Million in Financing 1123

15.8.5 AbbVie Recommends Shareholders to Reject Mini-Tender Offer of TRC Capital 1125

15.8.6 IONIQ Sciences to Raise Funds through Private Equity Offering 1126

15.8.7 Cardiff Oncology Raises USD2.5 Million in Private Placement of Shares and Warrants 1127

15.8.8 iBio to Raise USD1.1 Million in Equity Financing 1128

15.8.9 MaxCyte Raises USD9 Million in Private Placement of Shares 1130

15.8.10 MaxCyte Raises USD22.2 Million in Private Placement of Shares 1132

15.8.11 Oncocyte Raises USD10.7 Million in Registered Direct Offering of Shares 1134

15.8.12 Artemis Capital Partners Acquires BioDot 1136

15.8.13 VistaGen Therapeutics Raises USD0.25 Million in Private Placement of Shares 1137

15.8.14 Merck Rejects Tender Offer by TRC Capital (TRC) 1139

15.8.15 Verastem Oncology Raises USD100 Million in Private Placement of Shares 1140

15.8.16 Biomerica Raises USD2 Million in Private Placement of Convertible Preferred Stock 1143

15.8.17 Avisa Pharma to Raise up to USD39.2 Million in Financing 1144

15.8.18 Syndax Pharma to Raise USD35 Million in Private Financing 1146

15.8.19 Interpace Biosciences to Raise USD20 Million in Preferred Stock Financing 1148

15.8.20 OncoCyte to Raise USD7.6 Million in Private Placement of Shares 1149

15.8.21 Akoya Biosciences Raises USD50 Million in Private Financing 1150

15.8.22 Becton Dickinson Shareholders Reject Mini Tender Offer from TRC Capital 1152

15.8.23 TRACON Pharma Amends Terms of Private Placement of Shares 1153

15.8.24 Interpace Diagnostics Raises USD13 Million in Second Tranche of Financing 1154

15.8.25 Edgewater Capital Partners to Acquire Haematologic Technologies 1156

15.8.26 Arcline Investment Management Acquires Majority Stake in Akron Biotech 1157

15.8.27 Sema4 Raises Funds through Private Financing 1158

15.9 Venture Financing 1160

15.9.1 Pattern Bioscience Raises Additional USD9 Million in Series B-1 Financing 1160

15.9.2 Genobank.io Raises USD0.42 Million in Venture Financing 1161

15.9.3 BioROSA Technologies Raises USD0.58 Million in Venture Financing 1162

15.9.4 BioDirection (NanoDiagnosticsTM) Raises USD18 Million in Series C Financing 1163

15.9.5 TARA Biosystems Raises USD10 Million in A2 Financing 1164

15.9.6 Rheonix to Raise Funds through Venture Financing 1166

15.9.7 Noninvasix Raises Additional USD0.4 Million in Venture Financing 1167

15.9.8 Cue Health Raises USD100 Million in Series C Financing 1168

15.9.9 Voltron Therapeutics Raises USD3.5 Million in Series A Financing 1170

15.9.10 Adaptive Phage Therapeutics Raises USD2.8 Million in Venture Financing 1171

15.9.11 AxoSim Raises USD1.96 Million in Venture Financing 1172

15.9.12 Syapse Raises USD30 Million in Venture Financing 1173

15.9.13 Decipher Biosciences Raises USD8 Million in Venture Financing 1175

15.9.14 Genomenon Raises USD2.9 Million in Venture Financing 1176

15.9.15 Luna Genetics Raises USD1.2 Million in Venture Financing 1177

15.9.16 Immunai Raises USD20 Million in Seed Financing 1178

15.9.17 Pillar Biosciences Raises USD29.7 Million in Series C Financing 1179

15.9.18 Personal Genome Diagnostics Raises USD2.75 Million in Venture Financing 1180

15.9.19 Grail Raises USD390 Million in Series D Financing 1181

15.9.20 MOBILion Systems Raises USD6 Million in Venture Financing 1183

15.9.21 Blaire Biomedical Raises Funds through Venture Financing 1184

15.9.22 Ricovr Healthcare Raises USD1.1 Million in Seed Financing 1185

15.9.23 Ischemia Care Raises USD1.1 Million in Venture Financing 1186

15.9.24 Amplified Sciences Raises USD1 Million in Seed Financing 1187

15.9.25 Captis Biotechnology Raises Funds through Venture Financing 1189

15.9.26 QSM Diagnostics Raises Funds through Venture Financing 1190

15.9.27 Efferent Labs to Raise USD3 Million in Venture Financing 1191

15.9.28 SiDx Raises Additional USD0.5 Million in Venture Financing 1192

15.9.29 eLum Technologies Raises USD2 Million in Venture Financing 1193

15.9.30 54gene (Stack Diagnostics) Raises USD15 Million in Series A Financing 1194

15.9.31 Locus Biosciences Raises USD12.5 Million in Venture Financing 1196

15.9.32 Triad Life Sciences Raises USD6.6 Million in Venture Financing 1197

15.9.33 Optofluidics (Halo Labs) Raises USD12 Million in Series B1 Financing 1198

15.9.34 ClickDiagnostics Raises USD70 Million in Venture Financing 1199

15.9.35 Progenity Raises USD10 Million in Venture Financing 1200

15.9.36 Avails Medical Raises Funds through Venture Financing 1201

15.9.37 Proteowise Raises USD6.3 Million in Venture Financing 1202

15.9.38 Innovaprep Raises USD0.5 Million in Venture Financing 1203

15.9.39 Noninvasix Raises USD3.6 Million in Venture Financing 1204

15.9.40 Savran Technologies Raises USD0.2 Million in Venture Financing 1205

15.9.41 Tempus Secures USD100 Million in Series G Venture Funding 1206

15.9.42 Rational Vaccines Raises USD2.8 Million in Venture Financing 1208

15.9.43 BillionToOne Raises USD15 Million in Series A+ Financing 1209

15.9.44 Emulate Raises USD19.3 Million in Venture Financing 1211

15.9.45 Imcare Biotech Raises USD0.68 Million in Venture Financing 1212

15.9.46 Akouos Raises USD105 Million in Series B Financing 1213

15.9.47 Bloomer Health Tech Raises USD2.8 Million in Venture Financing 1216

15.9.48 Pillar Biosciences Raises USD18 Million in Venture Financing 1217

15.9.49 Arima Genomics Raises Funds through Series A Financing 1218

15.9.50 Karius Raises USD165 Million in Series B Financing 1220

15.9.51 Veravas Raises USD4 Million in Seed Financing 1222

15.9.52 Scipher Medicine Raises Additional Funds through Series B Financing 1223

15.9.53 Nuclein to Raise USD1 Million in Venture Financing 1224

15.9.54 Impact Proteomics Raises USD0.2 Million in Venture Financing 1225

15.9.55 Intabio Raises USD18 Million in Series B Financing 1226

15.9.56 GenapSys Raises USD75 Million in Financing 1227

15.9.57 mBio Diagnostics Raises USD0.55 Million in Venture Financing 1228

15.9.58 Lumos Diagnostics Raises USD15 Million in Series A Financing 1229

15.9.59 mBio Diagnostics Raises Additional USD1.08 Million in Venture Financing 1230

15.9.60 Adarza BioSystems Raises USD25 Million in Series D Financing 1231

15.9.61 Pattern Bioscience Raises USD6.4 Million in Series B Financing 1232

15.9.62 Affinity Biosensors Raises Additional USD0.1 Million in Venture Financing 1233

15.9.63 Mammoth Biosciences Raises USD45 Million in Series B Financing 1234

15.9.64 IDbyDNA Raises USD20 Million in Series B Financing 1236

15.9.65 NeuroDex Raises USD0.5 Million in Seed Financing 1238

15.9.66 Ricovr Healthcare Raises USD0.3 Million in Venture Financing 1239

15.9.67 Lucira Health Raises Additional USD17.5 Million in Series B Financing 1240

15.9.68 Hycor Holdings Raises Additional USD12.5 Million in Venture Financing 1241

15.9.69 Arpeggio Bio Raises USD3.2 Million in Seed Financing 1242

15.9.70 Color Genomics Raises USD75 Million in Financing 1243

15.9.71 Owl Peak Technologies to Raise USD1 Million in Venture Financing 1245

15.9.72 Inflammatix Raises USD32 Million in Series C Financing 1246

15.9.73 ReadCoor Raises USD27 Million in Series B Financing 1248

15.9.74 IsoPlexis Raises Additional USD20 Million in Series C Financing 1249

15.9.75 Element Biosciences Raises USD80.3 Million in Series B Financing 1250

15.9.76 KIYATEC Raises Funds through Venture Funding 1252

15.9.77 Progentec Diagnostics Raises USD5 Million in Series A Financing 1253

15.9.78 BioSkryb Raises USD11.5 Million in Seed Financing 1255

15.9.79 Canopy Biosciences Raises Funds through Venture Financing 1256

15.9.80 Biostage Raises USD2.18 Million in Venture Financing 1257

15.9.81 Prelude Raises USD10 Million in Venture Financing 1258

15.9.82 Emerge Diagnostics Raises USD0.27 Million in Venture Financing 1259

15.9.83 Elysium Health Raises USD40 Million in Series C Financing 1260

15.9.84 GastroKlenz (CloudCath) Secures USD7.05 Million in Funding Round 1262

15.9.85 RareCyte Raises USD22 Million in Venture Financing 1263

15.9.86 Scipher Medicine Raises Funds through Series B Financing 1264

15.9.87 J3 Bioscience Raises USD0.02 Million in Venture Financing 1265

15.9.88 ChromaCode Raises USD28 Million in Series C Financing 1266

15.9.89 ArcherDX Raises USD55 Million in Series C Financing 1268

15.9.90 Trialjectory Raises USD2.7 Million in Seed Financing 1270

15.9.91 Visiongate Raises Additional USD3 Million in Venture Financing 1271

15.9.92 TwinStrand Biosciences Raises USD16 Million in Series A Financing 1272

15.9.93 GRIP Molecular Technologies Raises USD0.35 Million in Venture Financing 1273

15.9.94 Aurora Bio Raises USD0.2 Million in Venture Financing 1274

15.9.95 S2 Genomics Raises USD2.2 Million in Venture Financing 1275

15.9.96 Hememics Biotechnologies Raises USD2.5 Million in Venture Financing 1276

15.9.97 NOWDiagnostics Raises USD18.9 Million in Venture Financing 1277

15.9.98 Triple Endoscopy Raises USD1.95 Million in Venture Financing 1278

15.9.99 Protego Biopharma Raises USD1 Million in Venture Financing 1279

15.9.100 Banyan Biomarkers Raises USD2.26 Million in Venture Financing 1280

15.9.101 Quadrant Biosciences Raises USD2.3 Million in Venture Financing 1281

15.9.102 Omniome Raises Additional USD60 Million in Series C Financing 1282

15.9.103 Durin Technologies Raises USD3.5 Million in Venture Financing 1284

15.9.104 Glycotest Raises USD3 Million in Second Tranche of Series A Financing 1285

15.9.105 Truvian Sciences Raises USD27.1 Million in Series B Financing 1286

15.9.106 GenapSys Raises USD90 Million in Series C Financing 1287

15.9.107 Sera Prognostics Raises USD36 Million in Series D Financing 1288

15.9.108 Mobilion Systems Raises USD15.4 Million in Series A Venture Funding 1290

15.9.109 BrickBio Raises USD5 Million in Venture Financing 1291

15.9.110 Minute Molecular Diagnostics Raises USD0.8 Million in Venture Financing 1292

15.9.111 Inanovate Raises USD0.4 Million in Venture Financing 1293

15.9.112 Laboratory for Advanced Medicine Raises USD86 Million in Venture Funding 1294

15.9.113 Kryptos Biotechnologies Raises USD2.7 Million in Pre-Series A Financing 1295

15.9.114 Cytovale Raises Additional USD7.4 Million in Series B Financing 1296

15.9.115 LungLife AI Raises Additional USD0.8 Million in Venture Financing 1297

15.9.116 Eleven P15 Raises USD1.6 Million in Venture Financing 1298

15.9.117 PierianDx Raises USD27 Million in Series B Financing 1299

15.9.118 Mesa Biotech Raises USD3 Million in Venture Financing 1301

15.9.119 Vigilant Biosciences Raises USD0.5 Million in Venture Financing 1302

15.9.120 Biological Dynamics Raises USD12 Million in Venture Financing 1303

15.9.121 Minerva Biotechnologies Raises USD1.5 Million in Venture Financing 1304

15.9.122 Phitonex Secures USD2 Million in Seed Funding 1305

15.9.123 Scipher Medicine Raises Additional USD5 Million in Venture Financing 1306

15.9.124 SEngine Precision Medicine Raises Additional USD8 Million in Venture Financing 1307

15.9.125 InnaMed Secures USD1 Million in Crowdfunding 1308

15.9.126 4D Path Raises USD1.4 Million in Venture Financing 1309

15.9.127 Immunexpress Raises Funds through Financing Round 1310

15.9.128 SEngine Precision Medicine Raises USD5.1 Million in Series A Financing 1311

15.9.129 Selux Diagnostics Raises USD11.4 Million in Venture Financing 1312

15.9.130 PROMISS Diagnostics Raises USD0.4 Million in Venture Financing 1313

15.9.131 XCR Diagnostics Raises USD1.8 Million in Venture Financing 1314

15.9.132 AltheaDx Raises USD1.3 Million in Venture Financing 1315

15.9.133 Geneoscopy Raises USD6.9 Million in Series A Financing 1316

15.9.134 Navrogen Raises USD3.2 Million in Financing Round 1317

15.9.135 Hycor Holdings Raises USD2.5 Million in Venture Financing 1318

15.9.136 Veravas Raises USD0.4 Million in Venture Financing 1319

15.9.137 OncoCell MDx Raises USD22.2 Million in Series B Financing 1320

15.9.138 InDevR Raises USD7 Million in Series A Financing 1321

15.9.139 CytoSite BioPharma Raises USD2.6 Million in Venture Financing 1322

15.9.140 Acuamark Diagnostics Raises USD2.3 Million in Venture Financing 1323

15.9.141 CirculoGene Theranostics Raises USD0.3 Million in Venture Financing 1324

15.9.142 Specific Diagnostics Raises USD12.5 Million in Financing 1325

15.9.143 Verax Biomedical Raises USD2.5 Million in Venture Financing 1326

15.9.144 LungLife AI Raises Additional USD1.4 Million in Venture Financing 1327

15.9.145 Hura Imaging Raises USD0.25 Million in Venture Financing 1328

15.9.146 Sense Diagnostics Raises USD2.3 Million in Venture Financing 1329

15.9.147 SeLux Diagnostics Raises USD9 Million in Venture Financing 1330

15.9.148 Brava Diagnostics Raises USD0.3 Million in Venture Financing 1331

15.9.149 MediBeacon Raises USD34.3 Million in Venture Financing 1332

15.9.150 Progenity Raises USD25 Million in Venture Financing 1333

15.9.151 Boston Microfluidics Raises USD17.5 Million in Series A Financing 1334

15.9.152 Nuclein Raises USD0.4 Million in Venture Financing 1335

15.9.153 Specific Diagnostics Raises USD17.5 Million in Venture Financing 1336

15.9.154 NeoLight Secures USD2.5 Million in Venture Funding 1337

15.9.155 Nurx Raises USD52 Million in Series C Financing 1338

15.9.156 Metabolon Raises USD1.5 Million in Venture Financing 1340

15.9.157 E25Bio Raises USD2.3 Million in Venture Financing 1341

15.9.158 ChromaCode Raises USD16.7 Million in Venture Financing 1342

15.9.159 Biodesix Raises USD4.9 Million in Venture Financing 1343

15.9.160 New Health Sciences Raises USD4.4 Million in Venture Financing 1344

15.9.161 Thermagenix Raises USD0.2 Million in Venture Financing 1345

15.9.162 EDP Biotech to Raise USD1.5 Million in Venture Financing 1346

15.9.163 CytoSite BioPharma Raises USD4.4 Million in Venture Financing 1347

15.9.164 Group K Diagnostics Raises USD1 Million in Venture Financing 1348

15.9.165 Affinity Biosensors Raises USD6 Million in Venture Financing 1349

15.9.166 Lucira Health (Diassess) Raises USD15 Million in Series B Financing 1350

15.9.167 BioIQ Raises USD14 Million in Venture Financing 1352

15.9.168 ArunA Bio Raises USD13 Million in Financing 1353

15.9.169 Stratify Genomics Raises Additional USD2.2 Million in Seed Financing 1354

15.9.170 Drawbridge Health Raises Funds through Venture Financing 1355

15.9.171 View Point Medical Raises USD7 Million in Venture Financing 1357

16 Recent Developments 1358

16.1 Corporate Communications 1358

16.1.1 Jul 15, 2020: Cambridge Isotope Laboratories appoints Warren Arenz as Vice President of Operations 1358

16.1.2 Jul 14, 2020: Genobank Surpasses $418K in crowdfunding to launch the first ever anonymous DNA test kit 1358

16.1.3 Jul 06, 2020: iBio : Departure of Certain Officers 1359

16.1.4 Jul 01, 2020: Humana appoints Noora Jayasekara as new CFO 1359

16.1.5 Jun 24, 2020: Sera Prognostics appoints Thomas J. Garite, M.D. as vice president of clinical sciences 1359

16.1.6 Jun 22, 2020: Seres Therapeutics appoints Terri Young, Ph.D., R.Ph., experienced commercial leader, as Executive Vice President, Chief Commercial and Strategy Officer 1360

16.1.7 Jun 17, 2020: Bionano Genomics : Departure of Directors 1361

16.1.8 Jun 16, 2020: Javier Rodriguez joins Gilead Sciences’ Board of Directors 1361

16.1.9 Jun 16, 2020: Zomedica Pharmaceuticals announces the appointment of Robert Cohen as the Company’s Interim Chief Executive Officer 1361

16.1.10 Jun 01, 2020: Mark Genovese joins Gilead to lead clinical development of company’s inflammation programs 1362

16.1.11 Apr 21, 2020: Personal Genome Diagnostics appoints Megan Bailey as chief executive officer 1363

16.1.12 Apr 10, 2020: Wave Life Sciences receives loan from JPMorgan Chase Bank, N.A. 1363

16.1.13 Apr 08, 2020: Dr. Ethan Russo Joins Endocanna Health’s Newly Created Science Board as Chairman 1364

16.1.14 Mar 24, 2020: Exagen appoints Debra Jeske Zack, M.D., Ph.D., as chief medical officer, and Anja Kammesheidt, Ph.D., as chief scientific officer 1364

16.1.15 Mar 23, 2020: McKesson announces executive vice president and chief strategy and business development officer to step down 1365

16.1.16 Mar 12, 2020: Plus Therapeutics welcomes two new Directors 1366

16.1.17 Mar 11, 2020: Amneal Pharmaceuticals appoints Tasos Konidaris as Senior Vice President, Chief Financial Officer 1366

16.1.18 Mar 03, 2020: NCCN and AstraZeneca announce projects to explore quality improvements in Lung Cancer 1367

16.1.19 Mar 02, 2020: Biocept announces pricing of $9.2 million registered direct offering priced at-the-market 1368

16.1.20 Feb 27, 2020: Immunomedics appoints Robert W. Azelby to board of directors 1368

16.1.21 Feb 27, 2020: James Quincey elected to Pfizer’s board of directors 1369

16.1.22 Feb 26, 2020: Thermo Fisher Scientific President and Chief Executive Officer Marc N. Casper elected Chairman of the Board of Directors 1369

16.1.23 Feb 24, 2020: Karius raises $165m through Series B funding round 1370

16.1.24 Feb 24, 2020: Halozyme announces CFO transition 1370

16.1.25 Feb 21, 2020: Purdue taps Tom Vilsack, former cabinet secretary and governor, to monitor compliance with voluntary injunction 1371

16.1.26 Feb 20, 2020: Humana elects Wayne A.I. Frederick, M.D., and John W. Garratt to Board of Directors 1371

16.1.27 Feb 20, 2020: Turning Point Therapeutics names Siegfried Reich as executive Vice President and Chief Scientific Officer 1372

16.1.28 Feb 19, 2020: Gilead appoints Michael Quigley to lead research biology group and names Linda Higgins as head of company’s external innovation center 1373

16.1.29 Feb 19, 2020: Incyte announces launch of the Incyte Ingenuity Award Program to recognize innovation within the GVHD Community 1373

16.1.30 Feb 18, 2020: First patient enrolled in the new clinical study FILTER-SCAD targeting 2,000 patients 1374

16.1.31 Feb 18, 2020: Precision Molecular announces investment by Alzheimer’s Drug Discovery Foundation to support Advancement of more effective agents for imaging neuroinflammation 1375

16.1.32 Feb 18, 2020: Ischemia Care welcomes Edward C. Jauch, M.D. as Newest Advisory Board Member 1376

16.1.33 Feb 18, 2020: Laboratory for Advanced Medicine appoints former Ancestry executive as Chief Operations Officer 1377

16.1.34 Feb 14, 2020: Immunomedics appoints Dr. Loretta Itri Chief Medical Officer 1377

16.1.35 Feb 14, 2020: Pfizer: Appointment of Mr. Samir Kazi as an executive director 1378

16.1.36 Feb 14, 2020: Pfizer: Resignation of Mr. Vivek Dhariwal 1379

16.1.37 Feb 14, 2020: GERON: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers 1379

16.1.38 Feb 13, 2020: Glooko names Zach Henderson as Chief Commercial Officer and Komathi Stem as Chief Operating Officer 1379

16.1.39 Feb 12, 2020: Introducing function upgrades of Medicom-SK electronic medical record system for improving clinical workflow 1380

16.1.40 Feb 12, 2020: Halo announces promotion of Katie Field to President of Halo and provides Bophelo Bioscience update 1381

16.1.41 Feb 11, 2020: Caris Life Sciences appoints new Executive Medical Director 1382

16.1.42 Feb 11, 2020: Maravai LifeSciences hires two senior executives for TriLink BioTechnologies 1382

16.1.43 Feb 11, 2020: OncoSec strengthens its Board of Directors with three new appointments 1383

16.1.44 Feb 11, 2020: InsideTracker announces addition of Dr. Emil Chiauzzi, PhD to its Scientific Advisory Board 1384

16.1.45 Feb 11, 2020: Decipher Biosciences announces addition of Dr. Robert S. Epstein as Chairman and Kathy Hibbs, Esq. to its Board of Directors 1384

16.1.46 Feb 11, 2020: Abbott Laboratories: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officer 1385

16.1.47 Feb 10, 2020: Chi-Med highlights updated phase II Savolitinib / Imfinzi combination data in advanced papillary renal cell carcinoma at 2020 ASCO Genitourinary Cancers Symposium 1386

16.1.48 Feb 07, 2020: Pacific Biosciences announces retirement of Michael Phillips, SVP of research and development 1387

16.1.49 Feb 06, 2020: Plus Therapeutics appoints Chief Financial Officer 1388

16.1.50 Feb 06, 2020: Plus Therapeutics announces changes to its Board of Directors 1388

16.1.51 Feb 06, 2020: Myriad announces leadership transition 1389

16.1.52 Feb 06, 2020: Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors 1389

16.1.53 Feb 05, 2020: StemExpress welcomes Dr. Victoria Hines as Vice President of Clinical 1390

16.1.54 Feb 05, 2020: Biodex appoints new head of global physical medicine sales 1390

16.1.55 Feb 05, 2020: Walgreens Boots Alliance appoints Richard Ashworth President of Walgreens 1391

16.1.56 Feb 04, 2020: Catalyst Pharmaceuticals appoints David Ailinger as vice president, business development 1391

16.1.57 Feb 03, 2020: IXICO supports the Alzheimer’s disease neuroimaging initiative 1392

16.1.58 Feb 03, 2020: Surmodics names Nusrath Sultana, MD, as Vice President, Clinical Affairs 1392

16.1.59 Feb 03, 2020: Truvian Sciences appoints Shane Bowen, Ph.D. as Senior Vice President of Engineering 1393

16.1.60 Feb 03, 2020: Eisai expands leadership team in the US with the appointment of two key leaders 1394

16.1.61 Jan 31, 2020: Dr. Christine Seidman and Kathy Warden elected to Merck Board of Directors 1394

16.1.62 Jan 28, 2020: Personal Genome Diagnostics appoints Megan Bailey as Chief Commercial Officer 1395

16.1.63 Jan 28, 2020: Syapse appoints Kirk Fjeldheim as Chief Information Security Officer 1396

16.1.64 Jan 28, 2020: 3M Company: Departure of directors or certain officers 1396

16.1.65 Jan 24, 2020: Cardinal Health: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers 1397

16.1.66 Jan 23, 2020: Agilent announces CrossLab Group leadership transition 1397

16.1.67 Jan 23, 2020: CytoDyn Appoints Maura Fleming as Vice President, General Counsel and Corporate Secretary 1397

16.1.68 Jan 23, 2020: Turning Point Therapeutics names Garry Nicholson to its Board of Directors 1398

16.1.69 Jan 23, 2020: Kura Oncology announces transition of Chief Medical Officer 1399

16.1.70 Jan 23, 2020: Spectrum Health Pennock expands surgical team 1399

16.1.71 Jan 22, 2020: ImmunoGen announces proposed public offering of common stock 1400

16.1.72 Jan 22, 2020: Mateon Therapeutics: Departure of directors or certain officers; election of directors 1400

16.1.73 Jan 21, 2020: CytoDyn appoints Alan Timmins as new Independent Director and Chair of the Audit Committee 1401

16.1.74 Jan 21, 2020: Guardant Health appoints High-Tech-Veteran Kumud Kalia Chief Information Officer 1401

16.1.75 Jan 21, 2020: OncoSec announces the appointment of Robert J. DelAversano, C.P.A, as Principal Accounting Officer and Controller 1402

16.1.76 Jan 17, 2020: INTERPACE Biosciences: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers 1403

16.1.77 Jan 16, 2020: Audax Private Debt provides financing to support Olympus Partners Investment in Soliant Health 1403

16.1.78 Jan 14, 2020: Dr. Thomas P. Slavin named Senior Vice President of Medical Affairs for Myriad Oncology 1404

16.1.79 Jan 14, 2020: Dale Mitchell elected Chief of Staff at Scripps Memorial La Jolla 1404

16.1.80 Jan 13, 2020: Foundation Medicine appoints Ritesh Khullar as Chief Commercial Officer 1405

16.1.81 Jan 13, 2020: T2 Biosystems promotes Tony Pare to Chief Commercial Officer 1406

16.1.82 Jan 10, 2020: Transplant Genomics appoints Dr. John Holman as VP Medical Affairs 1406

16.1.83 Jan 10, 2020: Entasis Therapeutics: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers 1407

16.1.84 Jan 09, 2020: Trifecta Med Spa – NYC’s top-recommended medical spa – introduces city’s first Allergan CoolTone procedures 1407

16.1.85 Jan 09, 2020: Akouos announces senior leadership team appointments 1408

16.1.86 Jan 09, 2020: T2 Biosystems appoints industry veteran John Sperzel as chief executive officer 1409

16.1.87 Jan 09, 2020: Turning Point Therapeutics announces management transition 1410

16.1.88 Jan 09, 2020: Tennessee Fertility Institute welcomes Reproductive Endocrinologist, Dr. Jane Ruman 1410

16.1.89 Jan 09, 2020: Mateon Therapeutics: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers 1411

16.1.90 Jan 09, 2020: Chembio Diagnostics announces CEO transition 1411

16.1.91 Jan 08, 2020: BioCardia announces new U.S. patent covering CardiAMP cell therapy and issuance of two Asian patents covering Radial Artery approach for Cardiac Cell and Gene Therapy Delivery 1412

16.1.92 Jan 08, 2020: ZAGENO bolsters leadership with appointment of CFO, Robert Cruickshank 1413

16.1.93 Jan 08, 2020: Avid Bioservices appoints Timothy Compton as Chief Commercial Officer 1414

16.1.94 Jan 08, 2020: ABBOTT LABORATORIES: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers. 1414

16.1.95 Jan 08, 2020: AbbVie announces leadership team and creation of new business, Allergan Aesthetics, upon completion of acquisition 1414

16.1.96 Jan 07, 2020: Summit Therapeutics launches online resource for patients with C. difficile Infection 1415

16.1.97 Jan 07, 2020: ArcherDX appoints Mark Massaro Chief Financial Officer 1416

16.1.98 Jan 07, 2020: Dr. Thomas J. Lynch Jr. named new president and director of Fred Hutch 1417

16.1.99 Jan 07, 2020: Cleveland Clinic appoints Lara Jehi, M.D., Chief Research Information Officer 1417

16.1.100 Jan 07, 2020: Lurie Children’s Hospital appoints Fatema Zanzi as Chief Legal Officer 1418

16.1.101 Jan 07, 2020: BioDirection appoints Dr. Jean-Luc Boulnois to its Board of Directors 1418

16.1.102 Jan 06, 2020: Cellectar receives orphan drug designation for CLR 131 in lymphoplasmacytic lymphoma (LPL) 1419

16.1.103 Jan 06, 2020: Kura Oncology appoints Kirsten Flowers as Chief Commercial Officer 1420

16.1.104 Jan 06, 2020: Bio-Rad appoints Dara Grantham Wright Executive Vice President and Clinical Diagnostics Group President 1421

16.1.105 Jan 06, 2020: Turning Point Therapeutics names Homa Yeganegi Senior Vice President, project team leader and head of Medical Affairs 1421

16.1.106 Jan 06, 2020: Jack Westfall, MD, MPH, Named Director of Robert Graham Center 1422

16.1.107 Jan 02, 2020: ThermoGenesis Holdings announces board of directors and management changes 1423

16.1.108 Jan 02, 2020: Aridis Pharmaceuticals appoints Michael A. Nazak as chief financial officer 1423

16.1.109 Jan 02, 2020: Experienced healthcare leader Oenone Duroe joins Inspirata as General Manager, Europe 1424

16.1.110 Jan 02, 2020: Plus Therapeutics appoints Dr. An van Es-Johansson to board of directors 1424

16.1.111 Dec 31, 2019: Enzo Biochem appoints Rebecca J. Fischer to Board of Directors 1425

16.1.112 Dec 31, 2019: Redbud Labs expands team in response to increased demand 1426

16.1.113 Dec 31, 2019: Mateon Therapeutics announces the resignation of CMO 1426

16.1.114 Dec 30, 2019: Titan Pharmaceuticals appoints Dr. Kate DeVarney to its board of directors 1426

16.1.115 Dec 26, 2019: Five Prime Therapeutics announces resignation of Dr. Lewis T. “Rusty” Williams from board of directors 1427

16.1.116 Dec 23, 2019: FibroGen submits New Drug Application to the U.S. FDA for Roxadustat in patients with anemia of chronic kidney disease 1428

16.1.117 Dec 23, 2019: Urovant Sciences initiates patient enrollment in phase 2a study of URO-902 1429

16.1.118 Dec 23, 2019: Mayo Clinic names chief digital officer to lead transformative digital strategy, create Center for Digital Health 1429

16.1.119 Dec 20, 2019: Syros announces appointment of Mark Alles to its board of directors 1430

16.1.120 Dec 20, 2019: ImmunoGen:Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers 1431

16.1.121 Dec 19, 2019: Zenith Epigenetics announces clinical advancement of ZEN-3694 1431

16.1.122 Dec 19, 2019: MaxCyte appoints new executive vice president, business development for CARMA Cellular Therapies and trial update 1432

16.1.123 Dec 19, 2019: Truffle Capital raises €250m for medical venture fund 1433

16.1.124 Dec 19, 2019: Incyte announces new member to its Board of Directors 1434

16.1.125 Dec 19, 2019: Molecular Templates appoints Corazon Dating Sanders, Ph.D., to its Board of Directors 1434

16.1.126 Dec 19, 2019: Incyte names new member to its board of directors 1435

16.1.127 Dec 18, 2019: Molecular diagnostics company ArcherDX raises series C funds 1435

16.1.128 Dec 18, 2019: Pfizer and Mylan announce two future Viatris board members 1436

16.1.129 Dec 18, 2019: IDEAYA Biosciences appoints Wendy Yarno to its board of directors 1437

16.1.130 Dec 18, 2019: XCR Diagnostics announces the appointment of J. Chuck Morrison to its board of directors 1437

16.1.131 Dec 18, 2019: KromaTiD announces the appointment of David Brunel to its board of directors 1438

16.1.132 Dec 16, 2019: Seres Therapeutics appoints Stephen Berenson as Chairman of its Board of Directors 1438

16.1.133 Dec 16, 2019: OncoSec to receive approximately $885,000 through New Jersey Technology Business Tax (NOL) program 1439

16.1.134 Dec 16, 2019: GRAIL appoints Gautam Kollu as Chief Commercial Officer 1439

16.1.135 Dec 16, 2019: Amneal appoints Jeff George, John Kiely and Shlomo Yanai to Board of Directors 1439

16.1.136 Dec 16, 2019: Aeterna Zentaris announces 2020 director changes 1440

16.1.137 Dec 16, 2019: InsideTracker announces continued expansion of leadership team 1441

16.1.138 Dec 13, 2019: Bristol-Myers Squibb announces leadership changes 1441

16.1.139 Dec 11, 2019: Steven King named as prospective CEO of EdgePoint AI 1442

16.1.140 Dec 11, 2019: Glooko earns privacy shield certification for policies to safeguard diabetes patient data 1443

16.1.141 Dec 10, 2019: National experts in autoimmunity tapped to serve on Exagen’s scientific advisory board 1444

16.1.142 Dec 10, 2019: Admera Health Announces Appointment of Omar Karame as Chief Financial Officer 1446

16.1.143 Dec 09, 2019: McKesson appoints Nancy Flores as executive vice president, chief information and chief technology officer 1447

16.1.144 Dec 06, 2019: Enzychem Lifesciences announces collaborative material transfer agreement (MTA) with the Armed Forces Radiobiology Research Institute (AFRRI) for the development of a radiation medical countermeasure. 1448

16.1.145 Dec 06, 2019: CStone appoints seasoned pharmaceutical executive Shirley Zhao as the General Manager for Greater China and head of commercial 1449

16.1.146 Dec 05, 2019: So-Young announces changes to Board of Directors 1450

16.1.147 Dec 05, 2019: Akers Biosciences continues strategic review; explores leveraging its 30-years of laboratory operations to enter into the hemp and minor cannabinoid processing industry 1450

16.1.148 Dec 05, 2019: PreludeDx announces David J. Dabbs, MD as Chief of Pathology and Director of BREAST SOS (Second Opinion Service) 1451

16.1.149 Dec 05, 2019: Celcuity announces appointment of Richard Buller to Board of Directors 1452

16.1.150 Dec 05, 2019: Bill & Melinda Gates Foundation CEO Sue Desmond-Hellmann to Step Down, Longtime Foundation Executive Mark Suzman Appointed to Role 1452

16.1.151 Dec 05, 2019: Johnson & Johnson names Hubert Joly, Executive Chairman of Best Buy and Mark A. Weinberger, Former EY Global Chairman and CEO to its Board of Directors 1454

16.1.152 Dec 05, 2019: AbGenomics welcomes Dr. Judy Chou as new President/CEO 1455

16.1.153 Dec 04, 2019: Sesen Bio completes successful CMC Type B pre-BLA Meeting with FDA 1455

16.1.154 Dec 04, 2019: SI-BONE names Jeryl Hilleman to Board of Directors 1457

16.1.155 Dec 04, 2019: Accelerate Diagnostics announces executive transition: Lawrence Mehren to retire as Chief Executive Officer; Jack Phillips appointed as Successor 1457

16.1.156 Dec 04, 2019: Deciphera Pharmaceuticals announces appointment of Ron Squarer to its Board of Directors 1458

16.1.157 Dec 04, 2019: Aruna Bio appoints Dr. James Paskavitz as Vice President of Research and Development 1459

16.1.158 Dec 04, 2019: Astarte Medical announces expansion of leadership team with recognized industry veterans to support its mission of improving preterm infant outcomes 1459

16.1.159 Dec 03, 2019: Laboratory for Advanced Medicine adds high-profile Cigna Health Senior Executive To Its Board of Directors 1460

16.1.160 Dec 03, 2019: Dr. John Halamka named president of Mayo Clinic Platform 1461

16.1.161 Dec 02, 2019: Agios appoints Bruce Car, Ph.D., as Chief Scientific Officer 1461

16.1.162 Nov 26, 2019: Hologic to launch Unifi Workspace, Comprehensive Reading Solution for Breast Health Diagnostics 1462

16.1.163 Nov 26, 2019: LabCorp appoints senior finance executive Jeffrey A. Davis to its Board of Directors 1463

16.1.164 Nov 26, 2019: Deciphera Pharmaceuticals expands its Board of Directors with appointment of Frank S. Friedman 1464

16.1.165 Nov 25, 2019: Agios appoints Jonathan Biller as Chief Legal Officer 1464

16.1.166 Nov 21, 2019: NM company secures funds, land for medical-isotope producing reactor using Sandia concept 1465

16.1.167 Nov 21, 2019: Cleveland Clinic names James Merlino, M.D., chief clinical transformation officer 1466

16.1.168 Nov 20, 2019: Former Cleveland Clinic CEO Toby Cosgrove, MD, joins InnovaHealth Partners as Senior Advisor 1467

16.1.169 Nov 19, 2019: Clinical Innovations hires Rebecca Liu as VP, general manager for CI Medical Instruments in China 1467

16.1.170 Nov 19, 2019: ATCC appoints Dr. Raymond D. Stapleton President and Chief Operating Officer 1468

16.1.171 Nov 19, 2019: Conversion right triggered for LabCorp’s zero coupon convertible subordinated notes due 2021 1469

16.1.172 Nov 18, 2019: MorphoSys’ tafasitamab B-MIND DLBCL study successfully passed futility analysis 1469

16.1.173 Nov 14, 2019: Studies prove VibraCool reduces opioid use and is 4x more effective for pain than other technologies 1470

16.1.174 Nov 14, 2019: Sera Prognostics funds commercialisation of PreTRM test 1471

16.1.175 Nov 14, 2019: PredictImmune pleased to announce the appointment of James Clark as Chief Technology Officer 1471

16.1.176 Nov 14, 2019: CytoDyn appoints new Chief Financial Officer 1472

16.1.177 Nov 14, 2019: Sema4 appoints biotech leader Joel Sendek as Chief Financial Officer 1474

16.1.178 Nov 14, 2019: Insmed appoints Dr. Clarissa Desjardins to its Board of Directors and names Roger Adsett Chief Operating Officer 1474

16.1.179 Nov 14, 2019: SEngine Precision Medicine names Surgical Oncologist and Cancer Care Advocate Dr. Astrid Margossian as Chief Medical Officer 1475

16.1.180 Nov 13, 2019: MC10 announces the use of BioStamp nPoint in phase III study of Huntington Disease 1476

16.1.181 Nov 13, 2019: Abbott announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020 1477

16.1.182 Nov 13, 2019: Dr. Melvin Weinstein becomes a member of First Light Diagnostics Clinical Advisory Board 1478

16.1.183 Nov 13, 2019: Danaher announces appointment of Jessica L. Mega, MD, MPH and Pardis C. Sabeti MD, D.Phil to Danaher Board 1478

16.1.184 Nov 13, 2019: Aruna Bio appoints Dr. Renee Boerner as Vice President of Regulatory Affairs 1479

16.1.185 Nov 12, 2019: Prescient Medicine hires new Chief Commercial Officer 1480

16.1.186 Nov 11, 2019: Centerline Biomedical’s Intra-Operative Positioning System Technology showcased at VIVA Disruptive Technologies Session 1480

16.1.187 Nov 08, 2019: Dana-Farber Cancer Institute earns “LGBTQ Health Care Equality Top Performer” Designation in HRC Foundation’s Healthcare Equality Index 1481

16.1.188 Nov 08, 2019: Big Lots raises $3 million during its fall “Give Big for Kids” campaign for Nationwide Children’s Hospital 1482

16.1.189 Nov 07, 2019: Armonica Technologies appoints Dr. Victor Esch as Chief Executive Officer 1482

16.1.190 Nov 06, 2019: ViiV Healthcare presents on Juluca at the 17th European AIDS Conference 1483

16.1.191 Nov 06, 2019: LabCorp announces Departure of John Ratliff, names New LabCorp Diagnostics leadershin 1485

16.1.192 Nov 06, 2019: Vericel announces appointment of Sean C. Flynn as Vice President and General Counsel 1485

16.1.193 Nov 05, 2019: New preclinical data on naptumomab estafenatox will be presented at the Society for Immunotherapy of Cancer’s 34th Annual Meeting 1486

16.1.194 Nov 05, 2019: Biodesix appoints Scott Hutton as chief executive officer 1486

16.1.195 Nov 05, 2019: IDEAYA Biosciences announces leadership updates in research organization 1487

16.1.196 Nov 05, 2019: DNA Script to open U.S. Office in South San Francisco to support commercialization of the company’s industry-leading enzymatic synthesis technology 1488

16.1.197 Nov 05, 2019: Montefiore Medicine names Philip O. Ozuah, MD, PhD, as CEO 1489

16.1.198 Nov 05, 2019: Loop Genomics launches long-read microbiome sequencing service at short-read price 1490

16.1.199 Nov 05, 2019: Quest Diagnostics Earns Gold Status in American Heart Association’s 2019 Workplace Health Achievement Index 1490

16.1.200 Nov 04, 2019: Minnetronix Medical names Jeremy Maniak President and CEO 1491

16.1.201 Nov 04, 2019: Accelerate Diagnostics appoints Roland Diggelmann to its board of directors 1491

16.1.202 Nov 04, 2019: Laboratory for Advanced Medicine appoints Kenneth Chahine, Ph.D., J.D., as chief executive officer 1492

16.1.203 Oct 31, 2019: NanoString appoints Don Kania, Ph.D. to its board of directors 1492

16.1.204 Oct 31, 2019: Harvard Bioscience Announces Executive Appointment 1493

16.1.205 Oct 31, 2019: Reeti Khare, PhD, D(ABMM), Named Infectious Disease Laboratory Director, Advanced Diagnostic Laboratories at National Jewish Health 1493

16.1.206 Oct 30, 2019: AMRA Technology added to Dallas Hearts and Minds Study, expands AMRA’s population database for body composition 1493

16.1.207 Oct 30, 2019: Entasis Therapeutics appoints Dr. David Altarac as chief medical officer 1494

16.1.208 Oct 29, 2019: Macadamian Technologies achieves Microsoft Gold Partner Status & Azure Cloud Platform Competency 1495

16.1.209 Oct 29, 2019: Tempus announces the appointment of Scott Gottlieb, MD, to its board of directors 1496

16.1.210 Oct 28, 2019: Anixa Biosciences names Novartis Executive Dr. Emanuele Ostuni to Scientific Advisory Board 1496

16.1.211 Oct 28, 2019: Roche Diagnostics Announces Matthew Sause As Chief Executive Officer – North America 1497

16.1.212 Oct 28, 2019: Vaxart announces changes to its board of directors 1497

16.1.213 Oct 24, 2019: Akouos appoints Rabia Gurses Ozden, M.D., as Chief Development Officer 1498

16.1.214 Oct 24, 2019: IDEXX Laboratories announces leadership changes 1499

16.1.215 Oct 24, 2019: LetsGetChecked appoints healthcare industry veteran Troy Cox to Board of Directors 1499

16.1.216 Oct 24, 2019: Thomas Lehner, PhD, MPH, Joins the New York Genome Center as scientific director of Neuropsychiatric Disease genomics 1500

16.1.217 Oct 23, 2019: Enrique Conterno, Senior Vice President and President of Lilly Diabetes and Lilly USA, to retire at end of year; Mike Mason to succeed Conterno 1501

16.1.218 Oct 23, 2019: Laboratory for Advanced Medicine appoints to its Board of Directors Dr. Alan List, President and CEO, Moffitt Cancer Center 1502

16.1.219 Oct 23, 2019: Katherine Hisert, MD, PhD, joins National Jewish Health Cystic Fibrosis Program 1502

16.1.220 Oct 22, 2019: ZAGENO names industry veteran, Paul Goetz as Chief Revenue Officer 1502

16.1.221 Oct 22, 2019: Progenity strengthens executive leadership team with appointment of Sami Shihabi as Chief Commercial Officer 1503

16.1.222 Oct 22, 2019: David Meline, Amgen’s Chief Financial Officer, to retire 1504

16.1.223 Oct 21, 2019: Retrospective real-world comparative analysis highlights safety of vedolizumab and Anti-TNFa therapies in biologic-naïve patients with Ulcerative Colitis or Crohn’s Disease 1504

16.1.224 Oct 21, 2019: Dr. Mark H. Pollack named Chief Medical Officer for Myriad Neuroscience 1506

16.1.225 Oct 21, 2019: Harvard Bioscience announces Executive appointment 1507

16.1.226 Oct 21, 2019: Exagen to be honored with National Research Innovation award by Lupus Foundation of America 1507

16.1.227 Oct 18, 2019: McKesson’s Board of Directors appoints Maria Martinez as new independent Director 1507

16.1.228 Oct 17, 2019: Joslin Diabetes Center’s president and CEO will step down at year’s end 1508

16.1.229 Oct 17, 2019: Innovative Cancer Treatment Medical Device Company appoints Dr. Jonathan Jarow, MD as Chief Medical Officer 1509

16.1.230 Oct 16, 2019: Bicycle Therapeutics to present new translational data for BT1718 at AACR-NCI-EORTC 2019 1510

16.1.231 Oct 16, 2019: Syapse appoints Dr. Thomas D. Brown as Chief Medical Officer 1511

16.1.232 Oct 16, 2019: ZAGENO appoints Josef H. von Rickenbach as Chairman of its Board of Directors 1512

16.1.233 Oct 15, 2019: Ashley Reynolds named Chief Experience Officer for BioIQ 1512

16.1.234 Oct 15, 2019: Kura Oncology expands Board of Directors with appointment of Diane Parks 1513

16.1.235 Oct 15, 2019: Anixa Biosciences appoints Dr. Thomas Schlumpberger as executive vice president of Diagnostics to head liquid biopsy development and commercialization efforts 1514

16.1.236 Oct 15, 2019: Caris Life Sciences further bolsters scientific advisory board with four new members 1514

16.1.237 Oct 15, 2019: Gilead Sciences appoints Andrew Dickinson as chief financial officer 1515

16.1.238 Oct 15, 2019: Bio-Path appoints Martina Molsbergen to Board of Directors 1516

16.1.239 Oct 15, 2019: Fluxergy appoints Dr. Ali Tinazli to lead commercial efforts 1516

16.1.240 Oct 15, 2019: Gemelli Biotech, innovator in Microbiome space, producer of ibs-smart, announces Scientific Advisory Board 1517

16.1.241 Oct 14, 2019: Drawbridge Health announces key leadership appointments 1518

16.1.242 Oct 14, 2019: Biocare Medical appoints Nicolas Barthelemy as Executive Chairman 1518

16.1.243 Oct 14, 2019: Claus Torp Jensen has been appointed first Chief Digital Officer and Head of Technology for Memorial Sloan Kettering Cancer Center 1519

16.1.244 Oct 11, 2019: TherapeuticsMD announces presentations on ANNOVERA at the 2019 Annual Meeting of the American Society for Reproductive Medicine 1520

16.1.245 Oct 11, 2019: Aridis Pharmaceuticals appoints infectious disease expert Paul Mendelman, MD as interim Chief Medical Officer 1520

16.1.246 Oct 10, 2019: Anixa Biosciences names Cancer Vaccine Pioneer Dr. Ian H. Frazer to Scientific Advisory Board 1521

16.1.247 Oct 10, 2019: Alexion announces appointment of Tanisha Carino, Ph.D., as Chief Corporate Affairs Officer 1522

16.1.248 Oct 10, 2019: Atrium Health welcomes new Senior Vice President, Enterprise Strategy and Planning 1523

16.1.249 Oct 10, 2019: City of Hope helps found biotechnology hub for Los Angeles county’s life sciences industry 1523

16.1.250 Oct 09, 2019: Agilent opens state-of-the-art spectroscopy site in the UK 1524

16.1.251 Oct 09, 2019: Avid Bioservices names Richard Richieri as Chief Operations Officer 1525

16.1.252 Oct 09, 2019: Dr. Angela Caliendo joins first Light Diagnostics Clinical Advisory Board 1526

16.1.253 Oct 08, 2019: Biodesix names Dr. James Jett Chief Medical Officer 1526

16.1.254 Oct 08, 2019: Instrumentation Laboratory awarded 2019 IMV ServiceTrak award for best Hemostasis System performance 1527

16.1.255 Oct 08, 2019: CardioWise named a top-ten finalist in Best Cardiovascular Digital Diagnostic Category by UCSF Health Hub 1527

16.1.256 Oct 07, 2019: Gilead Sciences appoints Merdad Parsey, MD, PhD as Chief Medical Officer 1528

16.1.257 Oct 07, 2019: BioMarin promotes Lon Cardon, Ph.D. to Chief Scientific Strategy Officer 1528

16.1.258 Oct 07, 2019: Humana management team members Tim Huval and Sam Deshpande assume additional areas of responsibility 1529

16.1.259 Oct 07, 2019: GRAIL appoints Matthew Young as Chief Operating Officer and Chief Financial Officer 1530

16.1.260 Oct 04, 2019: Aeterna Zentaris announces appointment of New President and Chief Executive Officer 1530

16.1.261 Oct 03, 2019: LabCorp announces new leadership roles for its two business segments and selects new Chief Human Resources Officer 1531

16.1.262 Oct 02, 2019: Deciphera Pharmaceuticals appoints Matthew L. Sherman, M.D. as executive vice president and chief medical officer 1532

16.1.263 Oct 02, 2019: NanoString appoints Mark Winham Senior Vice President of Operations 1533

16.1.264 Oct 02, 2019: Bioivt appoints Global Business Strategist Lori Ball as its Chief Operating Officer 1533

16.1.265 Oct 01, 2019: BrainsWay Announces Innovative Deep Transcranial Magnetic Stimulation System Showcase Presentation at this Year’s Psych Congress Meeting 1534

16.1.266 Oct 01, 2019: Charles River Laboratories Adds Virginia M. Wilson to Board of Directors 1535

16.1.267 Oct 01, 2019: HSS appoints Fahrenkopf to lead new Musculoskeletal Health Ecosystem 1536

16.1.268 Oct 01, 2019: Humana appoints Jennifer Bazante chief marketing officer 1537

16.1.269 Oct 01, 2019: Stewart B. Jacobson, DVM, DACVP, joins BASi as Vice President, Pathology, filling key scientific Leadership position 1538

16.1.270 Sep 30, 2019: Johnson & Johnson appoints Carlton Lawson to area Managing Director, Consumer, Northern Europe 1538

16.1.271 Sep 30, 2019: GRAIL appoints Marissa Song as General Counsel and Corporate Secretary 1539

16.1.272 Sep 27, 2019: Study shows safety and efficacy of Near Infrared Spectroscopy (NIRS) Imaging to identify patients and plaques at an increased risk for MACE 1539

16.1.273 Sep 27, 2019: Ian Read to retire as executive chairman of Pfizer’s board of directors; chief executive Officer Dr. Albert Bourla named chairman 1541

16.1.274 Sep 27, 2019: Pfizer awards “Golden Tickets” to Neutrolis and Mediar Therapeutics 1541

16.1.275 Sep 26, 2019: Scancell to present six posters at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference 1542

16.1.276 Sep 26, 2019: BD announces leadership succession plan 1544

16.1.277 Sep 26, 2019: HSS Names Harvinder S. Sandhu, MD, MBA, & Andrew A. Sama, MD, New Co-Chiefs of HSS Spine 1546

16.1.278 Sep 26, 2019: GENFIT reinforces corporate leadership in the U.S. 1546

16.1.279 Sep 26, 2019: Cofactor Genomics Expands Leadership Team and Opens New Boston Predictive Immune Modeling Center 1547

16.1.280 Sep 26, 2019: Sherlock Biosciences awarded contract from U.S. Defense Threat Reduction Agency to support the development of ultra-fast, ultra-sensitive diagnostics 1547

16.1.281 Sep 25, 2019: Dr. Andrew Peterson joins MedGenome as Chief Scientific Officer 1548

16.1.282 Sep 25, 2019: ZAGENO expands leadership to meet life science market demands 1549

16.1.283 Sep 25, 2019: Myriad Genetics expands Board of Directors with two additional members 1549

16.1.284 Sep 25, 2019: NanoCellect Biomedical adds to executive Leadership Team with New VP of Finance 1550

16.1.285 Sep 24, 2019: Children’s National Hospital taps Virginia Tech health sciences leader for advisory board 1550

16.1.286 Sep 24, 2019: Shiloh J. Barfield appointed as Vice President of Global Business Development 1551

16.1.287 Sep 23, 2019: Humana elects Karen W. Katz to Board of Directors 1552

16.1.288 Sep 23, 2019: Illumina names Joydeep Goswami senior vice president of corporate development and strategic planning 1552

16.1.289 Sep 23, 2019: Thrive Earlier Detection announces appointment of Seema Singh Bhan as Senior Vice President, Public Policy and External Affairs 1553

16.1.290 Sep 23, 2019: Cardiologist Minisha Kochar, MD, joins National Jewish Health 1554

16.1.291 Sep 19, 2019: Merrimack Pharmaceuticals announces changes to Board of Directors 1554

16.1.292 Sep 19, 2019: Zellkraftwerk wins multiple awards for innovative ChipCytometry platform 1556

16.1.293 Sep 19, 2019: Five Prime Therapeutics announces Management Transition 1556

16.1.294 Sep 18, 2019: Medisafe announces new executive appointments to support continued growth and market expansion 1557

16.1.295 Sep 17, 2019: Ampio Pharmaceuticals updates progress of SPA trial 1557

16.1.296 Sep 17, 2019: Ontera expands executive leadership team as the Nanopore Diagnostics Company advances towards product commercialization 1558

16.1.297 Sep 17, 2019: Specific Diagnostics announces that Eric B. Stang joins its Advisory Board 1559

16.1.298 Sep 17, 2019: Pressure BioSciences prepares for growth, adding Daniel J. Shea as Chief Financial Officer 1560

16.1.299 Sep 17, 2019: SGS appoints Steven Thys as Director of Global Clinical Operations 1561

16.1.300 Sep 16, 2019: DermTech announces appointment of Kevin Sun as Chief Financial Officer 1561

16.1.301 Sep 16, 2019: AIM ImmunoTech names Ellen Lintal as new chief financial officer 1562

16.1.302 Sep 12, 2019: Haemonetics Appoints Stewart W. Strong As President, Global Hospital 1562

16.1.303 Sep 12, 2019: Personalis Appoints Karin Eastham to Its Board of Directors 1563

16.1.304 Sep 11, 2019: Immunexpress appoints Jane Papadaki Markley as VP of Market Development and Commercial Operations 1563

16.1.305 Sep 11, 2019: Bristol-Myers Squibb Board announces election of three new Directors 1564

16.1.306 Sep 11, 2019: Mark Beaudouin to retire as Waters General Counsel; Company promotes Keeley Aleman 1565

16.1.307 Sep 10, 2019: Quest Diagnostics names Manuel O. Méndez as new commercial leader 1566

16.1.308 Sep 10, 2019: SetPoint Medical appoints Anna Gawlicka as VP of Clinical Affairs 1566

16.1.309 Sep 10, 2019: Patrick Terry announced as first Chief Commercial Officer of SomaLogic 1567

16.1.310 Sep 09, 2019: Epic Sciences expands Executive Leadership Team 1567

16.1.311 Sep 09, 2019: Celcuity announces appointment of Eric Lindquist as chief business officer 1568

16.1.312 Sep 05, 2019: BioIQ names Addison Giannini Senior Vice President, Payor Solutions 1568

16.1.313 Sep 05, 2019: Thermo Fisher Scientific elects New Director to Board 1569

16.1.314 Sep 04, 2019: William D. Pitchford joins BASi as chief human resources officer, as the company invests in unifying and strengthening corporate culture 1569

16.1.315 Sep 04, 2019: Harvard Bioscience elects Alan Edrick to Board of Directors 1570

16.1.316 Sep 04, 2019: Chembio Diagnostics announces $20 million term loan with perceptive advisors 1570

16.1.317 Sep 03, 2019: Feng Lin, MD, Ph.D., joins Therapeutic Solutions International as Chief Scientific Officer 1571

16.1.318 Sep 03, 2019: Tempus expands its management team with the appointment of Lauren Silvis as Senior Vice President of External Affairs 1572

16.1.319 Sep 03, 2019: Akouos announces executive leadership team appointments 1572

16.1.320 Aug 29, 2019: Natera appoints Rowan Chapman to its Board of Directors 1573

16.1.321 Aug 28, 2019: Waters names Jonathan M. Pratt as President of TA Instruments 1573

16.1.322 Aug 27, 2019: Shoreline Biome hires new CEO and VP of Business Development 1574

16.1.323 Aug 27, 2019: Chris Smith named next Chief Executive Officer of Ortho Clinical Diagnostics 1574

16.1.324 Aug 27, 2019: Chris Cournoyer joins CareDx Board of Directors 1575

16.1.325 Aug 26, 2019: Priya Chaturvedi, Ph.D., appointed Vice President of Global Clinical Quality Assurance at Eisai 1576

16.1.326 Aug 26, 2019: GRAIL appoints Rodger Currie as head of government affairs and alliance development 1576

16.1.327 Aug 23, 2019: Predictive Technology Group names biologic industry leader Jeff Acuff as Chief Commercial Officer Of Predictive Biotech 1577

16.1.328 Aug 22, 2019: Tempus expands leadership team with the appointment of Joel Dudley, PhD, as senior vice president of research 1578

16.1.329 Aug 21, 2019: Rebiotix and Karolinska Institutet expand partnership to shape the future of microbiome research 1579

16.1.330 Aug 21, 2019: PerkinElmer announces leadership succession plan 1579

16.1.331 Aug 20, 2019: Aeterna Zentaris announces director change 1579

16.1.332 Aug 20, 2019: Cleveland Clinic Akron General designated a Thrombectomy-Capable Stroke Center 1580

16.1.333 Aug 19, 2019: Merit Medical announces appointment of Lynne N. Ward to its Board of Directors 1580

16.1.334 Aug 19, 2019: Goodwin Biotechnology Announces the appointment of Kent Payne, Ph.D. and Brandon Price, Ph.D. to its Board of Directors 1581

16.1.335 Aug 19, 2019: Retirement of Dr. Sandra Horning & Appointment of Dr. Levi Garraway to Chief Medical Officer, Roche and Genentech 1581

16.1.336 Aug 15, 2019: Riot Blockchain announces CFO change 1582

16.1.337 Aug 14, 2019: Orasure Technologies appoints James a. Datin to its Board of Directors 1582

16.1.338 Aug 13, 2019: Biodesix adds Dr. Robert Georgantas III to Executive Leadership Team 1582

16.1.339 Aug 13, 2019: Microsoft welcomes new Chief Medical Officer Dr. David Rhew 1583

16.1.340 Aug 13, 2019: SI-BONE: Departure of directors or certain officers 1584

16.1.341 Aug 12, 2019: Kura Oncology announces appointment of Kathleen Ford as chief operating officer 1584

16.1.342 Aug 12, 2019: GSK announces leadership changes in the US 1585

16.1.343 Aug 08, 2019: Accelerate Diagnostics names Jack Phillips Chief Operating Officer 1585

16.1.344 Aug 08, 2019: ArunA Bio appoints Tony Townley to board of directors 1586

16.1.345 Aug 08, 2019: Laboratory for Advanced Medicine strengthens hepatology board with addition of three distinguished medical doctors 1586

16.1.346 Aug 08, 2019: NeoGenomics announces leadership transition and reiterates recently increased 2019 financial guidance 1587

16.1.347 Aug 07, 2019: Biodesix adds Dr. Charles Watts to Board of Directors 1587

16.1.348 Aug 07, 2019: Lilly announces leadership changes in corporate business development, oncology R&D, and managed healthcare services 1588

16.1.349 Aug 07, 2019: Humana names Kathie Mancini President, East Central Medicare Region 1588

16.1.350 Aug 07, 2019: Progenity Announces appointment of Brian Kotzin, M.D., to its board of directors 1589

16.1.351 Aug 07, 2019: Merck announces leadership changes to investor relations team 1589

16.1.352 Aug 07, 2019: Dean Scarborough and John Weiland to join Cardinal Health’s Board of Directors 1590

16.1.353 Aug 06, 2019: Daxor announces the acquisition of the BVA-100 Blood Volume Analyzer by a leading academic health center in the Pacific Northwest 1591

16.1.354 Aug 06, 2019: Goodwin Biotechnology announces the appointment of Gerald (“Jerry”) Orehostky as Vice President, Quality and Regulatory 1592

16.1.355 Aug 06, 2019: Seres Therapeutics appoints Stephen Berenson to its Board of Directors 1592

16.1.356 Aug 06, 2019: Predictive Technology Group names industry veteran Dr. E. Robert Wassman co-laboratory director of predictive laboratories 1593

16.1.357 Aug 05, 2019: Amneal Pharmaceuticals co-founders Chirag Patel and Chintu Patel return as co-chief executive officers 1594

16.1.358 Aug 05, 2019: Entasis Therapeutics appoints Dr. Howard Mayer to board of directors 1595

16.1.359 Aug 05, 2019: Fulgent Genetics names Linda Marsh to Board of Directors 1595

16.1.360 Aug 05, 2019: Foundation Medicine names Priti Hegde, Ph.D., as Chief Scientific Officer 1596

16.1.361 Aug 02, 2019: Veravas expands executive team with industry veteran Carroll E. Streetman Jr. as Chief Executive Officer 1596

16.1.362 Aug 01, 2019: Jonathan Day named VP, commercial operations, Americas 1597

16.1.363 Aug 01, 2019: Thrive Earlier Detection announces appointment of David J. Daly as Chief Executive Officer 1597

16.1.364 Jul 30, 2019: Oryzon closes enrolment in vafidemstat’s Phase IIa trials 1598

16.1.365 Jul 30, 2019: H-CYTE bolsters Board of Directors with appointment of Dr. Atta Behfar to its Board of Directors 1599

16.1.366 Jul 30, 2019: Codiak BioSciences expands Executive Leadership Team to advance Precision Exosome Therapeutics Pipeline 1600

16.1.367 Jul 30, 2019: Regulus Therapeutics appoints Cris Calsada as chief financial officer 1601

16.1.368 Jul 29, 2019: LabCorp announces election of director 1601

16.1.369 Jul 29, 2019: H-CYTE bolsters Board of Directors With appointment of Dr. Andre Terzic to Board of Directors 1601

16.1.370 Jul 29, 2019: Sherlock Biosciences strengthens leadership team with appointments of William J. Blake, Ph.D., as Chief Technology Officer and Don Haut, Ph.D., as Chief Business Officer 1602

16.1.371 Jul 29, 2019: Turning Point Therapeutics appoints biotechnology investment banker Yi Larson as Executive Vice President and Chief Financial Officer 1603

16.1.372 Jul 29, 2019: Verastem Oncology appoints Brian Stuglik as chief executive officer 1603

16.1.373 Jul 26, 2019: Sarah Hlavinka elected to Quanterix board of directors 1604

16.1.374 Jul 26, 2019: Avid Bioservices announces appointment of Catherine Mackey, Ph.D. to Board of Directors 1605

16.1.375 Jul 26, 2019: CytoDyn: change of Chief Medical Officer 1605

16.1.376 Jul 26, 2019: Exact Sciences: Resignation and appointment of Board of Directors 1605

16.1.377 Jul 25, 2019: Freenome raises $160m to advance cancer diagnostic test 1606

16.1.378 Jul 25, 2019: Bill W. Colston named to Fluidigm Board of Directors 1607

16.1.379 Jul 25, 2019: Turning Point Therapeutics names Carol Gallagher, Pharm.D. to its Board of Directors 1607

16.1.380 Jul 25, 2019: OncoCell appoints Marc Stapley to its board of directors 1608

16.1.381 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 1608

16.1.382 Jul 24, 2019: Pathnostics announces CEO appointment 1609

16.1.383 Jul 24, 2019: OncoCyte strengthens board of directors with addition of industry veteran Melinda Griffith 1610

16.1.384 Jul 23, 2019: MaxCyte adds Vice President, non-clinical and translational studies, to support advancement of programs from Its CARMA platform 1610

16.1.385 Jul 22, 2019: Adynxx adds Gregory J. Flesher to board of directors, completes up-listing to OTCQB market 1611

16.1.386 Jul 22, 2019: Fredrik Dalborg leaves the position as CEO of Boule Diagnostics 1611

16.2 Financial Announcements 1612

16.2.1 Jun 24, 2020: Cancer Genetics reports first quarter 2020 financial results and provides strategic business updates 1612

16.2.2 Jun 11, 2020: Babcock announces results for year ended March 31, 2020 1613

16.2.3 May 27, 2020: Thynk Health to support the ACR’s new COVID-19 data elements 1614

16.2.4 May 15, 2020: Novus Therapeutics reports first quarter 2020 financial results 1615

16.2.5 May 14, 2020: Aurinia reports first quarter 2020 financial results and recent operational highlights 1615

16.2.6 May 12, 2020: Turning Point Therapeutics reports first-quarter financial results, provides update on operations and COVID-19 response 1617

16.2.7 May 06, 2020: Alexion reports first quarter 2020 results 1619

16.2.8 May 06, 2020: Bruker announces Q1 2020 financial results 1622

16.2.9 May 06, 2020: Constellation Pharmaceuticals announces first-quarter 2020 financial results 1623

16.2.10 May 01, 2020: Honeywell announces earnings for Q1 of 2020 1625

16.2.11 May 01, 2020: ImmunoGen reports recent progress and first quarter 2020 financial results 1626

16.2.12 Apr 16, 2020: Abbott reports first-quarter 2020 results 1628

16.2.13 Mar 31, 2020: Akumin reports Q4 and year end 2019 results 1630

16.2.14 Mar 23, 2020: DiaMedica Therapeutics announces 2019 financial results and provides business update 1631

16.2.15 Mar 16, 2020: Turning Point Therapeutics reports fourth-quarter, full- year 2019 financial and operational results 1633

16.2.16 Mar 12, 2020: Geron reports fourth quarter and full year 2019 financial results and 2020 milestones 1634

16.2.17 Mar 12, 2020: Molecular Templates reports fourth quarter 2019 financial results 1636

16.2.18 Mar 12, 2020: Lineage Cell Therapeutics reports fourth quarter and full year 2019 financial results and provides business update 1638

16.2.19 Mar 11, 2020: Recipharm supports FDA approval of Perrigo’s AB-rated generic product 1642

16.2.20 Mar 11, 2020: Entasis Therapeutics reports full year 2019 financial results and business update 1643

16.2.21 Mar 10, 2020: Cocoon Medical Enters the U.S. Market with the Launch of their Signature Primelase System 1645

16.2.22 Mar 10, 2020: Avid Bioservices reports financial results for third quarter fiscal 2020 and recent developments 1646

16.2.23 Mar 10, 2020: Constellation Pharmaceuticals announces fourth-quarter and full-year 2019 financial results 1648

16.2.24 Mar 05, 2020: XCR Diagnostics secures patent for identifying infectious diseases 5X faster than the standard industry test 1650

16.2.25 Mar 05, 2020: Trevena announces FDA has set PDUFA date of August 7, 2020 for oliceridine 1651

16.2.26 Mar 02, 2020: Neon Therapeutics reports fourth quarter and full year 2019 financial results and provides business update 1653

16.2.27 Mar 02, 2020: Wave Life Sciences reports fourth quarter and full year 2019 financial results and provides business update 1654

16.2.28 Feb 28, 2020: NantHealth reports 2019 fourth-quarter, full-year financial results 1656

16.2.29 Feb 27, 2020: TRACON Pharmaceuticals reports fourth quarter and year-end 2019 financial results and provides corporate update 1658

16.2.30 Feb 27, 2020: Immunomedics reports fourth quarter and full year 2019 results and provides corporate update 1660

16.2.31 Feb 27, 2020: CareDx reports fourth quarter and full year 2019 results 1661

16.2.32 Feb 26, 2020: Fresenius Medical Care North America Advances Home Dialysis with New Telehealth Solution 1663

16.2.33 Feb 26, 2020: e-Stroke Suite launched across Slovakian stroke network 1664

16.2.34 Feb 26, 2020: MDxHealth reports financial year 2019 results and provides outlook for 2020 1666

16.2.35 Feb 26, 2020: Harvard Bioscience announces fourth quarter 2019 financial results 1668

16.2.36 Feb 26, 2020: United Therapeutics reports fourth quarter and full year 2019 financial results 1670

16.2.37 Feb 26, 2020: Amneal reports fourth quarter and full year 2019 financial results 1675

16.2.38 Feb 26, 2020: Adaptive Biotechnologies reports fourth quarter and full year 2019 financial results 1676

16.2.39 Feb 26, 2020: Natera reports fourth quarter and year 2019 financial results 1677

16.2.40 Feb 26, 2020: BioMarin announces fourth quarter and record full-year 2019 financial results 1679

16.2.41 Feb 25, 2020: InventHelp presents wound-cleaning device 1682

16.2.42 Feb 25, 2020: Canon Medical to commence development of a rapid genetic testing system for the Novel Coronavirus (COVID-19) 1684

16.2.43 Feb 25, 2020: Kura Oncology reports fourth quarter and full year 2019 financial results 1685

16.2.44 Feb 24, 2020: United Therapeutics announces INCREASE study of Tyvaso meets primary and all secondary endpoints 1687

16.2.45 Feb 24, 2020: Biotheranostics’ pivotal clinical study of the Breast Cancer Index featured on the cover of the Annals of Oncology 1689

16.2.46 Feb 24, 2020: Parallax provides mid-quarter update 1690

16.2.47 Feb 24, 2020: Guardant Health reports fourth quarter and full year 2019 financial results and provides full year 2020 outlook 1691

16.2.48 Feb 24, 2020: Merit Medical reports earnings for fourth quarter and year ended December 31, 2019, gives FY 2020 Guidance 1693

16.2.49 Feb 20, 2020: OpGen provides update on Curetis preliminary, unaudited 2019 condensed combined key financials and business update 1694

16.2.50 Feb 19, 2020: Invitae reports $216.8 million in annual revenue driven by more than 482,000 samples in 2019 1695

16.2.51 Feb 14, 2020: WAT Medical’s study finds that HeadaTerm TENS therapy provides a fast treatment for acute migraines in a randomized controlled trial 1697

16.2.52 Feb 13, 2020: Agios reports fourth quarter and full year 2019 financial results 1699

16.2.53 Feb 13, 2020: Zoetis reports fourth quarter and full year 2019 results 1700

16.2.54 Feb 13, 2020: Incyte reports 2019 fourth quarter and year-end financial results and provides 2020 financial guidance and updates on key clinical programs 1702

16.2.55 Feb 13, 2020: LabCorp announces 2019 fourth quarter and full year results and provides 2020 guidance 1705

16.2.56 Feb 13, 2020: Blueprint Medicines reports fourth quarter and full year 2019 financial results 1707

16.2.57 Feb 13, 2020: VistaGen Therapeutics reports fiscal 2020 third quarter financial results and provides CNS pipeline overview 1710

16.2.58 Feb 13, 2020: Bio-Rad reports fourth-quarter and full-year 2019 financial results 1712

16.2.59 Feb 12, 2020: Quidel reports fourth quarter and full year 2019 financial results 1714

16.2.60 Feb 11, 2020: Charles River Laboratories announces fourth-quarter and full-year 2019 results and provides 2020 guidance 1717

16.2.61 Feb 11, 2020: Psychemedics announces 4th quarter and year-end results 1719

16.2.62 Feb 11, 2020: Exact Sciences announces fourth-quarter 2019 results 1721

16.2.63 Feb 10, 2020: QT Ultrasound leaders to present breakthrough research on breast imaging technology 1721

16.2.64 Feb 10, 2020: Aethlon Medical announces third quarter financial results and provides corporate update 1722

16.2.65 Feb 10, 2020: Luminex reports fourth quarter and full-year 2019 results 1724

16.2.66 Feb 10, 2020: PRA Health Sciences reports fourth quarter and full year 2019 results and provides first quarter and full year 2020 guidance 1725

16.2.67 Feb 07, 2020: Meridian Bioscience reports first quarter fiscal 2020 operating results and reaffirms 2020 guidance 1726

16.2.68 Feb 06, 2020: BD announces results for 2020 first fiscal quarter; lowers fiscal 2020 guidance 1728

16.2.69 Feb 06, 2020: Cardinal Health reports second quarter results for fiscal year 2020 1729

16.2.70 Feb 06, 2020: Bristol-Myers Squibb reports fourth quarter and full year financial results for 2019 1730

16.2.71 Feb 06, 2020: Seattle Genetics reports fourth quarter and full year 2019 financial results 1733

16.2.72 Feb 06, 2020: Myriad Genetics reports fiscal second-quarter 2020 financial results 1736

16.2.73 Feb 06, 2020: Pacific Biosciences announces fourth quarter and annual 2019 financial results 1738

16.2.74 Feb 05, 2020: Humana reports fourth quarter 2019 financial results; provides full year 2020 financial guidance 1739

16.2.75 Feb 05, 2020: Merck announces fourth-quarter and full-year 2019 financial results 1740

16.2.76 Feb 05, 2020: Surmodics reports first quarter Fiscal 2020 results 1744

16.2.77 Feb 04, 2020: McKesson reports fiscal 2020 third quarter results 1745

16.2.78 Feb 04, 2020: Waters reports fourth quarter and full-year 2019 financial results 1746

16.2.79 Jan 31, 2020: IDEXX Laboratories announces fourth quarter and full year 2019 results 1747

16.2.80 Jan 30, 2020: Tech that detects cause of preemie blindness gets federal nod 1749

16.2.81 Jan 30, 2020: Alexion reports fourth quarter and full year 2019 results 1752

16.2.82 Jan 30, 2020: Quest Diagnostics reports record fourth quarter and full year 2019 revenues and earnings; provides guidance for full year 2020; increases dividend

5.7% to $0.56 per quarter 1755

16.2.83 Jan 30, 2020: Lilly reports strong fourth-quarter and full-year 2019 financial results, updates 2020 guidance for pending Dermira acquisition 1755

16.2.84 Jan 30, 2020: Danaher reports fourth quarter and full year 2019 results 1763

16.2.85 Jan 30, 2020: Thermo Fisher Scientific reports fourth quarter and full year 2019 results 1764

16.2.86 Jan 29, 2020: GE Healthcare unveils new imaging tech at Arab Health 1766

16.2.87 Jan 28, 2020: Four-year data from ILLUMENATE Pivotal trial reaffirms safety profile of Philips Stellarex low-dose Drug-Coated Balloon 1769

16.2.88 Jan 28, 2020: Pfizer reports fourth-quarter and full-year 2019 results 1771

16.2.89 Jan 27, 2020: Oncolytics Biotech announces statistically significant data identifying CEACAM6 as a prospective prognostic biomarker for pelareorep in the treatment of pancreatic adenocarcinoma 1778

16.2.90 Jan 27, 2020: Molecular Devices introduces new 3D imaging capabilities with water immersion technology 1780

16.2.91 Jan 27, 2020: PerkinElmer announces financial results for the fourth quarter 1782

16.2.92 Jan 22, 2020: Personalis to present at Precision Medicine World Conference 2020 1783

16.2.93 Jan 22, 2020: Johnson & Johnson reports 2019 fourth-quarter and full year results 1784

16.2.94 Jan 22, 2020: Abbott reports fourth-quarter 2019 results; announces strong forecast for 2020 1785

16.2.95 Jan 21, 2020: AIROS Medical granted FDA 510k clearance to market compression device for lymphedema treatment 1787

16.2.96 Jan 21, 2020: Myriad submits sPMA for BRACAnalysis CDx as a companion diagnostic for lynparza in metastatic castration-resistant prostate Cancer 1788

16.2.97 Jan 21, 2020: Adaptive announces preliminary unaudited revenue for full year 2019 1791

16.2.98 Jan 19, 2020: Bridge Biotherapeutics announces FDA IND clearance for BBT-176, an EGFR TKI for NSCLC 1792

16.2.99 Jan 15, 2020: Bluebird hires new Europe Head as gene therapy rollout starts 1793

16.2.100 Jan 14, 2020: Curetis launches Unyvero LRT Panel for BAL Specimens in the U.S. 1793

16.2.101 Jan 14, 2020: Fluidigm provides preliminary financial results for fourth quarter and fiscal year 2019 1796

16.2.102 Jan 13, 2020: Novus Therapeutics provides update on OP0201 1796

16.2.103 Jan 13, 2020: Accelerate Diagnostics announces preliminary fourth quarter and full-year 2019 financial results 1798

16.2.104 Jan 13, 2020: CareDx reports preliminary fourth quarter and full year 2019 results 1798

16.2.105 Jan 13, 2020: HTG Molecular Diagnostics announces preliminary 2019 unaudited financial results 1799

16.2.106 Jan 13, 2020: GenMark Diagnostics provides preliminary operational and financial results for 2019 1800

16.2.107 Jan 12, 2020: Exact Sciences announces preliminary fourth quarter 2019 results 1800

16.2.108 Jan 12, 2020: Hologic announces preliminary financial results for first quarter of fiscal 2020 1801

16.2.109 Jan 12, 2020: Baxter announces preliminary net sales for the fourth-quarter and full-year 2019 and announces preliminary full-year 2020 guidance 1802

16.2.110 Jan 12, 2020: NanoString provides preliminary operational and financial results for fourth quarter and FY 2019 1803

16.2.111 Jan 10, 2020: EMA recommends extension of therapeutic indications for Daratumumab 1804

16.2.112 Jan 09, 2020: AMAG Pharmaceuticals announces leadership transition, results of strategic review to unlock shareholder value and financial update 1805

16.2.113 Jan 09, 2020: SI-BONE reports preliminary unaudited revenue for fourth quarter and full year 2019 and provides full year 2020 revenue guidance 1806

16.2.114 Jan 09, 2020: T2 Biosystems announces preliminary fourth quarter 2019 financial results 1807

16.2.115 Jan 09, 2020: Quidel announces preliminary revenue for fourth quarter 2019 1807

16.2.116 Jan 09, 2020: Castle Biosciences announces preliminary fourth quarter and full-year 2019 performance results, delivering 29% DecisionDx-Melanoma Test report volume growth in 2019 1808

16.2.117 Jan 07, 2020: Immunexpress to present at Biotech Showcase 2020 in San Francisco 1809

16.2.118 Jan 07, 2020: Clovis Oncology announces product revenues for the fourth quarter and full year 2019 1810

16.2.119 Jan 02, 2020: FDA approves UVA-developed artificial pancreas 1811

16.2.120 Dec 29, 2019: Illumina reports financial results for fourth quarter and fiscal year 2019 1812

16.2.121 Dec 23, 2019: Significant milestone reached – product tested on patient 1814

16.2.122 Dec 23, 2019: Calmark’s product Neo-Bilirubin will obtain CE Mark approval in January 2020 1817

16.2.123 Dec 23, 2019: Neogen reports second quarter results 2019 1818

16.2.124 Dec 23, 2019: BASi closes fiscal 2019 with strong fourth quarter 1820

16.2.125 Dec 19, 2019: REDBUD LABS STR microfluidic chip enables 1000x faster sample prep for on-cartridge magnetic bead assay 1822

16.2.126 Dec 19, 2019: Pressure BioSciences reports third quarter 2019 financial results and provides business update 1823

16.2.127 Dec 16, 2019: Sectra announces imaging contract with BJC HealthCare 1825

16.2.128 Dec 10, 2019: Enzo Biochem reports fiscal first quarter results 1827

16.2.129 Dec 09, 2019: Kezar Life Sciences highlights therapeutic potential of protein secretion inhibitors at the 61st American Society of Hematology annual meeting 1829

16.2.130 Dec 09, 2019: Avid Bioservices reports financial results for second quarter fiscal 2020 and recent developments 1831

16.2.131 Dec 05, 2019: Epic Sciences to present new data showing feasibility of its liquid biopsy test in breast cancer 1833

16.2.132 Dec 03, 2019: How a single blood test may provide a ‘Head-to-Toe’ health check 1836

16.2.133 Nov 27, 2019: VUNO presents the future of medical AI solutions at RSNA 2019 1839

16.2.134 Nov 20, 2019: Cancer Genetics reports third quarter 2019 financial results and provides strategic business update 1841

16.2.135 Nov 19, 2019: International Isotopes announces financial results for the third quarter 2019 1842

16.2.136 Nov 19, 2019: ThermoGenesis Holdings announces improved third quarter 2019 financial results and provides corporate update 1844

16.2.137 Nov 18, 2019: Parallax Health Sciences reports third quarter 2019 financial results 1846

16.2.138 Nov 18, 2019: Sintx technologies releases 2019 third quarter and year to date earnings report and provides business update 1847

16.2.139 Nov 15, 2019: Bio-Path Holdings reports third quarter 2019 financial results 1848

16.2.140 Nov 15, 2019: AIM ImmunoTech provides business update for the third quarter of 2019 1849

16.2.141 Nov 14, 2019: Entasis Therapeutics reports third quarter 2019 financial results and provides business update 1850

16.2.142 Nov 14, 2019: Cleveland BioLabs reports third quarter 2019 financial results and development progress 1852

16.2.143 Nov 14, 2019: Predictive Technology Group reports first quarter fiscal 2020 financial results and provides corporate update 1853

16.2.144 Nov 14, 2019: Titan Pharmaceuticals reports third quarter 2019 financial results 1855

16.2.145 Nov 13, 2019: Palatin Technologies reports first quarter fiscal year 2020 results and provides corporate update 1856

16.2.146 Nov 13, 2019: IDEAYA Biosciences reports third quarter 2019 financial results and provides business update 1858

16.2.147 Nov 13, 2019: DiaMedica Therapeutics announces third quarter 2019 financial results and provides business update 1860

16.2.148 Nov 13, 2019: Personalis reports third quarter 2019 financial results 1862

16.2.149 Nov 13, 2019: Biocept reports third quarter 2019 financial results 1863

16.2.150 Nov 13, 2019: Aridis Pharmaceuticals announces third quarter 2019 results 1865

16.2.151 Nov 13, 2019: AdaptHealth Corp. announces third quarter 2019 financial results for its AdaptHealth Holdings LLC subsidiary 1868

16.2.152 Nov 13, 2019: Atossa Genetics announces third quarter 2019 financial results and provides company update 1869

16.2.153 Nov 13, 2019: Novus Therapeutics reports third quarter 2019 financial results 1871

16.2.154 Nov 12, 2019: Action urgent care selects MyDario 1872

16.2.155 Nov 12, 2019: New collagen rope patent for CelGro platform technology 1873

16.2.156 Nov 12, 2019: Syros reports third quarter 2019 financial results and highlights key accomplishments and upcoming milestones 1876

16.2.157 Nov 12, 2019: Biostage reports third quarter 2019 financial results 1877

16.2.158 Nov 12, 2019: Molecular Templates reports third quarter 2019 financial results 1878

16.2.159 Nov 12, 2019: Neon Therapeutics reports third quarter 2019 financial results and recent highlights 1880

16.2.160 Nov 12, 2019: T2 Biosystems reports third quarter 2019 financial highlights and provides corporate update 1881

16.2.161 Nov 12, 2019: Lineage Cell Therapeutics reports third quarter 2019 financial results and provides business update 1882

16.2.162 Nov 12, 2019: Celldex Provides Corporate Update and Reports Third Quarter 2019 Results 1885

16.2.163 Nov 12, 2019: Exagen reports third quarter 2019 results 1888

16.2.164 Nov 12, 2019: Vaxart announces third quarter 2019 financial results and provides corporate update 1889

16.2.165 Nov 12, 2019: Catalyst Pharmaceuticals reports third quarter 2019 financial results and provides corporate update 1890

16.2.166 Nov 12, 2019: Regulus Therapeutics reports third quarter 2019 financial results and recent updates 1892

16.2.167 Nov 12, 2019: Halozyme reports third quarter 2019 results 1894

16.2.168 Nov 12, 2019: Vermillion reports third quarter 2019 financial results 1895

16.2.169 Nov 12, 2019: Adaptive Biotechnologies reports third quarter 2019 financial results 1896

16.2.170 Nov 11, 2019: ImmuCell announces unaudited financial results for third quarter of 2019 1897

16.2.171 Nov 11, 2019: SI-BONE reports third quarter 2019 financial results and updates full-year 2019 revenue guidance 1898

16.2.172 Nov 11, 2019: Castle Biosciences reports third quarter 2019 results 1899

16.2.173 Nov 07, 2019: Meridian Bioscience reports fourth quarter and full-year fiscal 2019 operating results and provides fiscal 2020 guidance 1902

16.2.174 Nov 07, 2019: VistaGen Therapeutics reports fiscal 2020 second quarter financial results and provides pipeline overview 1904

16.2.175 Nov 07, 2019: Clovis Oncology announces third quarter 2019 operating results 1906

16.2.176 Nov 07, 2019: Cardinal Health reports first quarter results for fiscal year 2020 1909

16.2.177 Nov 07, 2019: Guardant health reports third quarter 2019 financial results and raises 2019 revenue guidance 1910

16.2.178 Nov 07, 2019: miRagen reports third quarter 2019 results and provides corporate update 1911

16.2.179 Nov 07, 2019: NantHealth reports 2019 third-quarter financial results 1913

16.2.180 Nov 07, 2019: Pacific Biosciences of California announces third quarter 2019 financial results 1914

16.2.181 Nov 07, 2019: Trovagene announces third quarter 2019 results and highlights 1915

16.2.182 Nov 07, 2019: DermTech reports third quarter 2019 financial results and provides corporate update 1918

16.2.183 Nov 07, 2019: Syndax Pharmaceuticals reports third quarter 2019 financial results and provides clinical and business update 1921

16.2.184 Nov 07, 2019: Aeterna Zentaris reports third quarter 2019 financial and operating results 1923

16.2.185 Nov 07, 2019: Accelerate diagnostics reports third quarter 2019 financial results 1924

16.2.186 Nov 07, 2019: Bionano Genomics reports third quarter 2019 financial results and provides business update 1925

16.2.187 Nov 07, 2019: Celcuity reports third quarter 2019 financial results 1927

16.2.188 Nov 06, 2019: Humana reports third quarter 2019 financial results; raises full year 2019 EPS guidance 1929

16.2.189 Nov 06, 2019: Amneal reports third quarter 2019 financial results 1930

16.2.190 Nov 06, 2019: Genmab announces financial results for the first nine months of 2019 1932

16.2.191 Nov 06, 2019: Charles River Laboratories announces third-quarter 2019 results 1932

16.2.192 Nov 06, 2019: OpGen reports third quarter 2019 financial results and provides business update 1934

16.2.193 Nov 06, 2019: GenMark Diagnostics reports third quarter 2019 results 1935

16.2.194 Nov 06, 2019: Constellation Pharmaceuticals announces third-quarter and nine-month 2019 financial results 1936

16.2.195 Nov 06, 2019: ARCA Biopharma announces third quarter 2019 financial results and provides corporate update 1938

16.2.196 Nov 06, 2019: Geron reports third quarter 2019 financial results and recent events 1939

16.2.197 Nov 06, 2019: OraSure announces 2019 third quarter financial results 1942

16.2.198 Nov 06, 2019: Natera reports third quarter 2019 financial results 1943

16.2.199 Nov 06, 2019: Invitae reports $56.5 million in quarterly revenue driven by 129,000 samples 1945

16.2.200 Nov 06, 2019: Five Prime Therapeutics reports third quarter 2019 results 1946

16.2.201 Nov 06, 2019: Quanterix releases operating results for third quarter 2019 1948

16.2.202 Nov 06, 2019: Hologic announces financial results for fourth quarter of fiscal 2019 1950

16.2.203 Nov 05, 2019: BD announces results for 2019 fourth fiscal quarter and full year; provides fiscal 2020 guidance 1951

16.2.204 Nov 05, 2019: Seres Therapeutics reports third quarter financial results and provides business update 1953

16.2.205 Nov 05, 2019: Blueprint Medicines outlines precision therapy research vision, provides update on discovery and clinical-stage portfolio at R&D Day and reports third quarter 2019 financial results 1954

16.2.206 Nov 05, 2019: Harvard Bioscience announces third quarter financial results 1956

16.2.207 Nov 05, 2019: Vericel reports record third quarter revenues, net income and operating cash flow 1957

16.2.208 Nov 05, 2019: Kura Oncology reports third quarter 2019 financial results and provides corporate update 1959

16.2.209 Nov 05, 2019: TRACON Pharmaceuticals reports third quarter 2019 financial results and provides corporate update 1961

16.2.210 Nov 05, 2019: OPKO Health reports 2019 third quarter business highlights and financial results 1962

16.2.211 Nov 05, 2019: Fluidigm announces third quarter 2019 financial results 1963

16.2.212 Nov 04, 2019: Luminex reports third quarter 2019 results and submission of VERIGENE II Gastrointestinal Flex Assay to the FDA 1965

16.2.213 Nov 04, 2019: NanoString Technologies releases operating results for third quarter of 2019 1965

16.2.214 Nov 04, 2019: Fulgent Genetics reports third quarter 2019 financial results 1967

16.2.215 Nov 04, 2019: Myriad Genetics reports fiscal first-quarter 2020 financial results 1968

16.2.216 Nov 04, 2019: Turning Point Therapeutics reports third quarter 2019 financial and operational results 1969

16.2.217 Nov 04, 2019: Addus HomeCare announces third-quarter 2019 financial results 1971

16.2.218 Nov 04, 2019: Deciphera Pharmaceuticals announces third quarter 2019 financial results 1972

16.2.219 Nov 04, 2019: Luminex Corporation reports third quarter 2019 results and submission of VERIGENE II Gastrointestinal Flex Assay to the FDA 1974

16.2.220 Nov 01, 2019: AbbVie reports third-quarter 2019 financial results 1975

16.2.221 Nov 01, 2019: ImmunoGen reports recent progress and third quarter 2019 financial results 1977

16.2.222 Nov 01, 2019: AMAG Pharmaceuticals announces third quarter 2019 financial results and provides corporate update 1979

16.2.223 Nov 01, 2019: Aethlon Medical announces second quarter financial results and provides corporate update 1981

16.2.224 Nov 01, 2019: Haemonetics reports 2nd quarter and 1st half fiscal 2020 results; raises fiscal 2020 adjusted operating margin and adjusted EPS guidance 1983

16.2.225 Oct 31, 2019: Agios reports business highlights and third quarter 2019 financial results 1985

16.2.226 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results 1986

16.2.227 Oct 31, 2019: Surmodics reports fourth quarter fiscal 2019 results and issues fiscal 2020 revenue and EPS Guidance 1987

16.2.228 Oct 31, 2019: CareDx reports third quarter 2019 results 1988

16.2.229 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results. 1989

16.2.230 Oct 31, 2019: Bruker reports third quarter 2019 financial results 1990

16.2.231 Oct 30, 2019: Quidel reports third quarter 2019 financial results 1991

16.2.232 Oct 30, 2019: Insmed reports third quarter 2019 financial results and provides business update 1992

16.2.233 Oct 30, 2019: PerkinElmer announces financial results for the third quarter of 2019 1994

16.2.234 Oct 30, 2019: United Therapeutics reports third quarter 2019 financial results 1995

16.2.235 Oct 30, 2019: McKesson reports fiscal 2020 second-quarter results 1997

16.2.236 Oct 30, 2019: Merit Medical reports earnings for third quarter of 2019 1998

16.2.237 Oct 30, 2019: Immunomedics reports third quarter 2019 results and provides corporate update 2001

16.2.238 Oct 30, 2019: PRA Health Sciences reports third quarter 2019 results and updates full year 2019 guidance 2003

16.2.239 Oct 29, 2019: Amgen reports third quarter 2019 financial results 2004

16.2.240 Oct 29, 2019: Pfizer reports third-quarter 2019 results 2007

16.2.241 Oct 29, 2019: Merck announces third-quarter 2019 financial results 2013

16.2.242 Oct 29, 2019: Incyte reports 2019 third quarter financial results and provides updates on key clinical programs 2018

16.2.243 Oct 29, 2019: Waters reports third quarter 2019 financial results 2020

16.2.244 Oct 29, 2019: Bio-Techne releases first quarter fiscal 2020 results 2022

16.2.245 Oct 29, 2019: Cassava Sciences announces recent clinical highlights and third quarter 2019 financial results 2023

16.2.246 Oct 29, 2019: Exact Sciences reports third-quarter revenue growth of 85 percent to $219 million 2025

16.2.247 Oct 29, 2019: Verastem Oncology reports third quarter 2019 financial results and recent company progress 2025

16.2.248 Oct 29, 2019: Seattle Genetics reports third quarter 2019 financial results 2028

16.2.249 Oct 29, 2019: Corvus Pharmaceuticals provides business update and reports third quarter 2019 financial results 2030

16.2.250 Oct 29, 2019: NeoGenomics reports 51% revenue growth to $105 million in the third quarter 2032

16.2.251 Oct 24, 2019: Baxter reports preliminary third quarter 2019 operating results 2032

16.2.252 Oct 24, 2019: Danaher reports third quarter 2019 results 2034

16.2.253 Oct 24, 2019: LabCorp announces 2019 third quarter results and updates 2019 guidance 2035

16.2.254 Oct 24, 2019: Illumina reports financial results for third quarter of fiscal year 2019 2037

16.2.255 Oct 24, 2019: Gilead Sciences announces third quarter 2019 financial results 2039

16.2.256 Oct 23, 2019: Lilly reports strong third-quarter 2019 financial results, raises 2019 EPS Guidance 2040

16.2.257 Oct 23, 2019: Alexion reports third quarter 2019 results 2044

16.2.258 Oct 23, 2019: Thermo Fisher Scientific reports third quarter 2019 results 2047

16.2.259 Oct 23, 2019: BioMarin announces third quarter 2019 financial results 2048

16.2.260 Oct 22, 2019: Novartis delivered another strong quarter with double digit sales growth and core1 margin expansion; 2019 sales and profit guidance raised; Beovu launched in US 2052

16.2.261 Oct 22, 2019: Quest Diagnostics reports third quarter 2019 financial results 2057

16.2.262 Oct 22, 2019: Veracyte announces third quarter 2019 financial results and business progress 2057

16.2.263 Oct 17, 2019: Solos Endoscopy appoints distributor to expand their MammoView sales into India 2058

16.2.264 Oct 16, 2019: GE Healthcare and Premier to develop model for one-stop breast cancer diagnostic center to give Women in the United States Same-Day Results 2059

16.2.265 Oct 16, 2019: Abbott reports third-quarter 2019 results 2061

16.2.266 Oct 16, 2019: Biomerica reports 1st quarter fiscal 2020 financials 2064

16.2.267 Oct 15, 2019: Introducing AncestryHealth: Actionable Health insights for you and your family 2064

16.2.268 Oct 15, 2019: Johnson & Johnson reports 2019 Third-Quarter Results 2067

16.2.269 Oct 15, 2019: Enzo Biochem reports fiscal fourth quarter and full year financial results 2068

16.2.270 Oct 03, 2019: Aroa Biosurgery growsiInto additional markets with positive outcomes from Canadian clinical study 2071

16.2.271 Oct 03, 2019: MEI pharma announces updated clinical data from voruciclib 2072

16.2.272 Oct 02, 2019: Cepheid Receives FDA Clearance for Xpert BCR-ABL Ultra Test 2073

16.2.273 Oct 02, 2019: T2 Biosystems to Showcase Latest Innovations at IDWeek 2019 2075

16.2.274 Oct 01, 2019: InterSystems streamlines adoption of InterSystems IRIS Data Platform with enhanced availability on AWS marketplace 2077

16.2.275 Oct 01, 2019: Northwell, Allscripts to jointly develop next-gen electronic health record 2079

16.2.276 Oct 01, 2019: BioCardia Initiates Commercial Release of AVANCE Steerable Introducer Designed to Enhance Physician Control for Complex Cardiac Procedures 2080

16.2.277 Oct 01, 2019: Cheetah Medical Presents Update on FRESH Clinical Trial at the European Society of Intensive Care Medicine 32nd Annual Congress 2083

16.2.278 Oct 01, 2019: Angel Medical Systems Assembles World-Class Medical Advisory Board 2084

16.2.279 Sep 28, 2019: Tolero Pharmaceuticals presents preliminary findings from phase 1 study evaluating investigational agent TP-0903 in patients with Advanced Solid Tumors at ESMO 2019 2086

16.2.280 Sep 24, 2019: ACADIA Pharmaceuticals announces that The Journal of Clinical Psychiatry publishes positive phase 2 CLARITY results for Pimavanserin as Adjunctive treatment for patients with Major Depressive Disorder 2088

16.2.281 Sep 24, 2019: Scandion Oncology CEO Newsletter autumn 2019 2090

16.2.282 Sep 17, 2019: Canon Xephilio OCT-A1 Optical Coherence Tomography Device receives FDA 510(k) clearance 2092

16.2.283 Sep 17, 2019: MaxCyte: Results for the Six Months ended 30 June 2019 2094

16.2.284 Sep 16, 2019: Gala Therapeutics receives FDA Breakthrough Device Designation for the minimally invasive RheOx system for chronic bronchitis 2095

16.2.285 Sep 05, 2019: Avid Bioservices reports financial results for first quarter fiscal 2020 and recent developments 2097

16.2.286 Sep 04, 2019: Enlivex Therapeutics to present At The 21st Annual Global Investment Conference, Sponsored By HC Wainwright & Co 2099

16.2.287 Sep 03, 2019: Castle Biosciences reports second quarter 2019 results 2100

16.2.288 Aug 30, 2019: Fukuda orders 100 TetraGraph systems after regulatory approval 2101

16.2.289 Aug 30, 2019: Biomerica announces fiscal year end 2019 financial results 2102

16.2.290 Aug 29, 2019: Topcon announces the release of Harmony Into the EMEA region 2103

16.2.291 Aug 29, 2019: Therapeutic Solutions International reports revenues up 850% for Q2 2105

16.2.292 Aug 23, 2019: KYORIN Rimedio announces release of Mometasone Nasal 50µg 56 sprays, 112 sprays 2105

16.2.293 Aug 22, 2019: Bihlermed announces availability of innovative Surgilight surgical lighting system 2106

16.2.294 Aug 22, 2019: Aimmune begins enrolling egg allergy patients in Phase II study 2108

16.2.295 Aug 22, 2019: Torque expands leadership team with appointment of Sok Cheng Soh as CFO and Ana Radeljevic as VP, Head of Business Operations 2109

16.2.296 Aug 20, 2019: Parallax Health Sciences reports second quarter 2019 financial results 2111

16.2.297 Aug 20, 2019: Cancer Genetics reports second quarter 2019 financial results and provides strategic business update 2112

16.2.298 Aug 20, 2019: HemaCare reports first half 2019 results 2113

16.2.299 Aug 19, 2019: Acrux’s third generic dossier accepted by FDA for review 2114

16.2.300 Aug 16, 2019: Humana reports second quarter results 2019 2115

16.2.301 Aug 15, 2019: BioPorto announces Q2 2019 report 2117

16.2.302 Aug 15, 2019: Bio-Path Holdings reports second quarter 2019 financial results 2118

16.2.303 Aug 15, 2019: Hemispherx issues 2019 second quarter report citing strong steady progress in cancer clinical trials 2119

16.2.304 Aug 15, 2019: Pressure Biosciences reports second quarter 2019 financial results and provides business update 2121

16.2.305 Aug 14, 2019: Agilent Technologies reports third quarter fiscal year 2019 financial results 2123

16.2.306 Aug 14, 2019: Titan Pharmaceuticals reports second quarter 2019 financial results 2124

16.2.307 Aug 14, 2019: Aethlon Medical announces first quarter financial results and provides corporate update 2125

16.2.308 Aug 14, 2019: Edesa Biotech reports quarterly financial results 2126

16.2.309 Aug 14, 2019: Cleveland Biolabs reports second quarter 2019 financial results and development progress 2127

16.2.310 Aug 14, 2019: ABMC reports second quarter 2019 results 2128

16.2.311 Aug 13, 2019: AcuCort participates at the Nordic Life Science Days in Malmo, Sweden 2128

16.2.312 Aug 13, 2019: Atossa Genetics announces second quarter 2019 financial results and provides company update 2129

16.2.313 Aug 13, 2019: Myriad Genetics reports fiscal fourth-quarter and full-year 2019 financial results 2130

16.2.314 Aug 13, 2019: Biostage reports second quarter 2019 financial results 2132

16.2.315 Aug 13, 2019: Adaptive Biotechnologies reports second quarter 2019 financial results 2133

16.2.316 Aug 13, 2019: Interpace Diagnostics reports second quarter 2019 financial results and provides business update 2134

16.2.317 Aug 13, 2019: Novus Therapeutics reports second quarter 2019 financial results 2137

16.2.318 Aug 13, 2019: Personalis reports second quarter 2019 financial results 2138

16.2.319 Aug 13, 2019: Cesca Therapeutics announces improved second quarter 2019 financial results and provides corporate update 2139

16.2.320 Aug 13, 2019: VistaGen Therapeutics reports fiscal 2020 first quarter financial results 2140

16.2.321 Aug 13, 2019: DiaMedica Therapeutics announces second quarter 2019 financial results and provides business update 2141

16.2.322 Aug 13, 2019: Aeterna Zentaris reports second quarter 2019 financial and operating results 2145

16.2.323 Aug 12, 2019: SMC rejects (ivacaftor + lumacaftor) medicine for use by NHSScotland 2146

16.2.324 Aug 12, 2019: Cassava Sciences announces second quarter 2019 financial results 2147

16.2.325 Aug 12, 2019: Entasis Therapeutics reports second quarter 2019 financial results and provides business update 2147

16.2.326 Aug 12, 2019: Molecular Templates reports second quarter 2019 financial results 2148

16.2.327 Aug 12, 2019: Halo Labs reports Q2 2019 financial results 2150

16.2.328 Aug 12, 2019: Aridis Pharmaceuticals announces second quarter 2019 results 2151

16.2.329 Aug 12, 2019: Biocept reports second quarter 2019 financial results 2154

16.2.330 Aug 12, 2019: IDEAYA Biosciences reports second quarter 2019 financial results and provides business update 2156

16.2.331 Aug 08, 2019: NIH-funded study will test Flublok Quadrivalent Influenza Vaccine with two experimental adjuvants 2158

16.2.332 Aug 08, 2019: BeiGene reports second quarter 2019 Financial Results 2159

16.2.333 Aug 08, 2019: Cardinal Health reports fourth quarter and full year results for fiscal year 2019 2163

16.2.334 Aug 08, 2019: Quidel reports second quarter 2019 Financial Results 2165

16.2.335 Aug 08, 2019: Regulus Therapeutics reports second quarter 2019 financial results and recent updates 2167

16.2.336 Aug 08, 2019: Vaxart announces second quarter 2019 financial results and provides corporate update 2169

16.2.337 Aug 08, 2019: BioTime reports second quarter 2019 financial results and provides business update 2171

16.2.338 Aug 08, 2019: NantHealth reports 2019 second-quarter financial results 2173

16.2.339 Aug 08, 2019: Trovagene announces second quarter 2019 results and highlights 2174

16.2.340 Aug 08, 2019: Celcuity reports second quarter 2019 financial results 2177

16.2.341 Aug 08, 2019: Accelerate Diagnostics reports second quarter 2019 financial results 2178

16.2.342 Aug 08, 2019: Vermillion reports second quarter 2019 financial results 2179

16.2.343 Aug 08, 2019: Bionano Genomics reports second quarter 2019 financial results and provides business update 2181

16.2.344 Aug 07, 2019: New KEDRAB dose calculator launches to help hospitals in treating rabies exposures 2182

16.2.345 Aug 07, 2019: AMAG Pharmaceuticals announces second quarter 2019 financial results and provides corporate update 2183

16.2.346 Aug 07, 2019: Five Prime Therapeutics reports second quarter 2019 results 2185

16.2.347 Aug 07, 2019: Natera reports second auarter 2019 Financial Results 2187

16.2.348 Aug 07, 2019: Syndax Pharmaceuticals reports second quarter 2019 financial results and provides clinical and business update 2188

16.2.349 Aug 07, 2019: Catalyst Pharmaceuticals announces second quarter 2019 financial results and provides corporate update 2189

16.2.350 Aug 07, 2019: OpGen reports second quarter 2019 financial results and provides business update 2191

16.2.351 Aug 07, 2019: Celldex Provides corporate update and reports second quarter 2019 results 2192

16.2.352 Aug 07, 2019: Immunomedics reports second quarter 2019 results and provides corporate update 2196

16.2.353 Aug 07, 2019: Constellation Pharmaceuticals announces second-quarter and six-month 2019 financial results 2198

16.2.354 Aug 07, 2019: TRACON Pharmaceuticals reports second quarter 2019 financial results and provides corporate update 2200

16.2.355 Aug 07, 2019: miRagen reports second quarter 2019 results; Regains Global Rights to MRG-110 and announces corporate restructuring 2202

16.2.356 Aug 06, 2019: Xenon Pharmaceuticals reports second quarter 2019 financial results and provides corporate update 2204

16.2.357 Aug 06, 2019: Seres Therapeutics reports second quarter financial results and provides progress update 2206

16.2.358 Aug 06, 2019: Vericel reports second quarter 2019 financial results and raises full year 2019 Revenue Guidance 2207

16.2.359 Aug 06, 2019: Bio-Techne releases fourth quarter fiscal 2019 results 2208

16.2.360 Aug 06, 2019: Quanterix releases operating results for second quarter 2019 2211

16.2.361 Aug 06, 2019: BD announces results for 2019 third fiscal quarter; reaffirms fiscal 2019 guidance 2212

16.2.362 Aug 06, 2019: Neon Therapeutics Reports Second Quarter 2019 Financial Results 2213

16.2.363 Aug 06, 2019: Halozyme reports second quarter 2019 results 2215

16.2.364 Aug 06, 2019: Pacific Biosciences of California announces second quarter 2019 financial results 2216

16.2.365 Aug 06, 2019: OraSure announces 2019 second quarter financial results 2217

16.2.366 Aug 06, 2019: Columbia Care reports second quarter 2019 results 2219

16.2.367 Aug 06, 2019: HTG Molecular Diagnostics reports second quarter 2019 results 2220

16.2.368 Aug 06, 2019: Turning Point Therapeutics reports second quarter 2019 financial and operational results 2221

16.2.369 Aug 06, 2019: Guardant Health reports second quarter 2019 financial results and raises 2019 revenue guidance 2223

16.2.370 Aug 06, 2019: Invitae reports $53.5 million in quarterly revenue driven by more than 111,000 samples in quarterly volume 2224

16.2.371 Aug 06, 2019: SI-BONE reports second quarter 2019 financial results 2226

16.2.372 Aug 06, 2019: Haemonetics reports 1st Quarter Fiscal 2020 results, updates Fiscal 2020 earnings guidance and launches operational excellence program 2226

16.2.373 Aug 05, 2019: Radius Health initiates phase 3 wearABLe study of Abaloparatide-Patch in Postmenopausal Osteoporosis leads new era of health care innovation 2228

16.2.374 Aug 05, 2019: Quotient Limited Provides Updates on European Hypercare Launch, the CE Mark Submission and U.S. Field Trial for the Initial Serological Disease Screening Microarray, and Reports First Quarter Fiscal 2020 Results 2230

16.2.375 Aug 05, 2019: Amneal reports second quarter 2019 financial results 2231

16.2.376 Aug 05, 2019: Addus HomeCare announces second-quarter 2019 financial results 2232

16.2.377 Aug 05, 2019: Fulgent Genetics reports second quarter 2019 financial results 2233

16.2.378 Aug 05, 2019: GenMark Diagnostics reports second quarter 2019 financial results 2234

16.2.379 Aug 02, 2019: Deciphera Pharmaceuticals announces second quarter 2019 Financial Results 2235

16.2.380 Aug 02, 2019: ImmunoGen reports recent progress and Second Quarter 2019 Financial Results 2236

16.2.381 Aug 01, 2019: 3M scores major legal victory in Bair Hugger litigation 2238

16.2.382 Aug 01, 2019: Insmed reports second quarter 2019 financial results and provides business update 2240

16.2.383 Aug 01, 2019: Clovis Oncology announces second quarter 2019 Operating Results 2242

16.2.384 Aug 01, 2019: BioMarin announces second quarter 2019 Financial Results 2245

16.2.385 Aug 01, 2019: Corvus Pharmaceuticals provides Business update and reports second quarter 2019 Financial Results 2248

16.2.386 Aug 01, 2019: CareDx reports second quarter 2019 results 2249

16.2.387 Aug 01, 2019: Blueprint Medicines reports second quarter 2019 financial results 2251

16.2.388 Aug 01, 2019: Agios reports business highlights and second quarter 2019 financial results 2252

16.2.389 Aug 01, 2019: Syros reports second quarter 2019 financial results 2254

16.2.390 Aug 01, 2019: Geron reports second quarter 2019 financial results and recent events 2254

16.2.391 Aug 01, 2019: Kura Oncology reports second quarter 2019 financial results and provides corporate update 2256

16.2.392 Aug 01, 2019: Bruker reports second quarter 2019 financial results 2258

16.2.393 Aug 01, 2019: Verastem Oncology reports second quarter 2019 financial results and highlights recent company progress 2259

16.2.394 Aug 01, 2019: Bio-Rad reports second-quarter 2019 financial results 2262

16.2.395 Aug 01, 2019: Fluidigm announces second quarter 2019 financial results 2263

16.2.396 Aug 01, 2019: ARCA biopharma announces second quarter 2019 financial results and provides corporate update 2264

16.2.397 Jul 31, 2019: Researchers develop soft wearable for health monitoring 2265

16.2.398 Jul 31, 2019: United Therapeutics reports second quarter 2019 financial results 2267

16.2.399 Jul 31, 2019: Charles River Laboratories announces second-quarter 2019 results 2269

16.2.400 Jul 31, 2019: NanoString Technologies releases operating results for second quarter of 2019 2271

16.2.401 Jul 31, 2019: McKesson reports fiscal 2020 first-quarter results 2273

16.2.402 Jul 31, 2019: Luminex reports second quarter 2019 financial results and increase in quarterly dividend 2274

16.2.403 Jul 31, 2019: Hologic announces financial results for third quarter of fiscal 2019 2275

16.2.404 Jul 31, 2019: Surmodics reports third quarter fiscal 2019 results and raises fiscal 2019 revenue and EPS guidance 2276

16.2.405 Jul 31, 2019: PRA Health Sciences reports second quarter 2019 results and updates full year 2019 guidance 2277

16.2.406 Jul 31, 2019: Humana reports second quarter 2019 financial results; Raises full year 2019 EPS Guidance 2278

16.2.407 Jul 30, 2019: Class 2 Medicines Recall: Aripiprazole 1mg/ml oral solution (EL (19)A/20) 2279

16.2.408 Jul 30, 2019: Merck announces second-quarter 2019 financial results 2280

16.2.409 Jul 30, 2019: Lilly reports second-quarter 2019 financial results, raises 2019 EPS guidance 2284

16.2.410 Jul 30, 2019: Amgen reports second quarter 2019 financial results 2289

16.2.411 Jul 30, 2019: ORYZON reports financial results and corporate update for the first half ended June 30, 2019 2291

16.2.412 Jul 30, 2019: Meridian Bioscience reports third quarter 2019 operating results 2293

16.2.413 Jul 30, 2019: Incyte reports 2019 second quarter financial results and provides updates on key clinical programs 2294

16.2.414 Jul 30, 2019: Waters reports second quarter 2019 financial results 2298

16.2.415 Jul 30, 2019: T2 Biosystems reports second quarter 2019 financial results and provides corporate update 2300

16.2.416 Jul 30, 2019: NeoGenomics reports 50% revenue growth to record $102 Million in the Second Quarter 2302

16.2.417 Jul 30, 2019: Gilead Sciences announces second quarter 2019 financial results 2303

16.2.418 Jul 30, 2019: Veracyte announces second quarter 2019 financial results 2306

16.2.419 Jul 29, 2019: Crinetics Pharmaceuticals to receive final award of SBIR grant from NIH for congenital hyperinsulinism 2307

16.2.420 Jul 29, 2019: Illumina reports financial results for second quarter of fiscal year 2019 2309

16.2.421 Jul 29, 2019: Genomic Health reports 19% revenue growth and record profit in second quarter 2019, raises full-year guidance 2310

16.2.422 Jul 29, 2019: Pfizer reports second-quarter 2019 results 2311

16.2.423 Jul 29, 2019: Second-quarter revenue increased 94 percent to $200 million and Cologuard test volume increased 93 percent to 415,000 2317

16.2.424 Jul 29, 2019: PerkinElmer announces financial results for the second quarter of 2019 2318

16.2.425 Jul 26, 2019: Robotic Surgical Tool, Not Medical Evidence, Drives free Hernia Screenings 2319

16.2.426 Jul 26, 2019: AbbVie reports second-quarter 2019 financial results 2322

16.2.427 Jul 25, 2019: LabCorp announces 2019 second quarter results and updates 2019 guidance 2324

16.2.428 Jul 25, 2019: Baxter reports second-quarter 2019 results 2327

16.2.429 Jul 25, 2019: Merit Medical reports earnings for second quarter of 2019 2329

16.2.430 Jul 25, 2019: Harvard Bioscience announces quarter ended June 30, 2019 financial results 2331

16.2.431 Jul 25, 2019: Bristol-Myers Squibb reports second quarter financial results 2332

16.2.432 Jul 24, 2019: Alexion reports second quarter 2019 results 2334

16.2.433 Jul 24, 2019: Thermo Fisher Scientific reports second quarter 2019 results 2336

16.2.434 Jul 23, 2019: Quest Diagnostics reports second quarter 2019 financial results 2338

16.2.435 Jul 23, 2019: Psychemedics announces second quarter results and declares 92nd consecutive quarterly dividend 2338

16.2.436 Jul 22, 2019: Study investigates the ability of continuous noninvasive hemoglobin monitoring with Masimo SpHb to reflect acute hemodilution during incremental fluid administration 2340

16.2.437 Jul 22, 2019: Visioneering wins award of excellence for its NaturalVue Multifocal 1 Day Contact Lenses at Australia’s Largest Eyecare Event 2341

16.3 Government and Public Interest 2343

16.3.1 Jul 10, 2020: National Lipid Association releases official scientific statement on genetic testing in Dyslipidemia 2343

16.3.2 Jul 10, 2020: HHS releases May and June COVID-19 state testing plans 2344

16.3.3 Jul 02, 2020: Coronavirus (COVID-19) Update: FDA authorizes additional COVID-19 combination diagnostic test ahead of flu season 2345

16.3.4 Jul 02, 2020: Coronavirus (COVID-19) Update: Daily Roundup July 2nd, 2020 2345

16.3.5 Jul 02, 2020: In Vitro Diagnostics EUAs 2346

16.3.6 Jun 29, 2020: Engineers 3D-print sensors onto moving organs 2347

16.3.7 Jun 24, 2020: Neural network can determine lung cancer severity 2348

16.3.8 Jun 11, 2020: To help West Virginia reopen safely, WVU researchers develop new COVID-19 tests 2348

16.3.9 Jun 09, 2020: Targeting SARS-CoV-2 enzyme with inhibitors 2351

16.3.10 Jun 04, 2020: AACC releases guidance document on using point-of-care tests to improve patient care 2352

16.3.11 May 27, 2020: Coronavirus (COVID-19) Update: Daily Roundup May 27, 2020 2353

16.3.12 May 21, 2020: Coronavirus (COVID-19) Update: FDA provides promised transparency for antibody tests 2355

16.3.13 May 13, 2020: Illumina to sequence genomes for new UK-wide COVID-19 study 2355

16.3.14 May 13, 2020: CMS issues nursing homes best practices toolkit to combat COVID-19 2356

16.3.15 May 12, 2020: Scientists show MRI predicts the efficacy of a stem cell therapy for brain injury 2357

16.3.16 Apr 21, 2020: Intermountain Healthcare joins national protocol to give COVID-19 patients access to plasma donations; performs Utah’s first COVID-19 transfusion 2358

16.3.17 Apr 11, 2020: Trump Administration announces expanded coverage for essential diagnostic services amid COVID-19 public health emergency 2360

16.3.18 Apr 06, 2020: Coronavirus (COVID-19) Update: Daily Roundup 2360

16.3.19 Apr 02, 2020: Hybrid microscope creates digital biopsies 2361

16.3.20 Mar 30, 2020: Coronavirus (COVID-19) Update: FDA expedites review of diagnostic tests to combat COVID-19 2362

16.3.21 Mar 23, 2020: OncoMX knowledgebase enables research of cancer biomarkers and related evidence 2363

16.3.22 Mar 20, 2020: Artificial Intelligence may help predict responses to systemic therapies in patients with Non-small Cell Lung Cancer 2364

16.3.23 Mar 20, 2020: HHS, DOD coordinate international airlift of covid-19 supplies 2365

16.3.24 Mar 13, 2020: Coronavirus (COVID-19) Update: FDA gives flexibility to New York State Department of Health, FDA issues Emergency Use Authorization diagnostic 2366

16.3.25 Mar 05, 2020: German Lab demonstrates feasibility to detect SARS-Coronavirus-2 (SARS-CoV-2) using Hologic’s Panther Fusion System 2366

16.3.26 Mar 05, 2020: AirAnswers detects viruses in the air 2367

16.3.27 Mar 05, 2020: OPKO Health’s BioReference Laboratories to Introduce Coronavirus Disease (COVID-19) Test 2367

16.3.28 Mar 05, 2020: Quest Diagnostics to launch Coronavirus Disease 2019 (COVID-19) Test 2368

16.3.29 Mar 05, 2020: LabCorp launches test for Coronavirus disease 2019 (COVID-19) 2368

16.3.30 Mar 04, 2020: High-Tech contact lenses correct color blindness 2370

16.3.31 Mar 04, 2020: DECN fills in the gaps, adds to knowledge base for its GenViro Coronavirus (Covid19) multi-dimensional diagnostic methodology announced march 2 2371

16.3.32 Mar 04, 2020: Luminex provides updates on critical efforts related to novel coronavirus 2371

16.3.33 Mar 03, 2020: BGI receives CE mark for novel coronavirus test 2372

16.3.34 Mar 03, 2020: DECN Jumps into screening and testing channel for Coronavirus (COVID19) using its innovative impedance technology first implemented in its GenUltimate TBG 2373

16.3.35 Mar 03, 2020: Co-Diagnostics invited to speak on coronavirus at Molecular Med Tri-Con in San Francisco 2373

16.3.36 Mar 03, 2020: Responding to Coronavirus testing problems, U.S. Government expands number of labs that can run tests 2374

16.3.37 Mar 02, 2020: Co-Diagnostics to provide COVID-19 tests to US CLIA Labs following FDA policy change 2374

16.3.38 Mar 02, 2020: Daxor announces engagement with hospitals and government for use of the Blood Volume Analyzer (BVA-100) to stem COVID-19 deaths 2375

16.3.39 Mar 02, 2020: Daxor announces rise in kit sales and files form N-CSR for 2019 2376

16.3.40 Mar 02, 2020: GenMark Diagnostics announces global shipments of ePlex RUO Test Kits designed for SARS-CoV-2 detection 2376

16.3.41 Mar 02, 2020: Longhorn Vaccines & Diagnostics encouraged by FDA to help solve coronavirus testing bottleneck by teaming PrimeStore MTM with diagnostic developers 2377

16.3.42 Feb 28, 2020: Novacyt: Major distribution agreement for COVID-19 test 2378

16.3.43 Feb 28, 2020: Cepheid and Sherlock Biosciences establish collaboration on new GeneXpert tests for infectious diseases and oncology leveraging CRISPR technology 2379

16.3.44 Feb 27, 2020: AnPac Bio files Coronavirus detection patent and initiates related research project 2380

16.3.45 Feb 26, 2020: Wake up world – get tested for Coronavirus COVID-19 2380

16.3.46 Feb 25, 2020: Co-Diagnostics receives CE mark for Logix Smart COVID-19 Test 2381

16.3.47 Feb 25, 2020: Anitoa introduces rapid, on-site nucleic acid test for new coronavirus (2019-nCoV) 2381

16.3.48 Feb 23, 2020: Rapid Dx for life calls on all international airports to implement better screening of passengers for Coronavirus 2382

16.3.49 Feb 22, 2020: Novel data on sphingotec’s biomarkers for acute and critical care settings to be presented at AKI & CRRT 2020 2383

16.3.50 Feb 20, 2020: Assay development for SARS-CoV-2 testing successfully completed 2383

16.3.51 Feb 20, 2020: LX Analyzer successfully detects Coronavirus RNA 2384

16.3.52 Feb 19, 2020: Swri’s virtual screening software Rhodium increases processing power for coronavirus research 2385

16.3.53 Feb 18, 2020: Covaris launches novel viral RNA extraction kits for swab sample collection devices 2385

16.3.54 Feb 13, 2020: The decision of the German federal court of justice confirms that Wuxi Hisky Medical was infringing the German part of Echosens’ Patent: Hisky FibroTouch is found to be illegal in Germany 2386

16.3.55 Feb 13, 2020: AbbVie’s SKYRIZI now listed on the Nova Scotia formulary for the treatment of moderate to severe plaque psoriasis 2388

16.3.56 Feb 13, 2020: Coronavirus: CDC finds some test kits sent to states are faulty 2389

16.3.57 Feb 13, 2020: Co-Diagnostics to present its rapid response to new Coronavirus in Washington D.C. conference 2389

16.3.58 Feb 11, 2020: Cepheid to develop automated molecular test for coronavirus 2390

16.3.59 Feb 07, 2020: Athenahealth adds tools to enable rapid preparedness and continuous monitoring of novel Coronavirus outbreak 2390

16.3.60 Feb 07, 2020: Co-Diagnostics launches RUO test for new coronavirus 2391

16.3.61 Feb 07, 2020: Novacyt seeks Emergency Use Approval for coronavirus test 2391

16.3.62 Feb 05, 2020: HHS seeks abstract submissions for 2019-nCoV diagnostics development 2392

16.3.63 Feb 05, 2020: FDA approves emergency use of coronavirus diagnostic test 2393

16.3.64 Jan 31, 2020: CDC recommends nasopharyngeal Swabs AND oropharyngeal swabs as suitable for upper respiratory tract specimens for investigations of Novel Coronavirus (2019-nCoV) 2393

16.3.65 Jan 28, 2020: BGI responds to novel coronavirus with real-time detection kits, deploys emergency team to Wuhan 2394

16.3.66 Jan 28, 2020: IDbyDNA’s Explify Respiratory Test can detect coronavirus 2395

16.3.67 Jan 27, 2020: Merit Medical issues statement regarding director nominations from starboard 2395

16.3.68 Jan 27, 2020: LexaGene’s Analyzer is designed to detect pathogens such as the Novel Coronavirus to help avert a pandemic 2396

16.3.69 Jan 27, 2020: Meridian Bioscience Lyo-Ready 1-Step RT-qPCR Mix is used in the development of molecular diagnostics for new Coronavirus Outbreak 2397

16.3.70 Jan 20, 2020: Skin cancer gives patient plenty of Mohs surgery experience 2397

16.3.71 Jan 15, 2020: First randomized clinical trial found no harms from dementia screening in primary care 2398

16.3.72 Jan 13, 2020: Enzo Biochem responds to series of misleading and inaccurate statements from activist hedge fund harbert 2400

16.3.73 Jan 10, 2020: Quanterix to present at 38th Annual J.P. Morgan Healthcare Conference 2404

16.3.74 Jan 06, 2020: BioMarker strategies to present at biotech showcase 2020 in San Francisco during J.P. Morgan healthcare conference week 2405

16.3.75 Jan 06, 2020: Applied BioCode Receives FDA 510(k) Clearance for Syndromic Respiratory Pathogen Panel 2406

16.3.76 Dec 30, 2019: Direct-to-consumer fertility tests confuse and mislead consumers, Penn study shows 2406

16.3.77 Dec 20, 2019: BioUtah applauds passage of medical device tax repeal 2408

16.3.78 Dec 18, 2019: Single-molecule detection of cancer markers brings liquid biopsy closer to clinic 2408

16.3.79 Dec 03, 2019: Study highlights potential for ‘liquid health check’ to predict disease risk 2409

16.3.80 Nov 27, 2019: The Center for Diagnostic Imaging discusses how breast MRIs can help prevent breast cancer 2411

16.3.81 Nov 15, 2019: VA uses innovative means to help reduce diabetic limb loss 2411

16.3.82 Nov 11, 2019: Evgen Pharma: SFX-01 results in SAS study 2412

16.3.83 Nov 06, 2019: New technique lays foundation for regenerative cardiac therapies 2413

16.3.84 Oct 23, 2019: Federal study finds unregulated genetic testing industry fails to provide balanced view of disability; calls on FDA, FTC for oversight 2414

16.3.85 Oct 22, 2019: HTG Molecular Diagnostics to host key opinion leader meeting on breast cancer molecular diagnostics on October 29 2415

16.3.86 Oct 16, 2019: Castle Biosciences announces presentation of prospective, multicenter study demonstrating significant impact of DecisionDx-UM on treatment plan recommendations for patients with uveal melanoma 2416

16.3.87 Oct 16, 2019: AbbVie – Rule

2.10 announcement – Relevant securities in issue 2417

16.3.88 Oct 16, 2019: Johns Hopkins Center for Health Security, World Economic Forum and Bill & Melinda Gates Foundation host pandemic exercise and livestream 2418

16.3.89 Oct 16, 2019: Digital breast tomosynthesis increases cancer detection over full-field mammography 2418

16.3.90 Oct 04, 2019: Zacks Small Cap Research initiates coverage on Pressure BioSciences 2419

16.3.91 Sep 20, 2019: Chugai obtained approval for additional indication and Formulation for Tecentriq in PD-L1-Positive Triple Negative Breast Cancer 2419

16.3.92 Sep 18, 2019: FDA In Brief: FDA continues steps to promote innovation in medical devices that help advance patient safety through the Safer Technologies Program 2422

16.3.93 Sep 18, 2019: Paralympic Skier Danelle Umstead Teams Up with Spark Therapeutics to help people living with inherited retinal diseases (IRDs) access genetic testing 2423

16.3.94 Sep 11, 2019: Workforce Drug Positivity increases in more than one-third of U.S. industry sectors examined, According to Quest Diagnostics multi-year analysis 2424

16.3.95 Sep 09, 2019: Gaps exist in understanding of genomic tests 2426

16.3.96 Sep 04, 2019: New England Biolabs celebrates 10 years of advancing next generation sequencing sample preparation 2427

16.3.97 Aug 27, 2019: Smiths Medical announces partnership with Medline Industries 2428

16.3.98 Aug 02, 2019: Reps. Peters, Shimkus introduce bill to expand whole genome sequencing for children 2429

16.4 Legal And Regulatory 2430

16.4.1 Jul 14, 2020: NanoSurface Biomedical is now Curi Bio 2430

16.4.2 Jul 02, 2020: Alexion finalizes settlement with the U.S. Securities and Exchange Commission 2430

16.4.3 Jul 02, 2020: SEC charges Alexion Pharmaceuticals with FCPA violations 2431

16.4.4 Jun 25, 2020: FlowMetric Life Sciences receives CLIA High Complexity Laboratory Certification 2431

16.4.5 Jun 25, 2020: SEC charges Novartis with FCPA violations 2432

16.4.6 Jun 16, 2020: Illumina announces that U.S. Federal Court issues preliminary injunction against BGI Companies 2432

16.4.7 Jun 15, 2020: AbGenomics Holding announces company name change to AltruBio 2433

16.4.8 Jun 09, 2020: Neonode reports that Neonode Smartphone, an independent third-party and a subsidiary Of Aequitas Technologies, has filed patent infringement lawsuits Against Apple., and Samsung Electronics Co. and Samsung Electronics America, respectively, in the Western District Of Texas 2433

16.4.9 Jun 08, 2020: Molecule Holdings secures distribution for FDA/EUA approved COVID-19 Rapid Antibody Tests 2433

16.4.10 Jun 05, 2020: Biocept to relocate corporate offices and CLIA-Certified Laboratory to New San Diego Location 2434

16.4.11 May 27, 2020: Medibio settles joint venture dispute 2434

16.4.12 May 20, 2020: Personal Genomics files patent infringement complaint against Pacific Biosciences of California in China 2435

16.4.13 May 18, 2020: Natera and Illumina settle patent dispute 2436

16.4.14 May 15, 2020: Reference laboratory, Pain Clinic, and two individuals agree to pay $41 million to resolve allegations of unnecessary urine drug testing 2436

16.4.15 May 07, 2020: Intabio announces new website and digital marketing strategy to support Blaze system commercial launch 2437

16.4.16 Apr 17, 2020: Promega successfully completes first fully remote quality surveillance assessment amid covid-19 restrictions 2438

16.4.17 Apr 15, 2020: Natera asserts three new oncology patents against ArcherDX 2439

16.4.18 Apr 08, 2020: No Borders announces that the FDA has granted the company’s medical device importer registration 2439

16.4.19 Mar 25, 2020: Twist Bioscience synthetic SARS-CoV-2 RNA controls added to FDA website as reference materials 2440

16.4.20 Mar 03, 2020: Baron & Budd moves forward with false claims act case against AstraZeneca 2440

16.4.21 Feb 29, 2020: MGI’s response to Illumina’s complaint 2441

16.4.22 Feb 24, 2020: Eurofins DiscoverX grants Bioassay Certification to VelaLabs of Austria 2441

16.4.23 Feb 17, 2020: MedPharm completes successful FDA Inspection at its Durham, NC Center of Excellence 2442

16.4.24 Jan 30, 2020: MagBio Genomics receives ISO 9001:2015 accreditation for quality management system 2442

16.4.25 Jan 27, 2020: Roche seeks FDA approval for liver cancer treatment 2443

16.4.26 Jan 27, 2020: Natera files suit against ArcherDX for Patent Infringement 2444

16.4.27 Jan 23, 2020: Vulnerability disclosure regarding GE Healthcare monitoring products 2444

16.4.28 Jan 13, 2020: Oncology Venture to present a poster at upcoming PARP & DDR inhibitor summit on clinical development of 2X-121 2445

16.4.29 Jan 13, 2020: Natera announces new early priority date cfDNA patent, files suit against CareDx 2446

16.4.30 Jan 10, 2020: Illumina files patent infringement suits against BGI in Sweden and the United Kingdom 2447

16.4.31 Jan 09, 2020: Pomerantz law firm investigates claims on behalf of investors of Baxter 2447

16.4.32 Jan 08, 2020: CareDx’s false advertising complaint upheld by court 2448

16.4.33 Jan 06, 2020: Parallax Health Sciences announces patent enforcement initiative 2449

16.4.34 Jan 06, 2020: Atossa Genetics announces Corporate name change to Atossa Therapeutics 2449

16.4.35 Dec 23, 2019: The International Trade Commission issues final decision affirming 10X Genomics infringement of three of Bio-Rad’s Patents 2450

16.4.36 Dec 23, 2019: The International Trade Commission issues final decision affirming 10X genomics infringement of three of Bio-Rad’s patents 2450

16.4.37 Dec 10, 2019: Celmatix files $100 million lawsuit against 23andMe 2451

16.4.38 Dec 09, 2019: Laboratory to pay $26.67 million to settle allegations of kickbacks to physicians 2452

16.4.39 Dec 02, 2019: Rosen, a highly ranked firm, announces filing of securities class action lawsuit against Baxter International 2453

16.4.40 Nov 27, 2019: ASX/nasdaq announcement: Re-domiciliation to the united states 2453

16.4.41 Nov 13, 2019: Interpace Diagnostics changes name to Interpace Biosciences; announces plans for next phase of growth and third quarter 2019 financial results 2454

16.4.42 Nov 06, 2019: Calmare Therapeutics has $842,000 judgment vacated by the U.S. Court Of Appeals for the second circuit 2457

16.4.43 Oct 31, 2019: Cesca Therapeutics to change name and ticker symbol to reflect new strategic focus 2457

16.4.44 Oct 16, 2019: ImmunoCellular Therapeutics announces settlement of derivative action lawsuit 2458

16.4.45 Oct 10, 2019: Five Prime announces restructuring 2458

16.4.46 Oct 09, 2019: Genetic testing company and three principals agree to pay $42.6 million to resolve kickback and medical necessity claims 2459

16.4.47 Oct 07, 2019: New test for thyroid cancer could prevent unnecessary surgery 2460

16.4.48 Oct 04, 2019: Intellipharmaceutics announces an update in the Purdue Litigation 2461

16.4.49 Oct 03, 2019: Lilly announces voluntary delisting from Euronext Paris 2461

16.4.50 Oct 02, 2019: MGI sues Illumina again for patent infringement in the United States 2463

16.4.51 Oct 01, 2019: PGI files Patent Infringement complaint against PacBio 2463

16.4.52 Oct 01, 2019: uBiome converts chapter 11 case to chapter 7 petition; company to cease operations and liquidate 2463

16.4.53 Sep 30, 2019: Adocia announces receipt of USD

14.3 million payment from Eli Lilly following arbitration conclusion and the decision by mutual consent with Eli Lilly to conclude the civil case 2464

16.4.54 Sep 30, 2019: Mallinckrodt finalizes settlement to resolve “Track 1” opioid cases with the Ohio Counties of Cuyahoga and Summit 2464

16.4.55 Sep 27, 2019: Federal law enforcement action involving fraudulent genetic testing results in charges against 35 individuals responsible for over $2.1 billion in losses in one of the largest health care fraud schemes ever charged 2465

16.4.56 Sep 26, 2019: Calithera Biosciences to present data on Telaglenastat at European Society for Medical Oncology (ESMO) Congress 2019 2466

16.4.57 Sep 26, 2019: CareDx files patent infringement lawsuit against Eurofins Viracor 2467

16.4.58 Sep 26, 2019: Dana-Farber Cancer Institute and the Jimmy Fund debut new visual identity 2468

16.4.59 Sep 20, 2019: Whole Biome announces corporate name change to Pendulum Therapeutics 2468

16.4.60 Sep 18, 2019: Mayo Clinic receives FDA approval for advanced cancer detection imaging facility 2469

16.4.61 Sep 11, 2019: PDL BioPharma announces favorable decision in Wellstat Diagnostics litigation 2470

16.4.62 Sep 11, 2019: Bio-Rad files new lawsuit against 10X Genomics for Patent Infringement 2470

16.4.63 Sep 09, 2019: Diagnomics added CLIA Certificates from Maryland, Pennsylvania, and Rhode Island 2471

16.4.64 Sep 04, 2019: uBiome files voluntary Chapter 11 petitions to accelerate an orderly and efficient sale process 2471

16.4.65 Sep 04, 2019: LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi encourages investors who suffered losses exceeding $100,000 in Cardinal Health to contact the firm 2472

16.4.66 Sep 02, 2019: Novartis reports positive Phase III data for multiple sclerosis drug 2472

16.4.67 Aug 27, 2019: Physicians and Cardiac Center agree to pay total of more than $1.1 Million to resolve allegations that they received Kickbacks from Northwest Medical Testing Company 2473

16.4.68 Aug 23, 2019: Adocia announces that the American Arbitration Association Tribunal Dismissed all Claims in Second Phase of Arbitration With Eli Lilly 2473

16.4.69 Aug 23, 2019: Hemispherx Biopharma changes name to AIM ImmunoTech reflecting Ampligen’s Immuno Modulation Progress in Ongoing Oncology Clinical Trials and ME/CFS 2474

16.4.70 Aug 16, 2019: Profound Medical receives U.S. FDA 510(k) clearance for TULSA-PRO 2475

16.4.71 Aug 12, 2019: Lineage Cell Therapeutics launches new corporate brand 2475

16.4.72 Aug 12, 2019: Lead plaintiff deadline alert: Faruqi & Faruqi encourages investors who suffered losses exceeding $100,000 In Cardinal Health to contact the firm 2476

16.4.73 Aug 01, 2019: Fulgent Genetics receives laboratory permit and genetic test approval from New York State Department of Health 2476

16.4.74 Jul 31, 2019: Carolina Liquid Chemistries receives warning letter from FDA 2477

16.4.75 Jul 25, 2019: BD Statement on Georgia facilities 2478

16.4.76 Jul 24, 2019: Delaware District Court grants Bio-Rad’s Motion for Permanent Injunction against 10X Genomics 2478

16.5 Other Significant Developments 2479

16.5.1 Jul 16, 2020: RRD builds on long-standing supply chain experience to provide rapidly mobilized diagnostic test kit production solution 2479

16.5.2 Jul 16, 2020: Widely used blood test could advance heart failure treatment 2479

16.5.3 Jul 16, 2020: Improving lung cancer CT screening performance in real-world settings 2480

16.5.4 Jul 15, 2020: Freenome Holdings chooses SYSPRO ERP to help enable next-generation early cancer detection 2481

16.5.5 Jul 15, 2020: UrbanSitter chooses collective go to help facilitate safer childcare for families 2482

16.5.6 Jul 15, 2020: Merit Medical announces agreement in principle with Department of Justice 2482

16.5.7 Jul 15, 2020: Cleveland-based companies come together to make PPE available through vending machines 2482

16.5.8 Jul 13, 2020: Government of Mexico city implements Avaya Contact Center solutions for contact tracing, conducting 2,700 tests daily across 117 health centers 2483

16.5.9 Jul 13, 2020: BIRD – Israel-U.S. Binational Industrial R&D Foundation to Invest $8 million in 10 new projects 2484

16.5.10 Jul 13, 2020: RWJBarnabas Health receives $2 million grant from the Walmart Foundation 2485

16.5.11 Jul 08, 2020: GenMark Diagnostics: Entry into a Material Definitive Agreement 2485

16.5.12 Jul 07, 2020: CARB-X is funding Spanish biotech Vaxdyn to develop a new vaccine to prevent infections that cause life-threatening pneumonia and other deadly infections 2486

16.5.13 Jul 07, 2020: GENETWORx, of Glen Allen VA, will hire hundreds of employees this month as part of their re-employ America campaign 2487

16.5.14 Jul 07, 2020: LI-COR near-infrared assays and technology offer insight to coronavirus researchers 2488

16.5.15 Jul 06, 2020: Vizient teams up with suppliers to offer remote patient monitoring solutions in wake of COVID-19 2488

16.5.16 Jul 02, 2020: Synergy H1’s continuously variable bandwidth monochromators optimize assay performance 2489

16.5.17 Jul 01, 2020: Quantabio RT-qPCR ToughMix given expanded role in CDC COVID-19 testing protocol 2490

16.5.18 Jul 01, 2020: NanoMosaic unveils ultra-sensitive, quantitative platform to further immunotherapy and to enable whole proteome biomarker discovery 2491

16.5.19 Jun 30, 2020: Universities across South Carolina turn to leading medical supply firm, Vessel Medical, for COVID-19 safety preparations 2491

16.5.20 Jun 30, 2020: Transcell Oncologics announces a new portfolio, Transtoxbio, for testing COVID-19 vaccines and drug candidates 2492

16.5.21 Jun 25, 2020: Confirm BioSciences’ groundbreaking healthState wellness platform takes the guesswork out of corporate wellness programs with a data-centric approach 2492

16.5.22 Jun 24, 2020: Personalis completes sequencing 75,000th whole human genome for VA MVP 2493

16.5.23 Jun 22, 2020: NuProbe and Weigao Group form strategic collaboration to evdelop liquid biopsy panel 2494

16.5.24 Jun 19, 2020: AnPac Bio signs a record multi-million dollar contract for cancer screening 2495

16.5.25 Jun 16, 2020: binx health and UPS jointly announce international partnership for at-home “Contactless” COVID-19 Sample Collection 2495

16.5.26 Jun 15, 2020: Epredia and Lunaphore Announce Commercial Agreement for Exclusive Distribution of LabSat Research 2496

16.5.27 Jun 15, 2020: Celldex Therapeutics provides business update 2498

16.5.28 Jun 11, 2020: Recent research and new multidisciplinary framework for genetic testing in prostate cancer supports broader use of panels, testing in early stage disease 2499

16.5.29 Jun 11, 2020: Therapeutic Solutions International reports QuadraMune reduces myeloid suppressor cells in 4T1 mouse model of breast cancer 2500

16.5.30 Jun 11, 2020: COVID-19 antibody test offered by Confirm BioSciences gets high marks for accuracy and quality in National Institutes of Health Research 2501

16.5.31 Jun 10, 2020: CELLUM BioMedical Joins Forces with BENEV Company to Broaden Availability of COVID-19 Specimen & Serological Antibody Testing to Hospitals, Healthcare Organizations and Businesses Looking to Reopen 2502

16.5.32 Jun 10, 2020: NIH awards Cleveland Clinic $7.2 million to study new diagnostic biomarker in multiple sclerosis 2503

16.5.33 Jun 04, 2020: PathSensors announced the completion of phase I of a SBIR 2504

16.5.34 Jun 03, 2020: Cyprotex awarded new 5 year agreement with The US Environmental Protection Agency (‘EPA’) 2504

16.5.35 Jun 02, 2020: Pfizer establishes new program to support continued biotechnology innovation 2505

16.5.36 Jun 02, 2020: Personalis announces scientific collaboration with Sarepta Therapeutics on immune response to precision genetic therapeutics 2505

16.5.37 May 29, 2020: Hesperos human-on-a-chip system used to model preclinical stages of Alzheimer’s Disease and mild cognitive impairment 2505

16.5.38 May 29, 2020: Emory, partners receive $31 million COVID-19 testing grant 2506

16.5.39 May 28, 2020: Synergy Laboratories adds to its arsenal of COVID-19 diagnostic tools 2507

16.5.40 May 28, 2020: Honeywell expedites development and production of vital vaccines and medical therapies with fast track automation 2508

16.5.41 May 27, 2020: Pacific Neuropsychiatric Specialists to offer discounted COVID-19 antibody testing 2509

16.5.42 May 27, 2020: At-home screening for ovarian, breast cancers is effective 2509

16.5.43 May 26, 2020: MeMD enables consumers, businesses to order COVID-19 Antibody Testing 2510

16.5.44 May 26, 2020: Next-generation analytical software strengthens data exploration 2511

16.5.45 May 26, 2020: CosmetiCare to offer COVID-19 antibody testing 2512

16.5.46 May 21, 2020: Rocky Mountain Biologicals providing viral transport medium for COVID-19 testing 2513

16.5.47 May 19, 2020: Voltron Therapeutics publishes letter to shareholders 2513

16.5.48 May 19, 2020: Arbor Assays’ newest oxidative stress assay 2515

16.5.49 May 14, 2020: Erisyon awarded Michael J. Fox Foundation grant to validate methods for early Parkinson’s detection 2515

16.5.50 May 13, 2020: Quanterix’ Simoa technology sets new standard in protein detection 2516

16.5.51 May 13, 2020: OPKO Health’s BioReference Laboratories and Westchester Medical Center Health Network enter into strategic laboratory collaboration to deliver operational and diagnostic services 2517

16.5.52 May 08, 2020: In recognition of the challenges providers are facing, NantHealth is offering free access to NaviNet AllPayer for a limited time 2518

16.5.53 May 07, 2020: National Institute on Aging and PHI sign collaboration agreement 2518

16.5.54 May 07, 2020: ICONMA announces COVID-19 Medical Screening Service 2519

16.5.55 May 06, 2020: LakePharma supplying Mount Sinai with SARS-CoV-2 proteins for serological assays 2519

16.5.56 May 02, 2020: Halo provides operational update 2520

16.5.57 May 01, 2020: NetNoggin releases 2020 first quarter NetNog: track Alzheimer’s (including MCI) 2521

16.5.58 May 01, 2020: Quanterix CEO and Powering Precision Health Founder Kevin Hrusovsky to appear on Passionate Pioneers Podcast 2522

16.5.59 May 01, 2020: PTs, OTs, & SLPs Added as Telehealth Providers 2523

16.5.60 Apr 30, 2020: Nature protocols article cites HemogloBind in drug target identification methods for malaria-parasite infected erythrocytes 2523

16.5.61 Apr 29, 2020: AIS Healthcare goes above and beyond to supply needed medication for COVID-19 ventilator patients 2524

16.5.62 Apr 27, 2020: New England Biolabs introduces 100% recyclable packaging for cold chain shipping in partnership with Temperpack 2524

16.5.63 Apr 27, 2020: Accurate Diagnostic Labs continues to be on forefront of the national fight against COVID-19 and announces the availability of serological antibody testing this week 2525

16.5.64 Apr 23, 2020: Reaction Biology and PharmaCore Labs announce China outreach 2525

16.5.65 Apr 22, 2020: Risk prediction model that combines clinical and genetic factors with circulating biomarkers could identify those at higher risk of pancreatic cancer 2526

16.5.66 Apr 21, 2020: Lenco Diagnostic provides update on its recent COVID-19 and IgG and IgM Serology Testing 2527

16.5.67 Apr 20, 2020: Conformis receives $4.7 million under the Paycheck Protection Program 2528

16.5.68 Apr 19, 2020: BGI Group supports france to secure equipment for two million COVID-19 Tests 2528

16.5.69 Apr 16, 2020: Steinberg Diagnostic Medical Imaging continues to evolve with changing needs of Southern Nevada during COVID-19 Pandemic 2529

16.5.70 Apr 15, 2020: High-res imaging with elastography may accurately detect breast cancer in surgical margins 2530

16.5.71 Apr 15, 2020: High-resolution imaging coupled with elastography may accurately detect breast cancer in surgical margins 2531

16.5.72 Apr 09, 2020: UPMC-led global effort fast tracks testing of covid-19 therapies 2532

16.5.73 Apr 08, 2020: Immunovia and Global Pharmaceutical Company agree on early termination of lung cancer Collaboration 2534

16.5.74 Apr 08, 2020: Pacific Biosciences powers SARS-CoV-2 research at commercial, academic and government labs 2534

16.5.75 Apr 07, 2020: Bristol Myers Squibb expands patient support programs to help newly uninsured patients in the U.S 2536

16.5.76 Apr 07, 2020: VITAL4 offers free healthcare employee screening software to all U.S. Healthcare Facilities impacted by COVID-19 2536

16.5.77 Apr 06, 2020: BioIVT opens new blood donor center to support Boston-area research into COVID-19 therapies, vaccines and diagnostics 2537

16.5.78 Apr 06, 2020: Synergy Laboratories joins the fight against the coronavirus with advanced testing capabilities 2537

16.5.79 Apr 06, 2020: Penumbra provides update on COVID-19 response and impact 2538

16.5.80 Apr 05, 2020: Mako Medical launches programs aimed at helping seniors at risk of COVID-19 2539

16.5.81 Apr 04, 2020: Radsource wins 11 new PACS contracts in the first quarter of 2019 2540

16.5.82 Apr 03, 2020: Mako Medical works to stop covid-19 impact to medical practices around the country 2540

16.5.83 Apr 03, 2020: NeoGenomics integrates HALO from Indica Labs 2541

16.5.84 Apr 02, 2020: Organovo Holdings founder calls on board of directors to accept stockholders’ opposition to the illogical merger with Tarveda Therapeutics 2541

16.5.85 Apr 02, 2020: SI-BONE provides business update in response to covid-19 pandemic 2542

16.5.86 Apr 01, 2020: DocTalkGo provides at-home coronavirus (covid-19) screening and FDA approved hydroxychloroquine 2542

16.5.87 Apr 01, 2020: Endocanna Health launches 25 new trait reports and personalized cannabinoid matching product marketplace 2544

16.5.88 Apr 01, 2020: PTS Diagnostics and MedPro Healthcare sales solutions enter into partnership 2544

16.5.89 Mar 31, 2020: Molina Healthcare of New Mexico offers support to the Navajo nation during coronavirus pandemic 2545

16.5.90 Mar 31, 2020: Chiesi USA increases support measures for employees, patients and community partners in response to COVID-19 pandemic 2545

16.5.91 Mar 30, 2020: Parallax announces International Medical Supply Chain Agreement for COVID-19 Testing Kits and FDA Registered Suppliers of Personal Protective Equipment (PPE) 2546

16.5.92 Mar 30, 2020: Promega part of new Wisconsin public-private partnership to increase covid-19 laboratory testing capacity 2547

16.5.93 Mar 26, 2020: ZOOM+Care pilots self-sampled coronavirus test 2547

16.5.94 Mar 25, 2020: DermTech announces response to COVID-19 2548

16.5.95 Mar 25, 2020: ZAGENO releases COVID-19 data addressing the laboratory supply chain 2548

16.5.96 Mar 23, 2020: Parallax announces immediate availability point-of-care COVID-19 diagnostic testing kits, personal protection equipment (PPE) and medical supplies 2549

16.5.97 Mar 22, 2020: Gladstone Institutes responds to COVID-19 Pandemic 2549

16.5.98 Mar 21, 2020: Quest Diagnostics dedicates special hours for non-COVID-19 testing for older and highly vulnerable patients 2550

16.5.99 Mar 19, 2020: Smart manufacturing company cuts costs for essential Covid-19 devices 2551

16.5.100 Mar 19, 2020: Cassava Sciences announces clinical update and business progress across Neuroscience pipeline 2551

16.5.101 Mar 19, 2020: LabCorp sets dedicated hours to serve the non-COVID-19 testing needs for elderly and most vulnerable people 2554

16.5.102 Mar 19, 2020: Sequencing.com launches free genetic analysis to assess risk and severity of coronavirus infection for each individual 2554

16.5.103 Mar 18, 2020: ATCC partners with global scientific community to respond to the coronavirus pandemic 2555

16.5.104 Mar 18, 2020: PathSensors continues operations with COVID – 19 Contingency Plan 2556

16.5.105 Mar 17, 2020: Covid-19: IDT launches large-scale production of Covid-19 test component 2556

16.5.106 Mar 17, 2020: Olympus supports national colorectal cancer awareness month 2556

16.5.107 Mar 17, 2020: Michigan Medicine to offer limited curbside COVID-19 screening to its patients 2557

16.5.108 Mar 16, 2020: The National Kidney Registry and Viracor Eurofins Announce Coronavirus COVID-19 Rapid Turnaround Transplant Testing for Donors and Recipients 2558

16.5.109 Mar 13, 2020: Sonic Healthcare USA announces testing availability for COVID-19 2559

16.5.110 Mar 13, 2020: BioTek Instruments: In vitro assays for antiviral drug development (covid-19) 2559

16.5.111 Mar 11, 2020: Dante Labs offers 200 free human whole genome sequencing tests to scientists for global research projects on coronavirus 2559

16.5.112 Mar 11, 2020: Fight Colorectal Cancer receives grant from exact sciences to launch program aimed at reducing patient barriers to colorectal cancer screening 2560

16.5.113 Mar 11, 2020: Vanderbilt Vaccine Center acquires Octet HTX System to speed antibody screening 2561

16.5.114 Mar 11, 2020: PreCheck Health to exclusively distribute coronavirus (COVID 19) test in Russia for a U.S based molecular diagnostics company 2561

16.5.115 Mar 10, 2020: Health Gorilla launches electronic ordering for COVID-19 testing 2562

16.5.116 Mar 10, 2020: Bright Health announces free COVID-19 diagnostic testing and early prescription refills 2562

16.5.117 Mar 09, 2020: OptimizeRx digital health network now delivering CDC coronavirus alerts to thousands of healthcare providers nationwide 2563

16.5.118 Mar 08, 2020: Northwell Labs begins manual testing of COVID-19 samples 2563

16.5.119 Mar 07, 2020: HAP waives cost-sharing for covid-19 testing 2564

16.5.120 Mar 06, 2020: Blue Cross and Blue Shield Companies announce coverage of Coronavirus testing for members and other steps to expand access to Coronavirus care 2565

16.5.121 Mar 06, 2020: Blue Cross Blue Shield of Massachusetts expedites access to testing and care related to the novel Coronavirus (COVID-19) 2566

16.5.122 Mar 06, 2020: Optima Health covers coronavirus testing and treatment coverage for members 2566

16.5.123 Mar 06, 2020: Enzo Biochem’s full service clinical laboratory to launch coronavirus (COVID-19) testing services next week 2567

16.5.124 Mar 06, 2020: BlueCross to cover full testing costs for COVID-19 2567

16.5.125 Mar 06, 2020: Co-diagnostics ready to meet U.S vice president’s plea for more domestic tests 2568

16.5.126 Mar 05, 2020: Cigna covers cost Of Coronavirus Tests for customers 2569

16.5.127 Mar 05, 2020: CMS develops additional code for coronavirus lab tests 2569

16.5.128 Mar 05, 2020: Regence BlueShield of Idaho to cover cost of coronavirus (COVID-19) testing for members 2570

16.5.129 Mar 04, 2020: The potential benefits of AI for breast cancer detection 2571

16.5.130 Mar 02, 2020: Todos Medical announces publication demonstrating potential of FTIR platform to identify bacterial and viral infections 2574

16.5.131 Mar 02, 2020: Northwell Labs to have coronavirus testing capabilities within a week 2575

16.5.132 Mar 02, 2020: NeoGenomics announces three-year contract to be cornerstone oncology and cancer testing laboratory for large, National Group Purchasing Organization 2575

16.5.133 Feb 24, 2020: AbbVie announces extension of expiration date for exchange offers for Allergan notes 2576

16.5.134 Feb 20, 2020: Konica Minolta Healthcare, RegenLab expand ultrasound solutions 2576

16.5.135 Feb 18, 2020: MilliporeSigma announced as contract manufacturer of Elypta’s kits 2577

16.5.136 Feb 11, 2020: Varex announces renewed pricing agreement with Canon Medical Systems 2577

16.5.137 Feb 06, 2020: Voycare enters into MOU with Incinta Medical Holding to further tap into China’s rapidly growing IVF market, of US$ 1.5 Billion by 2022 2578

16.5.138 Feb 05, 2020: ProDigest and CosmosID launch the ‘gut microbiome therapeutic innovation’ challenge 2578

16.5.139 Feb 05, 2020: Hologic launches new scalable options for panther system in the United States and Europe 2579

16.5.140 Feb 05, 2020: Bill & Melinda Gates Foundation dedicates additional funding to the novel Coronavirus response 2580

16.5.141 Feb 05, 2020: UMass Amherst study aims to develop new test for BRCA-positive lactating moms 2581

16.5.142 Feb 04, 2020: Bio-Rad brings FCS express flow cytometry analysis software to ZE5 cell analyzer users 2582

16.5.143 Feb 03, 2020: Siemens Healthineers Wins Bid to Become Primary Supplier for Quest Diagnostics Immunoassay Testing with Atellica Solution 2583

16.5.144 Jan 30, 2020: IDT offers preferred pricing and early access to complete portfolio of coronavirus research tools 2583

16.5.145 Jan 29, 2020: Massachusetts General Hospital selects Varian Radiotherapy Systems for Cancer Center 2584

16.5.146 Jan 28, 2020: OpGen achieves key milestone in planned business combination with Curetis 2584

16.5.147 Jan 27, 2020: CMS expands coverage of next generation sequencing as a diagnostic tool for patients with breast and ovarian cancer 2585

16.5.148 Jan 23, 2020: Johnson & Johnson announces $250 million commitment to support Frontline Health Workers, reaching 100 million people by 2030 2586

16.5.149 Jan 21, 2020: OptraHEALTH collaborates with Microsoft Azure to serve genomic health industry with the launch of “GeneFAX™ Pro” 2586

16.5.150 Jan 21, 2020: Genomic Vision technology to be tested by NIST (US Gaithersburg) for establishing standards methods for genome editing based product registration by FDA 2587

16.5.151 Jan 21, 2020: ImmuCell announces preliminary, unaudited product sales results for the year ended December 31, 2019 2588

16.5.152 Jan 20, 2020: Spectrum Health Employees Honor MLK’s Legacy Through Community Service 2589

16.5.153 Jan 15, 2020: Life Chiropractic College West uses biomarkers to support Vitalistic research 2589

16.5.154 Jan 14, 2020: Solos Endoscopy will look to become a women’s healthcare focused company 2591

16.5.155 Jan 14, 2020: Papa partners with Higi to support health screenings and ongoing support for senior citizens via accessible healthcare technology 2591

16.5.156 Jan 13, 2020: Geron announces 2019 accomplishments and key development priorities for 2020 2591

16.5.157 Jan 13, 2020: Blueprint Medicines announces 2020 corporate goals 2593

16.5.158 Jan 13, 2020: Deciphera Pharmaceuticals provides corporate update and highlights key 2020 milestones 2594

16.5.159 Jan 13, 2020: Turning Point Therapeutics announces program updates and milestones for 2020 2595

16.5.160 Jan 13, 2020: NextCure: Termination of a material definitive agreement 2596

16.5.161 Jan 13, 2020: Healthpeak announces lease with Johnson & Johnson Subsidiary at The Shore at Sierra Point 2596

16.5.162 Jan 12, 2020: Invitae preliminary 2019 financial results demonstrate strong momentum with nearly 60% growth in test volume and more than 45% growth in revenue year-over-year 2597

16.5.163 Jan 08, 2020: Molecular Templates provides corporate update and outlines 2020 milestones 2598

16.5.164 Jan 08, 2020: Bio-Path Holdings provides clinical update and 2020 business outlook 2600

16.5.165 Jan 08, 2020: Genetic testing provides insights to sudden unexplained deaths in Amish community 2602

16.5.166 Jan 07, 2020: Clovis Oncology announces debt refinancing transaction 2602

16.5.167 Jan 07, 2020: Jant Pharmacal is awarded contract from Vizient 2603

16.5.168 Jan 07, 2020: Shoreline Biome announces international distribution partnership in Japan 2603

16.5.169 Jan 06, 2020: Natera announces achievement of $55 million in pharma contracts and issuance of new oncology patents 2604

16.5.170 Jan 06, 2020: Catalyst Pharmaceuticals pre-announces estimated Firdapse revenues and provides updates on advancement of clinical development programs 2604

16.5.171 Jan 02, 2020: Agilent expands cross-vendor CDS instrument control 2606

16.5.172 Jan 02, 2020: Parallax Health Sciences engages Alston & Bird 2606

16.5.173 Jan 02, 2020: Lineage Cell Therapeutics conducts sale of shares in oncocyte 2607

16.5.174 Dec 23, 2019: EpiVax announces record year for growth in 2019 and sets new milestones for 2020 2607

16.5.175 Dec 20, 2019: On eve of new decade, EpiVax re-pledges commitment to improving health everywhere 2608

16.5.176 Dec 18, 2019: Envista completes separation from Danaher 2609

16.5.177 Dec 17, 2019: Humana announces Atlanta, Charlotte and Houston as its latest bold goal communities 2609

16.5.178 Dec 17, 2019: Precipio announces first IV-cell commercial order from Northwell Health 2610

16.5.179 Dec 17, 2019: AI improves breast cancer risk prediction 2611

16.5.180 Dec 17, 2019: Case Western Reserve researchers to lead Northeast Ohio initiative to prevent, detect and treat lung cancer in underserved communities 2612

16.5.181 Dec 16, 2019: Pfizer declares first-quarter 2020 dividend and announces upcoming investor day to highlight strength of innovative R&D pipeline 2613

16.5.182 Dec 16, 2019: CELLINK to partner with Made In Space to advance bioprinting technology in space 2613

16.5.183 Dec 13, 2019: Sunovion says SEP-363856 improved schizophrenia symptoms 2614

16.5.184 Dec 13, 2019: Bio-Rad makes progress recovering from recent ransomware attack 2615

16.5.185 Dec 12, 2019: McKesson selected by Department of Veterans Affairs as prime pharmaceutical provider 2615

16.5.186 Dec 11, 2019: Invicro supports the Alzheimer’s Disease neuroimaging initiative 2616

16.5.187 Dec 10, 2019: Invitae announces program with BioMarin to expand access to genetic testing for Skeletal Dysplasias 2616

16.5.188 Dec 10, 2019: Fluidigm expands Maxpar antibody portfolio for high-multiplex tissue imaging 2617

16.5.189 Dec 10, 2019: Genetype for Breast Cancer commissioned with sales to commence first quarter 2020 2618

16.5.190 Dec 06, 2019: SWOG: New markers for triple negative breast cancer 2618

16.5.191 Dec 05, 2019: CDC awards Aptagen $1MM contract for parasitic disease diagnostic 2619

16.5.192 Dec 05, 2019: Enzo Biochem issues open letter to shareholders 2620

16.5.193 Dec 04, 2019: Nordic Nanovector: New preclinical data offer insights into enhancing Betalutin-based therapies in NHL 2624

16.5.194 Dec 04, 2019: Caris Life Sciences and Ambry Genetics partner to advance cancer care 2625

16.5.195 Dec 04, 2019: Alzheimer’s Drug Discovery Foundation’s diagnostics accelerator announces second round of awards 2626

16.5.196 Dec 03, 2019: Groundbreaking study seeks volunteers to help modernize breast cancer screening 2627

16.5.197 Dec 03, 2019: Nature Medicine publication highlights use of NanoString’s Hyb & Seq technology to perform rapid genotypic and phenotypic antibiotic susceptibility testing 2628

16.5.198 Dec 03, 2019: How a single blood test may provide a ‘head-to-toe’ health check 2629

16.5.199 Dec 02, 2019: OpGen provides Curetis Group business update and announces completion of key milestones in planned business combination 2631

16.5.200 Nov 28, 2019: Commercial Contract With IMRA America – Additional Information 2632

16.5.201 Nov 27, 2019: Xtraction Services signs sale-leaseback agreement with Halo Labs 2632

16.5.202 Nov 26, 2019: Mountain View Medical Group signs new In-Network agreement with Humana 2633

16.5.203 Nov 26, 2019: €11.9m SFI research collaboration targets precision oncology 2633

16.5.204 Nov 21, 2019: LabCorp to expand use of Qiagen’s bioinformatics solutions 2634

16.5.205 Nov 21, 2019: Agilent announces applications open for LabCentral Golden Ticket 2635

16.5.206 Nov 20, 2019: InformedDNA unveils unique approach to genetic test policy development 2635

16.5.207 Nov 20, 2019: Humana and agilon health expand relationship, announce value-based agreements with Physician Groups 2636

16.5.208 Nov 20, 2019: QIAGEN and LabCorp deepen relationship with widespread use of bioinformatics solutions 2637

16.5.209 Nov 19, 2019: Rheonix files 510(K) seeking FDA clearance of triplex sexually transmitted infection assay 2638

16.5.210 Nov 19, 2019: New Cancer Center at Golden Valley Memorial Healthcare offers Physician Services Provided by Sarah Cannon Cancer Institute at HCA Midwest Health 2638

16.5.211 Nov 18, 2019: MedGenome selects Applied Biosystems Axiom genotyping platform to enable large-scale genetic studies in South Asian populations 2639

16.5.212 Nov 18, 2019: CytoDyn engages LifeSci Public Relations as Communications Partner 2640

16.5.213 Nov 18, 2019: Anteotech signs commercial contract with IMRA America 2641

16.5.214 Nov 18, 2019: UVM Health Network pilot project offers patients genomic DNA testing 2642

16.5.215 Nov 14, 2019: American BriVision announces issuance of a full Clinical Study Report (CSR) for ABV-1504 for Major Depressive Disorder phase II study 2643

16.5.216 Nov 14, 2019: BioIQ conducts one millionth colorectal cancer screening 2644

16.5.217 Nov 14, 2019: Precipio wins $750,000 Pharma Project 2645

16.5.218 Nov 11, 2019: NIH RO1 grant to help improve ultrasound tomography for breast cancer detection 2645

16.5.219 Nov 08, 2019: University of Vermont Health Network begins offering Genomic DNA Testing 2646

16.5.220 Nov 08, 2019: prismCDX implements Ultivue’s UltiMapper platform for standardized, comprehensive cancer tissue phenotypic characterization 2648

16.5.221 Nov 07, 2019: Leica Microsystems and Precision Lens sign agreement to expand Leica Ophthalmic Portfolio market opportunity in the U.S. Midwest 2648

16.5.222 Nov 06, 2019: Day Zero Diagnostics announces publication of research conducted using the company’s whole genome sequencing service 2649

16.5.223 Nov 06, 2019: Cofactor Genomics opens early access to new T cell exhaustion models through predictive immune Modeling platform 2649

16.5.224 Nov 06, 2019: ProtoKinetix AAGP operational update 2650

16.5.225 Nov 05, 2019: Thermo Fisher Scientific highlights expanded pharma services capabilities during CPhI 2650

16.5.226 Nov 05, 2019: Lucira Health and BARDA execute contract option for $11.5 million to bring OTC Flu Test to Market 2651

16.5.227 Nov 05, 2019: Bio-Techne to present at The Stephens Nashville Investment Conference 2652

16.5.228 Nov 04, 2019: MiraVista Diagnostics expanding laboratory, clinical capabilities, increasing diagnostic offerings 2652

16.5.229 Nov 04, 2019: Medical Care receives funding to validate its digital biomarkers for detecting pre-symptomatic Alzheimer’s Disease 2652

16.5.230 Nov 04, 2019: OpGen provides update on Curetis Group Company Ares Genetics Business 2653

16.5.231 Nov 04, 2019: Pro Medicus signs A$9M 5-year Contract with The Ohio State University Wexner Medical Center 2654

16.5.232 Oct 31, 2019: Predictive Technologies Group engages LifeSci Partners as Communications Partner 2654

16.5.233 Oct 31, 2019: SeraCare Life Sciences launches first-ever tumor mutational burden reference materials 2654

16.5.234 Oct 30, 2019: Shriners Hospitals for Children establishes new Genomics Institute to advance precision medicine in partnership with Genome Medical 2655

16.5.235 Oct 30, 2019: Ancestry makes $1 million Educational Grant to UpToDate to develop genetic testing information for medical providers 2656

16.5.236 Oct 29, 2019: Enesi Pharma awarded grant funding to develop and evaluate ImplaVax-enabled Solid Dose Vaccines Targeting Measles and Rubella 2657

16.5.237 Oct 29, 2019: Illumina celebrates grand opening of its solutions center in the University of Maryland BioPark 2658

16.5.238 Oct 29, 2019: AbbVie launches Let Me Be Clear to empower people with Psoriasis to speak up and seek freedom from their disease 2659

16.5.239 Oct 29, 2019: New grant aims to increase Colorectal Cancer screening, follow-up care in Appalachia 2659

16.5.240 Oct 28, 2019: Fight Colorectal Cancer Teams Up with Komodo Health to improve early intervention and close gaps in colorectal cancer care 2660

16.5.241 Oct 24, 2019: USA Today Article Confuses Patients on Benefits of 3D Mammography for Breast Cancer Screening 2661

16.5.242 Oct 24, 2019: Intermountain Riverton Hospital Health Fair to celebrate 10th Anniversary 2662

16.5.243 Oct 23, 2019: AdvaMed Statement on BD Sterilization Plant in Georgia 2662

16.5.244 Oct 23, 2019: Advancing early cancer detection methods 2663

16.5.245 Oct 22, 2019: Donate Life America and the Fresenius Medical Care Foundation announce groundbreaking National, Universal Living Donor Kidney Registry 2664

16.5.246 Oct 18, 2019: NIH funds new all of us research program genome center to test advanced sequencing tools 2665

16.5.247 Oct 18, 2019: Ochsner Health System to pilot genetic screening program in partnership with Color 2666

16.5.248 Oct 16, 2019: Orgenesis announces Co-Development Agreement with Accellix 2667

16.5.249 Oct 16, 2019: Inimmune receives $1M SBIR phase II grant 2667

16.5.250 Oct 15, 2019: LabCorp Celebrates 50 Years of Improving Health, Improving Lives 2668

16.5.251 Oct 14, 2019: Humana to provide Medicare Advantage Plans to Florida’s State Retirees 2669

16.5.252 Oct 11, 2019: Sema4 applies data-driven approach to expanded carrier screening, and will soon utilize exome sequencing for genetic testing 2670

16.5.253 Oct 10, 2019: HTG Molecular Diagnostics provides update regarding companion diagnostic development programs 2670

16.5.254 Oct 10, 2019: Penn researchers to develop a tool to help diagnose, track parkinson’s disease with $20 million NIH grant, 2671

16.5.255 Oct 10, 2019: clayton cuts ribbon on historic biopharma infrastructure 2672

16.5.256 Oct 09, 2019: Absorption Systems awarded 5-year IDIQ contract by the FDA 2673

16.5.257 Oct 09, 2019: Mammography screenings offered for transgender men and women 2674

16.5.258 Oct 08, 2019: Identifying rare diseases in newborns: Broader screening for better outcomes 2675

16.5.259 Oct 07, 2019: AstraZeneca launches signature STEM program to empower students to live healthier lives and inspire future scientists 2676

16.5.260 Oct 07, 2019: Diagnomics releases cardiovascular health panel on clinical microarray platform 2676

16.5.261 Oct 03, 2019: Quanterix announces recipients of annual accelerator grant program 2677

16.5.262 Oct 03, 2019: CMU and Yale receive NIH grant to further Gene Editing Technique 2678

16.5.263 Oct 01, 2019: First baby tested via Parent Project Muscular Dystrophy’s Newborn Screening Pilot 2679

16.5.264 Sep 30, 2019: Halo Labs provides Oregon business update company projects record september sales orders in Oregon 2680

16.5.265 Sep 30, 2019: Illumina and Broad Institute announce agreement to co-develop genomic secondary analysis tools 2681

16.5.266 Sep 30, 2019: Startup Sandbox graduates first class of innovators 2682

16.5.267 Sep 27, 2019: 23andMe and TrialSpark to offer new clinical trial solution 2683

16.5.268 Sep 25, 2019: Lupus Research Award supports early career scientists, funds study areas of critical need 2683

16.5.269 Sep 24, 2019: Global Medical Tech Companies Hamilton Bonaduz and Sonova select ANAQUA for IP Management 2684

16.5.270 Sep 20, 2019: Yesse Technologies awarded $750K SBIR phase II grant from The National Science Foundation 2685

16.5.271 Sep 20, 2019: INanoBio to receive up to $5.4 million to develop an Epigenetic Sequencer for Detecting WMD Exposures 2686

16.5.272 Sep 19, 2019: Adaptive to provide clonoSEQ MRD test for Amgen drug development 2686

16.5.273 Sep 19, 2019: Westfield Memorial Hospital offers lung screenings for those at risk for lung cancer 2687

16.5.274 Sep 19, 2019: Psychemedics announces new Brazilian distribution agreement 2688

16.5.275 Sep 19, 2019: Community Clinics receive grant for Point-of-Care Diagnostics 2688

16.5.276 Sep 19, 2019: Fizz and Feathers Event Raises $150,000 for National Jewish Health and Chronically Ill Children 2689

16.5.277 Sep 18, 2019: Piedmont Walton now offers 3-D mammograms 2689

16.5.278 Sep 18, 2019: OpGen provides update on Curetis Group’s R&D Collaboration 2690

16.5.279 Sep 17, 2019: TruMed Systems announces release of their newest model of the AccuVax Vaccine Management System, the AccuVax ES 2691

16.5.280 Sep 17, 2019: Alexion announces CFO Succession 2692

16.5.281 Sep 17, 2019: Biognosys and bruker collaborate to support ion mobility on timsTOF Pro with Spectronaut 2692

16.5.282 Sep 17, 2019: Intermountain Healthcare Launches Initiative and Resources to Increase Utah’s Low Mammography Screening Rates to Save More Lives 2693

16.5.283 Sep 17, 2019: AdventHealth, Moffitt Cancer Center join forces to improve cancer care for Floridians 2694

16.5.284 Sep 16, 2019: FDA authorises Roche’s cobas pro solutions for diagnostic labs 2695

16.5.285 Sep 16, 2019: Fulgent Genetics launches picture genetics, a consumer-initiated genetic testing offering 2696

16.5.286 Sep 16, 2019: Interpace enters strategic partnership agreement with Genecast Biotechnology to partner with Biopharma Solutions in China 2697

16.5.287 Sep 16, 2019: Sysmex America joins Clinical Lab

2.0 Movement to support collaboration around value-based healthcare 2697

16.5.288 Sep 10, 2019: Michigan-based memorial healthcare: First in U.S. to use new neurofilament light chain technology for multiple sclerosis patients 2698

16.5.289 Sep 10, 2019: T2 Biosystems to Host Conference Call to Discuss Awarding of Multi-Million Dollar BARDA Contract 2699

16.5.290 Sep 10, 2019: New biomarker for dementia improves risk prediction 2699

16.5.291 Sep 09, 2019: Harvard Bioscience announces strategic action plan and financial targets 2700

16.5.292 Sep 09, 2019: Liquid biopsies reveal genetic alterations linked to cancer drug resistance 2701

16.5.293 Sep 09, 2019: Cesca Therapeutics and ThermoGenesis announce major global distribution agreement for the company’s X-Series products 2702

16.5.294 Sep 05, 2019: Histologics cervical brush biopsy imparts immune response 2702

16.5.295 Sep 05, 2019: Simple CEUS Scan helps diagnose Liver Cancer when MRI is uncertain 2703

16.5.296 Sep 05, 2019: CTIP acceleratorannounces winners of 2019 catalyzing pediatric innovation grant competition 2704

16.5.297 Sep 04, 2019: Eon announces initiative to offer qualified lung cancer screening programs CMS compliance verification 2705

16.5.298 Sep 04, 2019: UniPath announces new clinical lab service in Colorado 2705

16.5.299 Sep 04, 2019: Instrumentation Laboratory awarded point-of-care coagulation/patient blood management agreement with Premier 2706

16.5.300 Sep 03, 2019: SCL Health announces Precision Oncology partnership with Strata Oncology 2707

16.5.301 Aug 29, 2019: SCOR Global Life partners with Human Longevity to bring data-driven health intelligence to life insurance policyholders 2707

16.5.302 Aug 28, 2019: UPMC’s strong financial results for first half of 2019 support continued commitment to clinical excellence & community health 2708

16.5.303 Aug 27, 2019: New $2.8M grant in hand, JABSOM scientist hopes to develop improved early breast cancer detection tool 2709

16.5.304 Aug 27, 2019: Neurological brain markers might detect risk for psychotic disorders 2709

16.5.305 Aug 27, 2019: Researchers to create quick, low-cost cancer diagnostic 2710

16.5.306 Aug 26, 2019: New technique isolates placental cells for non-invasive genetic testing 2710

16.5.307 Aug 20, 2019: Predictive Technology Group accelerates research sample collections to support development of personalized molecular diagnostics and clinical therapies 2711

16.5.308 Aug 13, 2019: Precipio Pathology sales metrics demonstrate continuous improvement in Q2 2019 2712

16.5.309 Aug 12, 2019: Curetis retains H.C. Wainwright as strategic advisor 2713

16.5.310 Aug 06, 2019: Non-invasive imaging method spots cancer at the molecular level 2713

16.5.311 Aug 06, 2019: Research article cites Cleanascite to study lipid metabolism in cancer 2715

16.5.312 Aug 06, 2019: Shoreline Biome announces international distribution partnerships worldwide 2715

16.5.313 Aug 05, 2019: $1.5M awarded from ORIEN new Oncologic Visionary awards program supports research by Rutgers Cancer Institute Investigators 2716

16.5.314 Aug 01, 2019: Genome Canada, Thermo Fisher and OICR collaborate for cancer testing 2717

16.5.315 Aug 01, 2019: Generex Biotechnology welcomes MediSource Partners to the NuGenerex Family of Companies 2718

16.5.316 Jul 31, 2019: Pancreatic Cancer detection study yields encouraging results 2718

16.5.317 Jul 31, 2019: Psoriasis therapy linked to reduced coronary inflammation in patients with the skin condition 2719

16.5.318 Jul 30, 2019: Strata Oncology announces partnerships with five additional health systems 2720

16.5.319 Jul 30, 2019: Hazelden Betty Ford, Mayo Clinic set out to find biological markers for treatment of alcoholism 2720

16.5.320 Jul 30, 2019: MedTest Dx launches certified performance guarantee program at 2019 AACC Scientific Meeting 2721

16.5.321 Jul 30, 2019: Array Biopharma a subsidiary of Pfizer announces effective date of make-whole fundamental change and fundamental change company notice relating to its

2.625% convertible senior notes due 2024 2722

16.5.322 Jul 30, 2019: Modulim granted CPT code from the American Medical Association for its Noninvasive Microvascular Assessment Technology 2723

16.5.323 Jul 30, 2019: BioReference notifies patients in AMCA incident 2723

16.5.324 Jul 29, 2019: SINTX Technologies provides business update 2724

16.5.325 Jul 29, 2019: Important notification from Natera regarding recent AMCA data security incident 2725

16.5.326 Jul 29, 2019: OBN announce Thermo Fisher Scientific as a new Corporate Sponsor 2725

16.5.327 Jul 26, 2019: Inform Diagnostics statement regarding AMCA data breach 2726

16.5.328 Jul 25, 2019: Quantimetrix and Somagen Diagnostics sign Exclusive Distribution Agreement 2726

16.5.329 Jul 24, 2019: Invitae launches detect programs to make it easier for patients to get genetic testing for prostate cancer, muscular dystrophy and heart conditions 2727

16.5.330 Jul 23, 2019: Nurx expands to Kentucky, providing convenient & affordable care for sensitive health needs 2728

16.5.331 Jul 22, 2019: Study finds common blood tests could predict diabetes 2729

16.5.332 Jul 22, 2019: Biocept announces laboratory services provider agreement with BeaconLBS 2729

16.5.333 Jul 22, 2019: LabCorp expands consumer-initiated test offering 2730

16.5.334 Jul 22, 2019: Precipio: Global expansion efforts begin yielding results 2731

16.6 Product News 2732

16.6.1 Jul 16, 2020: BioMark Diagnostics receives full registered trademark status from the US patent and trademark office for its company brand name “BioMark” 2732

16.6.2 Jul 13, 2020: Meridian Bioscience announces the launch of a high-sensitivity SARS-CoV-2 Nucleocapsid Antibody Pair for the Development of Rapid COVID-19 Antigen Assays 2732

16.6.3 Jul 13, 2020: Thermo Fisher Scientific and first genetics JCS partner to develop next-generation sequencing-based diagnostics in Russia 2733

16.6.4 Jul 10, 2020: Anixa Biosciences’ CAR-T cancer therapy receives intention to grant notice from the European Patent Office 2733

16.6.5 Jul 09, 2020: Lawrence J. Ellison Institute for transformative medicine of USC explores breakthrough tissue “fingerprints” concept for cancer diagnostics using Oracle Cloud technology 2734

16.6.6 Jul 07, 2020: Building safety tech provider Antlia Systems introduces advanced non-contact thermal detection systems amid pandemic 2734

16.6.7 Jul 06, 2020: Fralin Biomedical Research Institute scientists developing new strategy to thwart Alzheimer’s 2736

16.6.8 Jul 01, 2020: Thermo Fisher Scientific launches new MAS Omni infectious disease quality controls 2737

16.6.9 Jun 30, 2020: SCC Soft Computer introduces 90-day rapid implementation featuring new product SoftLIMS 2738

16.6.10 Jun 24, 2020: Novel radiotracer proves advantageous for imaging neuroendocrine tumor patients with liver-dominant disease 2738

16.6.11 Jun 23, 2020: LGC Maine Standards announces VALIDATE ACTH kit for Roche cobas with easy, fast, and reliable documentation of linearity, calibration verification, and analytical measurement range (AMR) verification 2739

16.6.12 Jun 22, 2020: Cancer diagnostics innovator KIYATEC advancing functional Ex Vivo 3D cell culture models that reveal response dynamics to immuno-oncology drugs 2740

16.6.13 Jun 18, 2020: IncellDx files patent for CCL5/RANTES utility as a diagnostic, prognostic, and therapeutic biomarker in COVID-19 and other cytokine storm conditions 2741

16.6.14 Jun 16, 2020: Continuous Glucose Monitoring helps young people with type 1 diabetes achieve better glycemic control 2741

16.6.15 Jun 15, 2020: Study demonstrates feasibility of hologram technology in liver tumor ablation 2743

16.6.16 Jun 11, 2020: Twist Bioscience expands offering of synthetic SARS-CoV-2 RNA controls 2743

16.6.17 Jun 10, 2020: Nanopatterned ‘lab-on-a-chip’ noninvasively detects early and advanced breast cancer 2744

16.6.18 Jun 09, 2020: ZIVO Bioscience receives notice of allowance for cytokine modulation patent application from US patent office, commences bioproduct scaleup 2744

16.6.19 Jun 08, 2020: AACC launches a new competition to support innovative research in diagnostic testing 2745

16.6.20 Jun 08, 2020: Bionano Genomics announces issuance of US Patent for combined nanochannel-nanopore device 2746

16.6.21 Jun 04, 2020: Alpine Immune Sciences presents preclinical data on novel dual BAFF/APRIL inhibitory domains for B cell mediated autoimmune diseases at the European Congress of Rheumatology E-Congress 2020 2746

16.6.22 Jun 03, 2020: New test for rare disease identifies children who may benefit from simple supplement 2747

16.6.23 Jun 02, 2020: HemaCare adds GMPrime Cryopreserved Leukopak to its GMP Product Portfolio 2748

16.6.24 Jun 02, 2020: SCIEX presents Echo MS System at ASMS Reboot 2749

16.6.25 Jun 01, 2020: Agilent announces new mass spectrometry products at ASMS 2020 Reboot 2750

16.6.26 Jun 01, 2020: Convenient spit test helps women assess cancer risk from the comfort of their own homes 2750

16.6.27 May 28, 2020: LexaGene places a pre-commercial instrument for COVID-19 testing in a major hospital laboratory 2752

16.6.28 May 28, 2020: QIAGEN builds on leading position in Precision Medicine with novel solutions in oncology 2753

16.6.29 May 21, 2020: Medical Marijuana investment company AXIM Biotechnologies files patent for unique early detection cancer biomarker 2754

16.6.30 May 19, 2020: CU Medicine team discovers a novel prognostic biomarker for a doubled survival in head and neck cancer 2754

16.6.31 May 19, 2020: Lineage Cell Therapeutics to participate in Maxim Group and M-Vest COVID-19 Virtual Conference Series on May 27, 2020 2755

16.6.32 May 15, 2020: Xencor to present data from four preclinical XmAb 2+1 bispecific antibody and cytokine programs at AACR Virtual Annual Meeting II 2756

16.6.33 May 14, 2020: Progressive Care launches COVID-19 IgG/IgM rapid result antibody testing program 2756

16.6.34 May 14, 2020: Immunai launches to fully map the entire immune system to better develop immunotherapies and cell therapies 2757

16.6.35 May 14, 2020: Retinal texture could provide early biomarker of Alzheimer’s Disease 2758

16.6.36 May 07, 2020: DCN Dx to present comprehensive webinar on rapid diagnostics 2759

16.6.37 May 07, 2020: Midwest health system deploys Black & Veatch’s Rapid Modular Health System to combat COVID-19 2760

16.6.38 May 05, 2020: Bayer and NeoGenomics launch the Test4TRK program to provide genomic cancer testing at no Cost for people living with advanced thyroid and colorectal cancers 2761

16.6.39 May 05, 2020: Oncocyte announces peer-reviewed publication of data demonstrating the potential of its TNBCType assay to inform triple negative breast cancer drug development 2762

16.6.40 May 04, 2020: Artificial intelligence algorithm can accurately predict risk, diagnose AD 2763

16.6.41 Apr 30, 2020: Nanodevices for the brain could thwart formation of Alzheimer’s plaques 2764

16.6.42 Apr 29, 2020: Quidel to present virtually at the BofA Securities 2020 Health Care Conference 2765

16.6.43 Apr 28, 2020: CopernicusMD launches The COVID Consortium to help companies navigate COVID-19 Testing in America’s Re-Opening 2766

16.6.44 Apr 27, 2020: CareDx engages European lab community in virtual meetings 2766

16.6.45 Apr 27, 2020: Meridian Bioscience simplifies COVID-19 sample prep and eliminates dependence on reagents in short supply 2767

16.6.46 Apr 27, 2020: Alluxa develops thin films for COVID-19 detection devices 2768

16.6.47 Apr 22, 2020: CareDx presents new heart and lung transplant data in virtual meetings 2768

16.6.48 Apr 21, 2020: AvantGen announces the rapid identification and promising initial testing of antibodies intended to diagnose SARS-CoV-2 infection and treat COVID-19 2769

16.6.49 Apr 21, 2020: CURE Pharmaceutical expands cannabis extraction patents, adding support for CBG for therapeutic solutions 2770

16.6.50 Apr 20, 2020: Genetron Health announces forthcoming unveiling of its cancer research papers at the AACR Annual Meeting 2770

16.6.51 Apr 20, 2020: AI may help brain cancer patients avoid biopsy 2771

16.6.52 Apr 16, 2020: Blood test may help doctors catch pancreatic cancer early 2772

16.6.53 Apr 10, 2020: Clarkson Faculty and Staff Develop Battery Modification for St. Lawrence Health System Positive Air Pressure Respirators 2773

16.6.54 Apr 09, 2020: Moffitt researchers develop mathematical model to predict patient outcomes to adaptive prostate cancer therapy 2774

16.6.55 Apr 08, 2020: DeNovix launches new RNA quantification assay 2775

16.6.56 Apr 08, 2020: Hands-Free LabElite products aid COVID-19 efforts; now available with fast-ship priority 2775

16.6.57 Apr 07, 2020: Invitae launches enhanced capabilities to support telemedicine 2776

16.6.58 Apr 07, 2020: EPA adds Neogen’s Synergize and COMPANION to list of approved disinfectants to fight COVID-19 2777

16.6.59 Apr 07, 2020: Polarity Medical announces development of virus-killing UV-C Light Automatic Sterilizing Devices for Doorknobs, Railings, Pin Pads and Other CDC-Defined High-Touch Areas 2777

16.6.60 Apr 06, 2020: Precipio launches new HemeScreen reagent rental program 2778

16.6.61 Apr 03, 2020: 90-minute rapid coronavirus tests now available 2779

16.6.62 Mar 31, 2020: Discovery of new biomarker in blood could lead to early test for Alzheimer’s Disease 2780

16.6.63 Mar 30, 2020: Viracor Eurofins launches Labs@HOME, a mobile phlebotomy service for post-transplant patient testing 2781

16.6.64 Mar 27, 2020: Praesidio Life Sciences bringing millions Of COVID-19 antibody tests to the U.S. 2781

16.6.65 Mar 25, 2020: RSNA publishes expert consensus on COVID-19 reporting 2782

16.6.66 Mar 16, 2020: Asuragen develops RNA Quant technology for coronavirus assays 2783

16.6.67 Mar 15, 2020: Healthcare Communication Platform, Pulsara, announces release of FREE COVID-19 management package 2783

16.6.68 Mar 12, 2020: IsoPlexis launches suite of new products enabling multiple automated applications on the IsoLight 2784

16.6.69 Mar 12, 2020: C-Path selects experienced neuroscientist to lead Alzheimer’s Consortium 2785

16.6.70 Mar 11, 2020: New publication demonstrates power of Mission Bio’s Tapestri platform to track minimal residual disease related to cancer relapse 2786

16.6.71 Mar 05, 2020: IDT launches Alt-R HDR design tool and templates 2786

16.6.72 Mar 05, 2020: NetNoggin announces the release of NetNog: track Alzheimer’s Disease 2787

16.6.73 Mar 04, 2020: Adding MRI-targeted biopsy leads to more reliable diagnosis of aggressive prostate cancer 2788

16.6.74 Mar 04, 2020: Testing with combined biopsy method improves prostate cancer diagnosis in NIH study 2789

16.6.75 Mar 02, 2020: Inspirata announces poster presentations at USCAP 2020 in Los Angeles 2790

16.6.76 Feb 27, 2020: RareCyte announces the first blood-to-result PD-L1 Circulating Tumor Cell Assay 2790

16.6.77 Feb 24, 2020: Dovetail Genomics introduces new Dovetail Micro-C and HiChIP kits 2791

16.6.78 Feb 24, 2020: ReadCoor unveils true spatial sequencing platform to drive groundbreaking insights into immuno-oncology, neuroscience, and infectious disease 2791

16.6.79 Feb 24, 2020: Researchers propose new disease classification system for obesity 2792

16.6.80 Feb 21, 2020: New England Biolabs to showcase next generation sequencing sample preparation innovations at AGBT 2020 2793

16.6.81 Feb 20, 2020: NanoString highlights groundbreaking spatial genomics research using expanding portfolio of GeoMxhigh-Pex RNA atlas products at 2020 advances in Genome Biology and Technology (AGBT) Conference 2794

16.6.82 Feb 17, 2020: The Latest in Pediatric Heart Disease: Benefits of Skin-to-Skin Care, Nurse-Initiated PIV training and improving cholesterol screening in high-risk patients 2795

16.6.83 Feb 13, 2020: CMS develops new code for coronavirus lab test 2797

16.6.84 Feb 10, 2020: New imaging technology shows potential for multiple uses, particularly in medicine 2798

16.6.85 Feb 06, 2020: UT Southwestern nearly doubles lifespan of mice with brain cancer 2799

16.6.86 Feb 05, 2020: Thermo Fisher Scientific introduces NGS-based solution for expanded carrier screening research 2800

16.6.87 Feb 05, 2020: MaxCyte’s CEO to present update on life sciences business & first-in-class CARMA Cellular Therapies at BIO CEO & Investor Conference in New York 2800

16.6.88 Feb 04, 2020: Co-Diagnostics to discuss new coronavirus test during genomeweb webinar on Feb 5 2801

16.6.89 Feb 04, 2020: Building a better breast 2802

16.6.90 Jan 29, 2020: Bone marrow chip opens research options for Shwachman-Diamond syndrome 2803

16.6.91 Jan 29, 2020: Microsoft launches $40M, 5-year AI for health initiative to advance health globally 2803

16.6.92 Jan 28, 2020: Aridis Pharmaceuticals presents APEX antibody discovery and production platform technology at the 19th Annual CHI PepTalk Conference 2805

16.6.93 Jan 24, 2020: Shoreline Biome to launch new DNA isolation kit at Miami Winter Symposium 2020 2805

16.6.94 Jan 23, 2020: CStone successfully hosted the first U.S. R&D Day in New York 2806

16.6.95 Jan 23, 2020: Meridian launched a new high-fidelity polymerase to offer robust amplification for NGS and PCR applications 2808

16.6.96 Jan 22, 2020: Coronavirus: CDC confirms first US case; search for cure underway 2808

16.6.97 Jan 22, 2020: Scientists isolate biomarkers that can identify delirium risk and severity 2809

16.6.98 Jan 17, 2020: Frequency, mutational patterns, and genomic profile of hypermutated Breast Cancer 2810

16.6.99 Jan 13, 2020: InterVenn Biosciences advances glycoproteomics to propel understanding and find new therapies in complex diseases 2811

16.6.100 Jan 10, 2020: Vaxess Technologies to present at Biotech Showcase 2020 in San Francisco 2812

16.6.101 Jan 09, 2020: OncoCell MDx, now Immunis.AI, to present at Biotech Showcase 2812

16.6.102 Jan 07, 2020: Bio-Techne rebrands Atlanta Biologicals Serum and Media as part of the R&D Systems Product Portfolio 2813

16.6.103 Jan 07, 2020: Co-Diagnostics breakthrough CoPrimer Technology to be featured at PAG XXVIII 2813

16.6.104 Jan 06, 2020: Parallax Health Sciences announces patent enforcement initiative 2814

16.6.105 Jan 06, 2020: Novel research that could advance testing, treatment for concussions 2815

16.6.106 Jan 03, 2020: Healthcare Solutions Holding a wholly owned subsidiary of Healthcare Solutions Management Group invites Dr. Sadeem Mahmood to speak on advanced cardio panels 2815

16.6.107 Jan 02, 2020: Closer to identifying leukemic stem cells 2816

16.6.108 Dec 19, 2019: US researchers develop new technique to detect cancer biomarkers 2816

16.6.109 Dec 17, 2019: Sengenics, a leading commercial stage precision medicine focused company, which enables pharma companies to identify drug responders, to present at Biotech Showcase 2020 2817

16.6.110 Dec 13, 2019: Residual cancer burden can predict outcomes for patients with any breast cancer type 2818

16.6.111 Dec 12, 2019: Blood test can quickly match advanced breast cancer patients to targeted treatment 2819

16.6.112 Dec 06, 2019: Biomarker may aid in determining treatment for cancer patients 2820

16.6.113 Dec 06, 2019: Michigan Health : New study has global impact on hepatitis C elimination efforts 2822

16.6.114 Dec 04, 2019: InterVenn Biosciences releases first-ever software for AI-enabled mass spec analysis 2823

16.6.115 Dec 03, 2019: Study finds proteins from single blood test helps predict disease risks 2823

16.6.116 Dec 03, 2019: Genomic Testing Cooperative to present data on its proprietary RNA profiling and artificial intelligence algorithms at American Society of Hematology Annual Meeting 2824

16.6.117 Nov 29, 2019: Researchers develop direct gene-circuit-to-electrode interface 2825

16.6.118 Nov 27, 2019: Sanford Health: Artificial intelligence may help spot cancer in image scans 2826

16.6.119 Nov 26, 2019: Biennial mammography screening yields more advanced-stage cancers 2826

16.6.120 Nov 22, 2019: Radiotracers are revolutionized with a novel method 2827

16.6.121 Nov 19, 2019: HemaCare expands its product portfolio with GMPrime Bone Marrow Aspirate 2828

16.6.122 Nov 19, 2019: Tiny Filters help detect cancerous blood cells 2829

16.6.123 Nov 13, 2019: New biomarker for cancer stem cells 2829

16.6.124 Nov 13, 2019: Canon Medical supports expert forums on advancements in imaging technology at RSNA 2019 2830

16.6.125 Nov 12, 2019: US researchers use biomarker blood test to reveal heart disease risk 2831

16.6.126 Nov 09, 2019: ADA2 is a Sensitive, Specific Biomarker for life-threatening macrophage activation syndrome in systemic JIA 2831

16.6.127 Nov 07, 2019: AbCellera announces the issuance of foundational patent claims around microfluidic screening assays for antibody discovery 2832

16.6.128 Nov 05, 2019: Researchers develop novel biopsy for retinoblastoma 2833

16.6.129 Nov 05, 2019: Invitae Highlights importance of medical genetics, honors excellence in genetic counseling at National Society of Genetic Counselors (NSGC) 38th Annual Conference 2833

16.6.130 Nov 04, 2019: Stars of Cancer Research Align to develop Ovarian Cancer Detection Test 2835

16.6.131 Nov 04, 2019: Scanwell Health announces nationwide launch of smartphone-enabled test and treatment service for urinary tract infections via partnership with Lemonaid Health 2835

16.6.132 Nov 04, 2019: Savonix and Boston University School of Public Health Launch Landmark Population Health Alzheimer’s Disease Discovery Study (ASSIST) to Digitally Collect Brain Health Data 2836

16.6.133 Oct 31, 2019: Mallinckrodt announces UVADEX (Methoxsalen) approved in Australia for use with the THERAKOS CELLEX Photopheresis System for Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in Adults 2837

16.6.134 Oct 31, 2019: US researchers use liquid biopsy to predict glioblastoma prognosis 2839

16.6.135 Oct 31, 2019: Potential genetic markers of multiple sclerosis severity 2839

16.6.136 Oct 30, 2019: Blood test can predict prognosis in deadly brain cancer 2840

16.6.137 Oct 29, 2019: 3D-Printed Device Finds ‘Needle in a Haystack’ Cancer Cells by Removing the Hay 2841

16.6.138 Oct 22, 2019: Arena Pharmaceuticals presented new data analyses demonstrating the long-term safety and efficacy of once-daily Etrasimod in patients with moderately to severely active Ulcerative Colitis at UEG Week 2843

16.6.139 Oct 17, 2019: Research presented by Invitae at the American Society of Human Genetics Meeting Pushes Science and Practice of Genetics Forward 2844

16.6.140 Oct 17, 2019: 4th Annual 2019 Global CESI-MS Symposium Highlights SCIEX Technology 2845

16.6.141 Oct 17, 2019: Combination of artificial intelligence & radiologists more accurately identified breast cancer 2846

16.6.142 Oct 17, 2019: Konica Minolta plans worldwide premiere at PRINTING United 2847

16.6.143 Oct 17, 2019: IDT launches custom enrichment panels for faster, lower cost NGS at ASHG 2019 2847

16.6.144 Oct 16, 2019: Changes in chromosome caps may be a marker for tumor aggression in neurofibromatosis type 1 2848

16.6.145 Oct 15, 2019: Onxeo to present final results of DRIIV-1 phase 1 study of AsiDNA in advanced solid tumors at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2850

16.6.146 Oct 15, 2019: Researchers develop genetic risk scores for epilepsy 2851

16.6.147 Oct 15, 2019: Miroculus to present latest developments of automated NGS library prep at ASHG 2019 2852

16.6.148 Oct 14, 2019: MAGBIO Genomics develops automation friendly RNA purification chemistry for Mawi iSWAB-RNA-v2 2852

16.6.149 Oct 07, 2019: Gestalt Diagnostics and Flagship Biosciences announce strategic relationship to deliver integrated image analysis for PD-L1 testing 2853

16.6.150 Oct 04, 2019: MEI Pharma announces updated clinical data from ME-401 phase 1b study in patients with Indolent B-cell Malignancies 2853

16.6.151 Oct 03, 2019: Biocept announces issuance of South Korean patent covering its Target Selector Oncogene Mutation enrichment and detection platform 2855

16.6.152 Oct 03, 2019: Co-Diagnostics to present technology applications at 4th ACTC Liquid Biopsy Conference in Corfu, Greece 2856

16.6.153 Oct 02, 2019: MGI sues Illumina again for patent infringement in the United States 2856

16.6.154 Sep 30, 2019: Blood test may replace biopsy in advanced lung cancer 2857

16.6.155 Sep 26, 2019: Pressure BioSciences’ PCT Platform Featured in Multiple Presentations at Major International Science Conference 2857

16.6.156 Sep 23, 2019: Perturbed genes regulating white blood cells linked to Autism genetics and severity 2859

16.6.157 Sep 20, 2019: Owkin to present at the ESMO Congress 2019 2860

16.6.158 Sep 19, 2019: Nebula Genomics launches anonymous Genetic Testing 2860

16.6.159 Sep 18, 2019: Bridgecom exhibits at Health Care IT Innovation Summit in Los Angeles 2860

16.6.160 Sep 17, 2019: Biocoat launches on-site contract coating service business unit 2861

16.6.161 Sep 16, 2019: Label-free microscope detects ovarian metastatic cancer 2861

16.6.162 Sep 10, 2019: Linnaeus Therapeutics scientific cofounder presents preclinical pancreatic cancer data at AACR Pancreas Cancer Meeting 2862

16.6.163 Sep 10, 2019: Pressure BioSciences’ PCT platform identified as pivotal for cancer biomarker discovery and for potential clinical diagnostics 2863

16.6.164 Sep 10, 2019: Study published by clinical cancer research shows PGDx’s liquid biopsy predictive of PD-1 blockade response 2864

16.6.165 Sep 09, 2019: Invitae expands detect program to offer no-charge genetic testing to pancreatic cancer patients 2865

16.6.166 Sep 09, 2019: Biocare Medical announces launch of a new p16 INK4a IVD monoclonal antibody for use in immunohistochemistry 2866

16.6.167 Sep 09, 2019: Lung cancer screening model favored in Europe detects more cancers than 1 preferred in the US 2866

16.6.168 Sep 08, 2019: BioMILD trial demonstrates lung cancer screening using microrna blood test enhance prevention effort 2867

16.6.169 Aug 30, 2019: Discovery paves the way for earlier detection of type 1 diabetes 2868

16.6.170 Aug 28, 2019: Smartphone device uses fluorescent beads to detect norovirus 2869

16.6.171 Aug 26, 2019: New diagnostic method predicts cancer therapy response, offering hope for lung cancer patients 2870

16.6.172 Aug 19, 2019: MilliporeSigma granted 20 CRISPR patents total worldwide 2871

16.6.173 Aug 13, 2019: Biocept receives three additional patents covering its antibody and microchannel technology and enhanced detection of cancer cells 2871

16.6.174 Aug 12, 2019: ForteBio introduces high precision Octet system biosensor for process development rigor 2872

16.6.175 Aug 08, 2019: Gluten response in coeliac patients could lead to diagnostic test 2872

16.6.176 Aug 07, 2019: Renovia study results published in neurology and urodynamics show positive results for Leva Pelvic Digital Therapeutic in treating female urinary incontinence 2873

16.6.177 Aug 06, 2019: Blood clotting proteins discovered as biomarkers of Lupus Nephritis 2875

16.6.178 Aug 06, 2019: Blood clotting proteins in urine discovered as biomarkers of lupus nephritis 2876

16.6.179 Aug 05, 2019: Findings that could help identify Alzheimer’s patients who will benefit from exercise announced at the 71st AACC Annual Scientific Meeting 2877

16.6.180 Aug 05, 2019: Longest-duration study of how Transgender Hormone Therapy alters medical test results featured at the 71st AACC Annual Scientific Meeting 2877

16.6.181 Aug 01, 2019: MedTest Dx releases a new line of Clinitox calibrators and controls for drugs of abuse toxicology t at 2019 AACC Scientific Meeting 2878

16.6.182 Aug 01, 2019: Mammoth Biosciences awarded key patents for novel CRISPR diagnostics methods 2879

16.6.183 Jul 30, 2019: Atossa genetics ceo Steven Quay gives tedx talk at University of Washington regarding the the relationship of dense breast tissue and breast cancer risk 2880

16.6.184 Jul 25, 2019: Curetis to present at Solebury Trout European Biotech Investor Day in NYC 2880

16.6.185 Jul 25, 2019: AI tool identifies cancer outcomes using radiology reports 2881

16.6.186 Jul 24, 2019: Better uses digital biomarkers to improve treatment outcomes 2882

16.6.187 Jul 24, 2019: Amgen seeks invalidation of Alexion’s key Soliris patents 2882

16.6.188 Jul 23, 2019: LifeSpan BioSciences releases best-in-class PathPlus top performing immunohistochemistry antibodies for cancer targets 2883

16.6.189 Jul 23, 2019: Microfluidic array catches, holds single cervical cells for faster screening 2883

16.7 Research And Development 2884

16.7.1 Jun 22, 2020: Mateon and GMP completed Research and Service Agreement 2884

16.7.2 Jun 10, 2020: Thermo Fisher and Agios to develop companion diagnostic for oncology 2885

16.7.3 Mar 16, 2020: Veravas, MIP sign agreement for improved diagnostics 2885

16.7.4 Mar 13, 2020: Thermo Fisher, Janssen partner to develop CDx for oncology 2886

16.7.5 Feb 24, 2020: Genapsys partners with Twist Bioscience to bring next-generation sequencing target enrichment and library preparation to world’s most accessible highly accurate sequencer 2886

16.7.6 Jan 13, 2020: Guardant Health, NRG Oncology begin NRG-GI005 COBRA trial 2887

16.7.7 Jan 09, 2020: Mayo Clinic to sequence 100,000 participants to build genomic database for improved care and research in collaboration with Helix 2888

16.7.8 Jan 06, 2020: US researchers to trial retinal scanning to diagnose Alzheimer’s 2888

16.7.9 Nov 26, 2019: Asuragen and Wave Life Sciences to create diagnostics for Huntington’s 2889

16.7.10 Nov 15, 2019: Ikonisys partners with Sheba Medical Center to develop CTC tests 2890

16.7.11 Nov 08, 2019: Thermo Fisher, Owlstone collaborate for bio marker cancer diagnosis 2890

16.7.12 Nov 07, 2019: Promega and Merck collaborate to develop MSI CDx for Keytruda use 2891

16.7.13 Oct 22, 2019: Arena Pharmaceuticals presented new data analyses demonstrating the long-term safety and efficacy of once-daily Etrasimod in patients with moderately to severely active Ulcerative Colitis at UEG Week 2892

16.7.14 Oct 22, 2019: Bloomberg Philanthropies, Johns Hopkins University School of Medicine, and The New York Stem Cell Foundation Research Institute Announce an Unprecedented Effort to Advance Precision Medicine 2893

16.7.15 Oct 21, 2019: UK-US alliance launched to boost early cancer detection rates 2894

16.7.16 Oct 18, 2019: Fitbit enters AFib diagnosis deal with BMS-Pfizer Alliance 2895

16.7.17 Oct 15, 2019: Onxeo to present final results of DRIIV-1 phase 1 study of AsiDNA in advanced solid tumors at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2895

16.7.18 Sep 10, 2019: Covance unveils new R&D center in Shanghai 2896

16.7.19 Aug 28, 2019: DarwinHealth announces compound-2-clinic (C2C) scientific collaboration with Celgene to deploy a quantitative systems biology discovery platform to characterize Celgene oncology compounds 2897

16.7.20 Jul 31, 2019: Predictive Laboratories announces research collaboration with the Preeclampsia Foundation 2898

16.8 Strategy And Business Planning 2899

16.8.1 Jul 15, 2020: Expesicor announces collaboration with Massachusetts General Hospital to develop novel imaging agents for pain management 2899

16.8.2 Jul 14, 2020: Thermo Fisher and First Genetics partner for NGS-based diagnostics 2899

16.8.3 Jul 14, 2020: Diaceutics partners with Targos and HistoCyte Laboratories to drive global diagnostic testing standardization 2900

16.8.4 Jul 14, 2020: Genedata automates biopharma R&D with seamless integration of lab equipment 2901

16.8.5 Jul 14, 2020: Celdara Medical announces the pandemic security initiative 2901

16.8.6 Jul 13, 2020: Menarini Silicon Biosystems partners with OpGen to broaden distribution of CELLSEARCH platform in North America 2902

16.8.7 Jul 10, 2020: MilliporeSigma opens its largest M Lab Collaboration Center in Shanghai 2903

16.8.8 Jul 09, 2020: Somalogic and NEC Solution Innovators announce launch of Foneslife 2904

16.8.9 Jul 07, 2020: The Prostate Cancer Foundation collaboration with Pan-Cancer Consortium clarifies and promotes consistent use of common terms for biomarker and germline genetic testing 2904

16.8.10 Jul 02, 2020: New strategic partnership to develop next-generation T cell detection reagents 2906

16.8.11 Jul 01, 2020: Nanommune partners With Velox Biosystems to offer laboratory testing of COVID-19 serological assays 2906

16.8.12 Jun 23, 2020: SkylineDx signs 10th collaboration agreement under Falcon Melanoma R&D Program 2907

16.8.13 Jun 23, 2020: C-Path launches CURE drug repurposing collaboratory to accelerate identification of new uses of existing drugs to treat infectious diseases, including COVID-19 2907

16.8.14 Jun 23, 2020: Illumina unveils first Cambridge cohort for global genomics accelerator 2908

16.8.15 Jun 23, 2020: Cognizant collaborates on Verily’s nationwide baseline COVID-19 testing program 2909

16.8.16 Jun 18, 2020: IntraOp and Lausanne University Hospital announce collaboration in FLASH 2910

16.8.17 Jun 18, 2020: renegade.bio and Primary form strategic alliance to streamline and expedite access to US Wide COVID-19 community testing 2911

16.8.18 Jun 17, 2020: Lexogen and OnRamp Bioinformatics partner to provide differential gene expression data analysis and interpretation for QuantSeq 3′ mRNA-Seq users 2911

16.8.19 Jun 17, 2020: Anju Software welcomes Natera to its PUBSTRAT partner community 2912

16.8.20 Jun 16, 2020: GeneIQ provides Dallas Children’s Advocacy Center with COVID-19 Testing 2913

16.8.21 Jun 15, 2020: Longhorn Vaccines and Diagnostics and Greenfield Global partner to accelerate COVID-19 Testing and Detection 2913

16.8.22 Jun 09, 2020: GENE-IQ announces expanded Ccpacity for COVID-19 testing 2914

16.8.23 Jun 04, 2020: United Nations Development Program, MCIT Egypt and Avaya collaborate to launch AI-Powered COVID-19 diagnosis service for people of determination 2914

16.8.24 Jun 03, 2020: Swift Biosciences and Arbor Biosciences Partner on Targeted NGS Workflows for Coronavirus 2915

16.8.25 Jun 02, 2020: Prescient Metabiomics and the Harvard Chan Microbiome in Public Health Center collaborate to advance research in colon cancer screening 2915

16.8.26 Jun 01, 2020: Olympus and PhenoVista collaborate to deliver an innovative 3D cell-based assay service for drug discovery 2916

16.8.27 Jun 01, 2020: Sema4 to deliver high capacity COVID-19 testing in partnership with the State of Connecticut 2917

16.8.28 May 21, 2020: CVS Health expands statewide COVID-19 response by opening 13 additional new drive-thru test sites in Connecticut 2918

16.8.29 May 21, 2020: CVS Health opens 36 new drive-thru test sites in new york as part of nationwide COVID-19 response 2919

16.8.30 May 21, 2020: Governor Cuomo partners with doctors From SOMOS community care to expand COVID-19 & antibody testing at faith-based churches in Hard-Hit Latino Communities 2920

16.8.31 May 21, 2020: Accurate Diagnostic Laboratories continues to assist our front-line workers by offering coronavirus testing for port Authority/PATH essential employees 2921

16.8.32 May 18, 2020: Goddard partners with Swab56 Project to ramp up production of swabs for COVID-19 testing 2922

16.8.33 May 14, 2020: IDT broadens capacity and customer support of COVID-19 products with new manufacturing facility 2922

16.8.34 May 12, 2020: ChemPartner assists the Mount Sinai Health System in producing reagent for COVID-19 research 2923

16.8.35 May 05, 2020: PierianDx and University Hospital of Augsburg announce strategic partnership 2923

16.8.36 May 01, 2020: AdvancedDX Biological Laboratories launches in the U.S. to bring covid-19 diagnostic and antibody tests to local communities 2924

16.8.37 Apr 30, 2020: Focused Ultrasound Foundation and Pancreatic Cancer UK Partner to Fund Innovative Study 2925

16.8.38 Apr 29, 2020: Convexity Scientific teams with Right2Breathe during national asthma and allergy awareness month 2926

16.8.39 Apr 23, 2020: Kroger Health Announces Expansion of Free Drive-Thru COVID-19 Testing Sites in Additional States and Pilots Associate Testing at Select Sites 2927

16.8.40 Apr 22, 2020: MOBILion partners with Investigators at the Complex Carbohydrate Research Center at the University of Georgia for COVID-19 Glycan Analysis 2927

16.8.41 Apr 21, 2020: AU Health to lead statewide expansion of coronavirus testing 2928

16.8.42 Apr 16, 2020: Patients Choice and Indiana Health Care Association partner to bring COVID-19 testing to long term care facilities 2929

16.8.43 Apr 16, 2020: Pressure BioSciences and RedShiftBio demonstrate potential of combining proprietary technologies to enable new tool for development and production of biotherapeutics 2929

16.8.44 Apr 10, 2020: JBS USA partners With White House, Governor Polis and Senator Gardner to provide free COVID-19 Tests for Greeley Beef Team Members 2930

16.8.45 Apr 02, 2020: NCMS announces partnership with DOD And FEMA for medical supplies 2931

16.8.46 Apr 02, 2020: Oxgene, Native Antigen Partner to increase reagent production for SARS-CoV-2 Tests 2932

16.8.47 Apr 01, 2020: SARS-CoV-2 detection kits now available for research labs 2933

16.8.48 Mar 30, 2020: Charles River Laboratories and Deciphex form a partnership to enhance drug discovery & development with digital pathology 2933

16.8.49 Mar 29, 2020: ICU Eyewear and Contour Optik Heed the Call and Expand Production Capacity to Hundreds of Millions of PPE and COVID-19 Test Kits 2934

16.8.50 Mar 26, 2020: SOPHiA GENETICS and Paragon Genomics join forces against the COVID-19 coronavirus pandemic 2935

16.8.51 Mar 26, 2020: ScitoVation and BioPredic International announce partnership for HepaRG contract service and research in the Americas 2935

16.8.52 Mar 24, 2020: Regenr8 launches industry-first epigenetic biomarker profile in partnership with physician’s lab 2936

16.8.53 Mar 23, 2020: Akumin designates imaging centers for COVID-19 response 2936

16.8.54 Mar 23, 2020: Invitae and Muscular Dystrophy Association (MDA) expand access to no-charge genetic testing in the U.S. and Canada 2937

16.8.55 Mar 20, 2020: UC San Diego partners with 5 leading diagnostics manufacturers to boost COVID-19 Testing 2938

16.8.56 Mar 18, 2020: Eurofins Transplant Genomics and Viracor will partner to offer Remote Sample Collection Options to support care for Kidney Transplant Recipients during COVID-19 Outbreak 2939

16.8.57 Mar 17, 2020: NuProbe, Qiagen partner to develop cancer diagnostic tests 2939

16.8.58 Mar 16, 2020: The National Kidney Registry and Viracor Eurofins Announce Coronavirus COVID-19 Rapid Turnaround Transplant Testing for Donors and Recipients 2940

16.8.59 Mar 13, 2020: Walgreens joins collaboration with Administration and Industry Partners to Provide Access to Government-Run COVID-19 Testing Facilities 2941

16.8.60 Mar 12, 2020: Thermo Fisher Scientific signs agreement with Janssen to co-develop Companion Diagnostic for Cancer 2941

16.8.61 Mar 10, 2020: Ethos Therapy continues global expansion 2942

16.8.62 Mar 04, 2020: Thermo Fisher Scientific to acquire Qiagen in $11.5bn deal 2943

16.8.63 Mar 04, 2020: Pulmonary Fibrosis Foundation launches industry consortium to identify biomarkers in Pulmonary Fibrosis 2943

16.8.64 Mar 03, 2020: Sema4 and VieCure collaborate to provide real-time patient insights 2944

16.8.65 Mar 03, 2020: Gilead Sciences to buy Forty Seven for $4.9bn 2945

16.8.66 Mar 03, 2020: DRE Health to manufacture Coronavirus face masks in the United States 2945

16.8.67 Mar 03, 2020: AnPac Bio-Medical Science announces cooperation with Dragon Gate Investment Partners 2946

16.8.68 Mar 02, 2020: Proscia and UCSF partner to deliver Artificial Intelligence applications that improve the accuracy and speed of cancer diagnosis 2946

16.8.69 Feb 28, 2020: Leica Microsystems announces new market representation for Mid-Atlantic medical market 2947

16.8.70 Feb 24, 2020: Myndshft and TrueMed IT announce partnership to bring real-time benefit checks to diagnostics and genomics labs 2947

16.8.71 Feb 24, 2020: BioSkryb partners with Argonaut Manufacturing Services to accelerate production of key genomic amplification products 2948

16.8.72 Feb 21, 2020: Lucid Diagnostics and Fred Hutchinson to evaluate BE Progression 2948

16.8.73 Feb 20, 2020: Integer acquires Israel-based medical device firm Inomec 2949

16.8.74 Feb 19, 2020: Duke University and Leica Microsystems establish Center of Excellence in Microscopy 2949

16.8.75 Feb 19, 2020: CCRM Fertility opens new Premier Office in Dallas 2950

16.8.76 Feb 18, 2020: Hologic Expands Costa Rican operations with new financial shared services center 2951

16.8.77 Feb 13, 2020: CCRM Fertility New York adds new physician to meet community’s needs for world-class fertility care 2952

16.8.78 Feb 13, 2020: Applied Biology to launch new Molecular Diagnostic laboratory for hair and skin disorders 2952

16.8.79 Feb 12, 2020: Kebotix, NCATS collaborate to deliver new treatments for diseases faster 2953

16.8.80 Feb 12, 2020: Sanford announces new Bemidji heart center 2954

16.8.81 Feb 11, 2020: Celerion expands clinical research to Nebraska Innovation Campus 2954

16.8.82 Feb 06, 2020: ProSciento and Nordic Bioscience launches culture station to increase capacity of its beacon and lightning optofluidic platforms for Nonalcoholic Steatohepatitis (NASH) 2955

16.8.83 Feb 05, 2020: Merck to focus on key growth pillars through spinoff of women’s health, trusted legacy brands and biosimilars products into new company (“newco”) 2956

16.8.84 Feb 03, 2020: Quest, Siemens to buy Atellica Solution immunoassay analysers 2959

16.8.85 Feb 03, 2020: Anderson supports leading-edge surgical center at Beaumont, Grosse Pointe 2959

16.8.86 Jan 30, 2020: Biodesix, Streck sign agreement to secure FDA approval for products 2960

16.8.87 Jan 30, 2020: Oncocyte announces relocation of its headquarters to Orange County, California 2960

16.8.88 Jan 30, 2020: Genedata and the Crohn’s & Colitis Foundation collaborate to improve patient care in Crohn’s Disease 2961

16.8.89 Jan 28, 2020: Precipio and TrialJectory partner on treatment options for cancer 2962

16.8.90 Jan 28, 2020: Biological Dynamics enters collaboration to advance access to novel diagnostic solutions to life science customers 2963

16.8.91 Jan 27, 2020: Swift Biosciences and Opentrons partner to provide a turnkey automated NGS Library Preparation Workflow 2963

16.8.92 Jan 15, 2020: Merit milestones: facilities in Galway and Tijuana reach 1,000 employees 2964

16.8.93 Jan 14, 2020: Roche signs 15-year deal with Illumina for cancer diagnostic 2964

16.8.94 Jan 14, 2020: BostonGene announces scientific collaboration with the Vaccine and Immunotherapy Center at Massachusetts General Hospital 2965

16.8.95 Jan 13, 2020: Illumina announces new sequencing system, partnership with Roche and Software Suite to Accelerate Adoption of Genomics 2965

16.8.96 Jan 13, 2020: SHINE year-end report highlights construction progress, strong investor confidence 2966

16.8.97 Jan 09, 2020: Zai Lab and Novocure announce first patient enrolled in a phase 2 pilot trial of tumor treating fields together with chemotherapy as first-line treatment of gastric cancer 2968

16.8.98 Dec 19, 2019: Quantum Genomics initiates its pivotal phase III FRESH trial in difficult-to-treat and resistant hypertension 2969

16.8.99 Dec 19, 2019: Truvian Sciences debuts new headquarters in San Diego 2970

16.8.100 Dec 17, 2019: Roche gets UK and US clearances for Spark Therapeutics acquisition 2970

16.8.101 Dec 13, 2019: 3M to divest drug delivery business to Altaris Capital in $650m deal 2971

16.8.102 Dec 11, 2019: Amneal Pharmaceuticals to buy majority stake in AvKARE for $340m 2971

16.8.103 Dec 11, 2019: Haemonetics opens new corporate headquarters in Downtown Boston 2972

16.8.104 Dec 09, 2019: Amgen selects location for R&D facility in the South San Francisco Biotechnology Hub 2973

16.8.105 Dec 04, 2019: Veracyte signs agreement for NanoString’s diagnostics platform 2973

16.8.106 Dec 02, 2019: Biomerics forms new business unit: Biomerics CRI 2974

16.8.107 Nov 27, 2019: Precision For Medicine significantly expands Berlin Lab as demand for immune monitoring continues to grow 2974

16.8.108 Nov 26, 2019: Columbia Care continues Florida expansion with four dispensary openings, receives approval to begin sales of flower 2975

16.8.109 Nov 25, 2019: Sekisui Diagnostics opens $1.9 million Bioprocess Innovation Centre 2975

16.8.110 Nov 14, 2019: Merck acquires Calporta Therapeutics for $576m 2976

16.8.111 Nov 14, 2019: BASi launches rebrand of its Contract Research Services Business under the name Inotiv 2976

16.8.112 Nov 13, 2019: Thermo Fisher Scientific opens Customer Solution Center in China to support pharmaceutical and biopharmaceutical laboratories 2977

16.8.113 Nov 13, 2019: Thermo Fisher Scientific announces membership of the Pistoia Alliance 2977

16.8.114 Nov 12, 2019: Invitae signs agreement to acquire Clear Genetics 2978

16.8.115 Nov 12, 2019: Mylan and Pfizer announce Viatris as the new company name in the planned Mylan-Upjohn combination 2979

16.8.116 Nov 12, 2019: ASG Superconductors – Paramed Medical Systems: A new MROpen MRI System Unit Installed in Texas 2979

16.8.117 Nov 11, 2019: Exact Sciences completes acquisition of Genomic Health for $2.8bn 2980

16.8.118 Nov 08, 2019: Abcam and BrickBio announce a partnership to incorporate conjugation-ready sites into recombinant antibodies across Abcam’s portfolio 2981

16.8.119 Nov 05, 2019: DNA Script to open U.S. Office in South San Francisco to support commercialization of the company’s industry-leading enzymatic synthesis technology 2981

16.8.120 Nov 05, 2019: Loop Genomics launches long-read microbiome sequencing service at short-read price 2982

16.8.121 Nov 05, 2019: Floyd Health System and Atrium Health to join in strategic combination 2982

16.8.122 Nov 04, 2019: MOBILion partners with Investigators at the Complex Carbohydrate Research Center at the University of Georgia to Explore Ion Mobility Technology in Glycoscience 2983

16.8.123 Nov 04, 2019: Atrium Health and Wake Forest one step closer to creating unique and transformative Academic Healthcare System 2983

16.8.124 Nov 01, 2019: Amgen to acquire stake in BeiGene for $2.7bn 2985

16.8.125 Oct 23, 2019: GE Healthcare opens lab for life science start-ups at Alderley Park, United Kingdom 2986

16.8.126 Oct 21, 2019: Humana and Microsoft announce multiyear strategic partnership to reimagine health for aging populations and their care teams 2987

16.8.127 Oct 21, 2019: HealthEC, LabCorp, and The New Jersey Primary Care Association announce strategic collaboration to advance value-based care at community health centers 2988

16.8.128 Oct 17, 2019: Vanessa Research undergoes a business expansion, opening a Branch Office in Gyor, Hungary 2988

16.8.129 Oct 16, 2019: BioDirection announces move of corporate headquarters to Southborough, Massachusetts 2989

16.8.130 Oct 16, 2019: Olympus Westborough scheduled to open in 2021 2990

16.8.131 Oct 15, 2019: Sanofi opens digital manufacturing facility in the US 2991

16.8.132 Oct 14, 2019: Anpac Bio launches major U.S. expansion, starting 2nd U.S. Clinical Lab in Philadelphia 2991

16.8.133 Oct 14, 2019: MD Anderson expanding its presence in The Woodlands 2992

16.8.134 Oct 12, 2019: Biodex and South West Exposures announce strategic partnership expanding innovation with global outreach in theranostics and nuclear medicine 2992

16.8.135 Oct 09, 2019: Qiagen and Illumina sign 15-year deal for IVD tests 2993

16.8.136 Oct 09, 2019: Agilent opens state-of-the-art spectroscopy site in the UK 2993

16.8.137 Oct 08, 2019: MOBILion opens new company headquarters, providing pharmaceutical and diagnostics companies access to industry-leading technology 2994

16.8.138 Oct 08, 2019: Omega Laboratories expands operations in Brazil with its own DENATRAN accredited hair drug testing laboratory 2995

16.8.139 Oct 07, 2019: Gerresheimer opens Glass Innovation and Technology Center in the U.S. 2995

16.8.140 Oct 04, 2019: Tricida to host investor day on October 15, 2019 2996

16.8.141 Sep 29, 2019: Lilly announces positive registrational data for Selpercatinib (LOXO-292) in heavily pretreated RET-altered Thyroid Cancers 2996

16.8.142 Sep 25, 2019: RSIP Vision and BioView to use AI for accurate genetic testing 2998

16.8.143 Sep 24, 2019: Guerbet, IBM Watson to develop AI-based prostate cancer detection 2999

16.8.144 Sep 24, 2019: GE Healthcare expands oncology PET tracer portfolio – aims to improve patient response rates to immunotherapies 3000

16.8.145 Sep 16, 2019: Varian to invest in Oncora to develop radiation oncology tools 3000

16.8.146 Sep 16, 2019: Paragon Genomics establishes subsidiary to market its advanced Cleanplex NGS target enrichment solutions in China 3001

16.8.147 Sep 11, 2019: AMRA partners with Micron to expand reach of trials in Japan 3001

16.8.148 Sep 10, 2019: Covance unveils new R&D center in Shanghai 3002

16.8.149 Sep 09, 2019: Genmab and Tempus enter into strategic collaboration agreement 3002

16.8.150 Aug 30, 2019: Brigham Health announces September opening of comprehensive care facility in Pembroke 3003

16.8.151 Aug 26, 2019: Halo Labs awarded two permanent licenses at second California facility 3003

16.8.152 Aug 21, 2019: Group K Diagnostics and Health Network agree to start clinical trials 3004

16.8.153 Aug 20, 2019: Caris Life Sciences accelerates growth through development of pioneering state-of-the-art corporate park 3004

16.8.154 Aug 19, 2019: Halo announces partnership with ilo to sell CBD products utilizing DabTabs Technology 3005

16.8.155 Aug 16, 2019: Nirmidas lays groundwork for In-vitro Diagnostic products with pGOLD slides registered under CE Mark 3005

16.8.156 Aug 08, 2019: K Health integrates with Health Gorilla’s API to power lab ordering 3006

16.8.157 Aug 07, 2019: Adaptive Biotechnologies executes lease for new 100,000 square foot corporate headquarters, tripling its footprint in Seattle’s Growing Biotech Hub 3007

16.8.158 Aug 01, 2019: Sema4 announces location of its second Connecticut Lab; Harbor Landing in Stamford Will Soon Be Home to 300+ Employees 3007

16.8.159 Aug 01, 2019: Inspirata and Fujifilm strike commercial partnership to supply digital pathology services to the UK National Health Service 3008

16.8.160 Jul 31, 2019: NeoGenomics announces grand opening of new pharma services laboratory in Singapore 3009

16.8.161 Jul 29, 2019: Arrayit announces global expansion of finger stick health and wellness testing services 3010

16.8.162 Jul 25, 2019: Neurogene offers access to genetic testing to patients suspected of having a lysosomal storage disease 3011

16.8.163 Jul 23, 2019: LakePharma announces expansion into the Dallas/Fort Worth Metroplex 3011

17 Appendix 3013

17.1 Research Methodology 3014

17.1.1 Coverage 3014

17.1.2 Secondary Research 3014

17.1.3 Primary Research 3015

17.1.4 Market Modeling and Forecasting 3016

17.1.5 Company Share Analysis 3018

17.1.6 Distribution Share Analysis 3018

17.1.7 Benchmarking 3018

17.2 GlobalData Consulting 3019

17.3 Contact Us 3019

17.4 Disclaimer 3020

Table 1: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, 2015-2025 117

Table 2: In Vitro Diagnostics Market, United States, Category Contribution by Revenue ($m), 2018 120

Table 3: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2015-2020 122

Table 4: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2021-2025 123

Table 5: In Vitro Diagnostics Market, United States, Volume (Units), 2015-2025 125

Table 6: In Vitro Diagnostics Market, United States, Volume (Units), Historic, 2015-2020 127

Table 7: In Vitro Diagnostics Market, United States, Volume (Units), Forecast, 2021-2025 128

Table 8: In Vitro Diagnostics Market, United States, Company Share by Revenue ($m), USD Constant, 2018 130

Table 9: Cardiac Disease Market, United States, Revenue ($m), USD Constant, 2015-2020 132

Table 10: Cardiac Disease Market, United States, Revenue ($m), USD Constant, 2021-2025 132

Table 11: Cardiac Marker Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 134

Table 12: Cardiac Marker Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 135

Table 13: Cardiac Disease Market, United States, Volume (Units), 2015-2020 137

Table 14: Cardiac Disease Market, United States, Volume (Units), 2021-2025 137

Table 15: Cardiac Marker Tests Market, United States, Volume (Units), 2015-2020 139

Table 16: Cardiac Marker Tests Market, United States, Volume (Units), 2021-2025 140

Table 17: Cardiac Disease Market, United States, Average Price ($), 2015-2020 141

Table 18: Cardiac Disease Market, United States, Average Price ($), 2021-2025 142

Table 19: Cardiac Disease Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 143

Table 20: Cardiac Disease Market, United States, Company Share by Revenue ($m), USD Constant, 2018 145

Table 21: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, 2015-2020 147

Table 22: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, 2021-2025 147

Table 23: Substrates Market, United States, Revenue ($m), USD Constant, 2015-2020 149

Table 24: Substrates Market, United States, Revenue ($m), USD Constant, 2021-2025 150

Table 25: Clinical Chemistry Market, United States, Volume (Units), 2015-2020 152

Table 26: Clinical Chemistry Market, United States, Volume (Units), 2021-2025 152

Table 27: Substrates Market, United States, Volume (Units), 2015-2020 154

Table 28: Substrates Market, United States, Volume (Units), 2021-2025 155

Table 29: Clinical Chemistry Market, United States, Average Price ($), 2015-2020 156

Table 30: Clinical Chemistry Market, United States, Average Price ($), 2021-2025 157

Table 31: Clinical Chemistry Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 158

Table 32: Clinical Chemistry Market, United States, Company Share by Revenue ($m), USD Constant, 2018 160

Table 33: Hematological Disorders Market, United States, Segment Contribution (%), 2018 162

Table 34: Hematological Disorders Market, United States, Revenue ($m), USD Constant, 2015-2020 164

Table 35: Hematological Disorders Market, United States, Revenue ($m), USD Constant, 2021-2025 164

Table 36: Hematology Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 166

Table 37: Hematology Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 167

Table 38: Hemostasis Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 169

Table 39: Hemostasis Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 170

Table 40: Hematological Disorders Market, United States, Volume (Units), 2015-2020 172

Table 41: Hematological Disorders Market, United States, Volume (Units), 2021-2025 172

Table 42: Hematology Tests Market, United States, Volume (Units), 2015-2020 174

Table 43: Hematology Tests Market, United States, Volume (Units), 2021-2025 175

Table 44: Hemostasis Tests Market, United States, Volume (Units), 2015-2020 177

Table 45: Hemostasis Tests Market, United States, Volume (Units), 2021-2025 178

Table 46: Hematological Disorders Market, United States, Average Price ($), 2015-2020 179

Table 47: Hematological Disorders Market, United States, Average Price ($), 2021-2025 181

Table 48: Hematological Disorders Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 183

Table 49: Hematological Disorders Market, United States, Company Share by Revenue ($m), USD Constant, 2018 185

Table 50: Hormonal Disorders Market, United States, Revenue ($m), USD Constant, 2015-2020 187

Table 51: Hormonal Disorders Market, United States, Revenue ($m), USD Constant, 2021-2025 187

Table 52: Thyroid Function Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 189

Table 53: Thyroid Function Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 190

Table 54: Hormonal Disorders Market, United States, Volume (Units), 2015-2020 192

Table 55: Hormonal Disorders Market, United States, Volume (Units), 2021-2025 192

Table 56: Thyroid Function Tests Market, United States, Volume (Units), 2015-2020 194

Table 57: Thyroid Function Tests Market, United States, Volume (Units), 2021-2025 195

Table 58: Hormonal Disorders Market, United States, Average Price ($), 2015-2020 196

Table 59: Hormonal Disorders Market, United States, Average Price ($), 2021-2025 197

Table 60: Hormonal Disorders Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 198

Table 61: Hormonal Disorders Market, United States, Company Share by Revenue ($m), USD Constant, 2018 200

Table 62: Infectious Disease Market, United States, Segment Contribution (%), 2018 203

Table 63: Infectious Disease Market, United States, Revenue ($m), USD Constant, 2015-2020 205

Table 64: Infectious Disease Market, United States, Revenue ($m), USD Constant, 2021-2025 206

Table 65: Chlamydia Trachomatis Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 209

Table 66: Chlamydia Trachomatis Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 209

Table 67: Clostridium difficile Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 211

Table 68: Clostridium difficile Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 212

Table 69: Cytomegalovirus (CMV) Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 214

Table 70: Cytomegalovirus (CMV) Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 215

Table 71: Hepatitis Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 217

Table 72: Hepatitis Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 217

Table 73: Human Immunodeficiency Virus (HIV) Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 219

Table 74: Human Immunodeficiency Virus (HIV) Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 220

Table 75: Human Papilloma Virus (HPV) Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 222

Table 76: Human Papilloma Virus (HPV) Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 222

Table 77: Human T-Lymphotropic Virus (HTLV) Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 224

Table 78: Human T-Lymphotropic Virus (HTLV) Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 224

Table 79: Mycobacterium Tuberculosis Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 226

Table 80: Mycobacterium Tuberculosis Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 226

Table 81: Neisseria Gonorrhoeae Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 228

Table 82: Neisseria Gonorrhoeae Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 228

Table 83: Treponema pallidum Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 230

Table 84: Treponema pallidum Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 231

Table 85: Infectious Disease Market, United States, Volume (Units), 2015-2020 233

Table 86: Infectious Disease Market, United States, Volume (Units), 2021-2025 235

Table 87: Chlamydia Trachomatis Tests Market, United States, Volume (Units), 2015-2020 238

Table 88: Chlamydia Trachomatis Tests Market, United States, Volume (Units), 2021-2025 238

Table 89: Clostridium difficile Tests Market, United States, Volume (Units), 2015-2020 240

Table 90: Clostridium difficile Tests Market, United States, Volume (Units), 2021-2025 241

Table 91: Cytomegalovirus (CMV) Tests Market, United States, Volume (Units), 2015-2020 243

Table 92: Cytomegalovirus (CMV) Tests Market, United States, Volume (Units), 2021-2025 243

Table 93: Hepatitis Tests Market, United States, Volume (Units), 2015-2020 246

Table 94: Hepatitis Tests Market, United States, Volume (Units), 2021-2025 246

Table 95: Human Immunodeficiency Virus (HIV) Tests Market, United States, Volume (Units), 2015-2020 248

Table 96: Human Immunodeficiency Virus (HIV) Tests Market, United States, Volume (Units), 2021-2025 249

Table 97: Human Papilloma Virus (HPV) Tests Market, United States, Volume (Units), 2015-2020 251

Table 98: Human Papilloma Virus (HPV) Tests Market, United States, Volume (Units), 2021-2025 251

Table 99: Human T-Lymphotropic Virus (HTLV) Tests Market, United States, Volume (Units), 2015-2020 253

Table 100: Human T-Lymphotropic Virus (HTLV) Tests Market, United States, Volume (Units), 2021-2025 253

Table 101: Mycobacterium Tuberculosis Tests Market, United States, Volume (Units), 2015-2020 255

Table 102: Mycobacterium Tuberculosis Tests Market, United States, Volume (Units), 2021-2025 255

Table 103: Neisseria Gonorrhoeae Tests Market, United States, Volume (Units), 2015-2020 257

Table 104: Neisseria Gonorrhoeae Tests Market, United States, Volume (Units), 2021-2025 257

Table 105: Treponema pallidum Tests Market, United States, Volume (Units), 2015-2020 259

Table 106: Treponema pallidum Tests Market, United States, Volume (Units), 2021-2025 260

Table 107: Infectious Disease Market, United States, Average Price ($), 2015-2020 261

Table 108: Infectious Disease Market, United States, Average Price ($), 2021-2025 264

Table 109: Infectious Disease Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 267

Table 110: Infectious Disease Market, United States, Company Share by Revenue ($m), USD Constant, 2018 269

Table 111: IVD Analyzers and Reagents Market, United States, Segment Contribution (%), 2018 271

Table 112: IVD Analyzers and Reagents Market, United States, Revenue ($m), USD Constant, 2015-2020 273

Table 113: IVD Analyzers and Reagents Market, United States, Revenue ($m), USD Constant, 2021-2025 274

Table 114: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, 2015-2020 276

Table 115: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, 2021-2025 276

Table 116: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, 2015-2020 278

Table 117: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, 2021-2025 279

Table 118: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, 2015-2020 281

Table 119: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, 2021-2025 282

Table 120: Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), USD Constant, 2015-2020 284

Table 121: Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), USD Constant, 2021-2025 285

Table 122: IVD Analyzers and Reagents Market, United States, Volume (Units), 2015-2020 287

Table 123: IVD Analyzers and Reagents Market, United States, Volume (Units), 2021-2025 288

Table 124: Clinical Chemistry Analyzers Market, United States, Volume (Units), 2015-2020 290

Table 125: Clinical Chemistry Analyzers Market, United States, Volume (Units), 2021-2025 290

Table 126: Hematology Analyzers Market, United States, Volume (Units), 2015-2020 292

Table 127: Hematology Analyzers Market, United States, Volume (Units), 2021-2025 293

Table 128: Immunochemistry Analyzers Market, United States, Volume (Units), 2015-2020 295

Table 129: Immunochemistry Analyzers Market, United States, Volume (Units), 2021-2025 296

Table 130: Polymerase Chain Reaction (PCR) Systems Market, United States, Volume (Units), 2015-2020 298

Table 131: Polymerase Chain Reaction (PCR) Systems Market, United States, Volume (Units), 2021-2025 299

Table 132: IVD Analyzers and Reagents Market, United States, Average Price ($), 2015-2020 300

Table 133: IVD Analyzers and Reagents Market, United States, Average Price ($), 2021-2025 302

Table 134: IVD Analyzers and Reagents Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 304

Table 135: IVD Analyzers and Reagents Market, United States, Company Share by Revenue ($m), USD Constant, 2018 306

Table 136: Metabolic Disorder Market, United States, Revenue ($m), USD Constant, 2015-2020 308

Table 137: Metabolic Disorder Market, United States, Revenue ($m), USD Constant, 2021-2025 308

Table 138: Diabetes Assays Market, United States, Revenue ($m), USD Constant, 2015-2020 310

Table 139: Diabetes Assays Market, United States, Revenue ($m), USD Constant, 2021-2025 311

Table 140: Metabolic Disorder Market, United States, Volume (Units), 2015-2020 313

Table 141: Metabolic Disorder Market, United States, Volume (Units), 2021-2025 313

Table 142: Diabetes Assays Market, United States, Volume (Units), 2015-2020 315

Table 143: Diabetes Assays Market, United States, Volume (Units), 2021-2025 316

Table 144: Metabolic Disorder Market, United States, Average Price ($), 2015-2020 317

Table 145: Metabolic Disorder Market, United States, Average Price ($), 2021-2025 317

Table 146: Metabolic Disorder Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 318

Table 147: Metabolic Disorder Market, United States, Company Share by Revenue ($m), USD Constant, 2018 320

Table 148: Oncology Market, United States, Segment Contribution (%), 2018 323

Table 149: Oncology Market, United States, Revenue ($m), USD Constant, 2015-2020 325

Table 150: Oncology Market, United States, Revenue ($m), USD Constant, 2021-2025 326

Table 151: ALK Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 328

Table 152: ALK Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 328

Table 153: BRCA Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 330

Table 154: BRCA Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 330

Table 155: Colorectal Cancer Screening Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 332

Table 156: Colorectal Cancer Screening Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 333

Table 157: EGFR Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 335

Table 158: EGFR Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 336

Table 159: HER2 Amplification Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 338

Table 160: HER2 Amplification Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 338

Table 161: KRAS Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 340

Table 162: KRAS Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 340

Table 163: Oncology Market, United States, Volume (Units), 2015-2020 342

Table 164: Oncology Market, United States, Volume (Units), 2021-2025 343

Table 165: ALK Tests Market, United States, Volume (Units), 2015-2020 345

Table 166: ALK Tests Market, United States, Volume (Units), 2021-2025 345

Table 167: BRCA Tests Market, United States, Volume (Units), 2015-2020 347

Table 168: BRCA Tests Market, United States, Volume (Units), 2021-2025 347

Table 169: Colorectal Cancer Screening Tests Market, United States, Volume (Units), 2015-2020 349

Table 170: Colorectal Cancer Screening Tests Market, United States, Volume (Units), 2021-2025 350

Table 171: EGFR Tests Market, United States, Volume (Units), 2015-2020 352

Table 172: EGFR Tests Market, United States, Volume (Units), 2021-2025 353

Table 173: HER2 Amplification Tests Market, United States, Volume (Units), 2015-2020 355

Table 174: HER2 Amplification Tests Market, United States, Volume (Units), 2021-2025 355

Table 175: KRAS Tests Market, United States, Volume (Units), 2015-2020 357

Table 176: KRAS Tests Market, United States, Volume (Units), 2021-2025 357

Table 177: Oncology Market, United States, Average Price ($), 2015-2020 358

Table 178: Oncology Market, United States, Average Price ($), 2021-2025 360

Table 179: Oncology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 362

Table 180: Oncology Market, United States, Company Share by Revenue ($m), USD Constant, 2018 364

Table 181: Women’s Health Market, United States, Segment Contribution (%), 2018 366

Table 182: Women’s Health Market, United States, Revenue ($m), USD Constant, 2015-2020 368

Table 183: Women’s Health Market, United States, Revenue ($m), USD Constant, 2021-2025 368

Table 184: Prenatal Screening Market, United States, Revenue ($m), USD Constant, 2015-2020 370

Table 185: Prenatal Screening Market, United States, Revenue ($m), USD Constant, 2021-2025 371

Table 186: Reproductive Hormones and Proteins Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 373

Table 187: Reproductive Hormones and Proteins Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 374

Table 188: Women’s Health Market, United States, Volume (Units), 2015-2020 376

Table 189: Women’s Health Market, United States, Volume (Units), 2021-2025 376

Table 190: Prenatal Screening Market, United States, Volume (Units), 2015-2020 378

Table 191: Prenatal Screening Market, United States, Volume (Units), 2021-2025 379

Table 192: Reproductive Hormones and Proteins Tests Market, United States, Volume (Units), 2015-2020 381

Table 193: Reproductive Hormones and Proteins Tests Market, United States, Volume (Units), 2021-2025 382

Table 194: Women’s Health Market, United States, Average Price ($), 2015-2020 383

Table 195: Women’s Health Market, United States, Average Price ($), 2021-2025 385

Table 196: Women’s Health Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 387

Table 197: Women’s Health Market, United States, Company Share by Revenue ($m), USD Constant, 2018 389

Table 198: In Vitro Diagnostics Market Pipeline Products 395

Table 199: Oncology Venture Acquires Oncology Venture US (2X Oncology) 400

Table 200: Smiths Detection to Acquire PathSensors 402

Table 201: Healthy.io Acquires Inui Health 403

Table 202: Invitae to Acquire ArcherDX 404

Table 203: Foundation Medicine Acquires Lexent Bio 406

Table 204: MEDNAX Plans to Sell MEDNAX Radiology Solutions 407

Table 205: Predictive Oncology Acquires BioDtech 408

Table 206: OraSure Technologies to Acquire UrSure for up to USD31 Million 410

Table 207: Premier and 15 Health Systems Acquires Minority Stake in Prestige Ameritech 412

Table 208: Moncef Slaoui to Divest Stake in Moderna for USD12.4 Million 416

Table 209: OncBioMune Pharma Acquires Avant Diagnostics 417

Table 210: Bio-Rad Labs Acquires Celsee 419

Table 211: Daniel Alain Acquires Stake in Applied Biology 420

Table 212: Maravai Life Sciences Acquires MockV Solutions 421

Table 213: Document Security Systems to Acquire Impact Biomedical from Global BioMedical 422

Table 214: Invitae to Acquire Genelex 424

Table 215: Abcam Acquires Marker Gene Technologies 426

Table 216: Nexelis to Acquire ImmunXperts 427

Table 217: Genovis Acquires QED Bioscience for USD2 Million 428

Table 218: Exact Sciences Acquires Paradigm Diagnostics and Viomics 430

Table 219: Conatus Pharma Acquires Histogen 432

Table 220: Alpha Holdings Revises offer to Acquire OncoSec Medical 434

Table 221: BioNTech Acquires Neon Therapeutics 435

Table 222: OncoCyte Acquires Insight Genetics 437

Table 223: Todos Medical Enters into Option Agreement to Acquire Provista Diagnostics 439

Table 224: Axim Biotechnologies Acquires Sapphire Biotech 440

Table 225: Illumina Terminates Acquisition of Pacific Biosciences of California 441

Table 226: Becton Dickinson Acquires NAT Diagnostics 443

Table 227: KNOW Bio Acquires Clinical Sensors 444

Table 228: Charles River Labs Acquires HemaCare 445

Table 229: Oncology Pharma Plans to Acquire Minority Stakes in Diagnomics and Eone Diagnomics Genome 447

Table 230: Canopy Biosciences Acquires Core Diagnostics 448

Table 231: Dare Bioscience Acquires Microchips Biotech 449

Table 232: Accumen Acquires 3DR Laboratories 451

Table 233: China Grand Pharma and Sirtex Medical Acquire 52.8% Stake in OncoSec Medical for USD30 Million 452

Table 234: OncoCyte Acquires Razor Genomics 454

Table 235: Bio-Rad Lab Acquires Exact Diagnostics 456

Table 236: Amgen May Acquire Alexion Pharma 457

Table 237: BioIVT Acquires Keystone Biologicals 458

Table 238: Exact Sciences Acquires Genomic Health for USD2.8 Billion 459

Table 239: P4 Diagnostix Acquires Assets of Strand Diagnostics 461

Table 240: Ligand Pharma Acquires Core Assets from Icagen 462

Table 241: Abcam Acquires Gene Editing Platform and Oncology Product Portfolio of Applied StemCell 464

Table 242: Haemonetics Acquires TEG 6s Hemostasis Analyzer System from CoraMed Technologies 466

Table 243: Gold Standard Diagnostics Acquires Assets from Diamedix for USD2.2 Million 467

Table 244: Psomagen Acquires Microbiome Patents and Data from uBiome for USD7 Million 469

Table 245: Phenomics Health Acquires Pharmacometabolomic Technology from Precera Bioscience 471

Table 246: Envigo RMS Acquires In Vivo Business Unit from Horizon Discovery 472

Table 247: Edan Diagnostics to Acquire ClariLight Molecular Diagnostic Platform from LGC 474

Table 248: Cleveland HeartLab Acquires Certain Assets from True Health Diagnostics for USD8.5 Million 475

Table 249: LineaRx Acquires Assets and Intellectual Property of Vitatex 476

Table 250: LabCorp Acquires Diagnostic Clinical Laboratory Assets from South Bend Medical Foundation 478

Table 251: Abbott Laboratories Raises USD650 Million in Public Offering of 1.4% Notes Due 2030 480

Table 252: Abbott Laboratories Raises USD650 Million in Public Offering of 1.15% Notes Due 2028 482

Table 253: Merck Raises USD1 Billion in Public Offering of 0.750% Notes Due 2026 484

Table 254: Merck Raises USD1.25 Billion in Public Offering of 1.450% Notes Due 2030 486

Table 255: Merck Raise USD1 Billion in Public Offering of 2.350% Notes Due 2040 488

Table 256: Merck Raises USD1.25 Billion in Public Offering of 2.450% Notes Due 2050 490

Table 257: Agilent Technologies Prices Public Offering of 2.1% Notes Due 2030 for USD500 Million 492

Table 258: ProLung Raises USD3 Million in Private Placement of Notes 494

Table 259: BioMarin Pharma Raises USD600 Million in Private Placement of 1.25% Notes Due 2027 495

Table 260: Quest Diagnostics Prices Public Offering of 2.800% Notes Due 2031 for USD550 Million 497

Table 261: Becton Dickinson Raises USD750 Million in Public Offering of 2.823% Notes Due 2030 499

Table 262: Becton Dickinson Raises USD750 Million in Public Offering of 3.794% Notes Due 2050 501

Table 263: Luminex Prices Private Placement of 3.00% Notes Due 2025 for USD260 Million 503

Table 264: Amgen Raises USD1 Billion in Public Offering of 2.2% Notes Due 2027 505

Table 265: Amgen Raises USD1.2 Billion in Public Offering of 2.3% Notes Due 2031 507

Table 266: Amgen Raises USD1 Billion in Public Offering of 3.375% Notes Due 2050 509

Table 267: Amgen Raises USD750 Million in Public Offering of 3.15% Notes Due 2040 511

Table 268: NeoGenomics Prices Public Offering of 1.25% Convertible Senior Notes Due 2025 for USD175 Million 513

Table 269: Eli Lilly Raises USD1.08 Billion in Public Offering of 2.25% Notes Due 2050 515

Table 270: Natera Prices Private Placement of 2.25% Notes Due 2027 for USD250 Million 517

Table 271: Danaher Raises USD163.4 Million in Public Offering of 1.7% Senior Notes Due 2024 519

Table 272: Danaher Raises USD327 Million in Public Offering of 2.1% Senior Notes Due 2026 521

Table 273: Danaher Raises USD327 Million in Public Offering of 2.5% Senior Notes Due 2030 523

Table 274: CytoDyn Raises USD15 Million in Private Placement of 10% Notes Due 2022 525

Table 275: Thermo Fisher Scientific Raises USD668 Million in Public Offering of 2.375% Notes Due 2032 526

Table 276: Thermo Fisher Scientific Raises USD668 Million in Public Offering of 1.750% Notes Due 2027 528

Table 277: Baxter International Raises USD500 Million in Private Placement of 3.95% Senior Notes Due 2030 530

Table 278: Baxter International Raises USD750 Million in Private Placement of 3.75% Senior Notes Due 2025 531

Table 279: Danaher Raises USD810.2 Million in Public Offering of 1.700% Senior Notes Due 2024 532

Table 280: Danaher Raises USD540 Million in Public Offering of 2.100% Senior Notes Due 2026 534

Table 281: Danaher Raises USD540 Million in Public Offering of 2.500% Senior Notes Due 2030 536

Table 282: Pfizer Raises USD1.25 Billion in Public Offering of 2.625% Notes Due 2030 538

Table 283: Thermo Fisher Scientific Raises USD1.1 Billion in Public Offering of 4.133% Notes Due 2025 540

Table 284: Thermo Fisher Scientific Raises USD1.1 Billion in Public Offering of 4.497% Notes Due 2030 543

Table 285: NanoString Technologies Prices Private Placement of 2.625% Notes Due 2025 for USD200 Million 546

Table 286: Exact Sciences Prices Public Offering of 0.3750% Notes Due 2028 for USD1 Billion 548

Table 287: Amgen Raises USD1.25 Billion in Offering of 3.150% Senior Unsecured Notes Due 2040 550

Table 288: Amgen Raises USD1.25 Billion in Debt Offering of 3.375% Senior Unsecured Notes Due 2050 552

Table 289: Amgen Raises USD750 Million in Debt Offering of 2.200% Senior Unsecured Notes Due 2027 554

Table 290: Amgen Raises USD1.25 Billion in Debt Offering of 2.450% Senior Unsecured Notes Due 2030 556

Table 291: Amgen Raises USD500 Million in Debt Offering of 1.900% Senior Unsecured Notes Due 2025 558

Table 292: Promis Diagnostics Raises USD10.8 Million in Private Placement of Convertible Notes 560

Table 293: Verastem Raises USD0.8 Million in Debt Financing 561

Table 294: Bruker Raises USD301.6 Million in Private Placement of Senior Notes 562

Table 295: Quest Diagnostics Prices Public Offering of 2.95% Notes Due 2030 for USD800 Million 563

Table 296: Fluidigm to Raise USD45 Million in Private Placement of Notes Due 2024 565

Table 297: LabCorp Raises USD400 Million in Public Offering of 2.3% Notes Due 2024 567

Table 298: LabCorp Raises USD650 Million in Public Offering of 2.95% Notes Due 2029 570

Table 299: Halozyme Therapeutics Raises USD460 Million in Public Offering of 1.25% Convertible Senior Notes Due 2024 573

Table 300: AbbVie Raises USD750 Million in Private Placement of Floating Rate Notes Due 2021 575

Table 301: AbbVie Raises USD750 Million in Private Placement of Floating Rate Notes Due 2022 576

Table 302: AbbVie Raises USD1.75 Billion in Private Placement of 2.150% Notes Due 2021 577

Table 303: AbbVie Raises USD3 Billion in Private Placement of 2.300% Notes Due 2022 578

Table 304: AbbVie Raises USD3.75 Billion in Private Placement of 2.600% Notes Due 2024 579

Table 305: AbbVie Raises USD4 Billion in Private Placement of 2.95% Notes Due 2026 580

Table 306: AbbVie Raises USD5.5 Billion in Private Placement of 3.2% Notes Due 2029 582

Table 307: AbbVie Raises USD4 Billion in Private Placement of 4.050% Notes Due 2039 583

Table 308: AbbVie Raises USD5.75 Billion in Private Placement of 4.250% Notes Due 2049 584

Table 309: AbbVie Raises USD750 Million in Private Placement of Senior Floating Rate Notes Due 2021 585

Table 310: Danaher Raises USD700 Million in Public Offering of 2.05% Senior Notes Due 2022 586

Table 311: Danaher Raises USD700 Million in Public Offering of 2.2% Senior Notes Due 2024 588

Table 312: Danaher Raises USD900 Million in Public Offering of 3.25% Senior Notes Due 2039 590

Table 313: Danaher Raises USD900 Million in Public Offering of 3.4% Senior Notes Due 2049 592

Table 314: Eli Lilly Prices Public Offering of 0.625% Notes Due 2031 for USD665.5 Million 594

Table 315: Eli Lilly Prices Public Offering of 1.7% Notes Due 2049 for USD1.1 Billion 596

Table 316: Danaher Raises USD800 Million in Public Offering of 2.6% Senior Notes Due 2029 598

Table 317: Charles River Labs Raises USD500 Million in Private Placement of 4.25% Notes Due 2028 600

Table 318: Thermo Fisher Scientific Raises USD990 Million in Public Offering of 1.500% Notes Due 2039 602

Table 319: Thermo Fisher Scientific Raises USD900 Million in Public Offering of 2.600% Notes Due 2029 605

Table 320: Thermo Fisher Scientific Raises USD1.1 Billion in Public Offering of 1.875% Notes Due 2049 608

Table 321: Thermo Fisher Scientific Raises USD880 Million in Public Offering of 0.500% Notes Due 2028 611

Table 322: Thermo Fisher Scientific Raises USD990 Million in Public Offering of 0.875% Notes Due 2031 614

Table 323: Thermo Fisher Scientific Raises USD880 Million in Public Offering of 0.125% Notes Due 2025 617

Table 324: AbbVie Raises USD719.6 Million in Public Offering of 1.25% Notes Due 2031 620

Table 325: AbbVie Raises USD830.3 Million in Public Offering of 0.75% Notes Due 2027 622

Table 326: PerkinElmer Raises USD850 Million in Public Offering of 3.3% Notes Due 2029 624

Table 327: Agilent Technologies Raises USD500 Million in Public Offering of 2.75% Senior Notes Due 2029 626

Table 328: Invitae to Raise USD200 Million in Private Placement of Notes Due 2024 628

Table 329: Danaher Raises USD1.37 Billion in Public Offering of 1.35% Notes Due 2039 629

Table 330: Danaher Raises USD1.92 Billion in Public Offering of 0.75% Notes Due 2031 631

Table 331: Danaher Raises USD823 Million in Public Offering of 1.8% Notes Due 2049 633

Table 332: Danaher Raises USD1.37 Billion in Public Offering of 0.2% Notes Due 2026 635

Table 333: Danaher Raises USD1.37 Billion in Public Offering of 0.45% Notes Due 2028 637

Table 334: Clovis Oncology Raises USD250 Million in Private Placement of 4.50% Notes Due 2024 639

Table 335: Mateon Therapeutics Raises USD0.2 Million in Private Placement of 8% Note 641

Table 336: Daxor Prices Private Placement of Shares and Warrants for USD7 Million 642

Table 337: SINTX Technologies Prices Private Placement of Shares for USD3 Million 644

Table 338: Adaptive Biotechnologies Prices Public Offering of Shares for USD320 Million 645

Table 339: ARCA biopharma to Raise up to USD7.3 Million in Public Offering of Shares 647

Table 340: Bio-Path Holdings to Raise USD7 Million in Public Offering of Common Stock 648

Table 341: Vaxart Files Registration Statement for Public Offering of Securities 649

Table 342: Personalis Files Registration Statement for Public Offering of Securities for up to USD250 Million 650

Table 343: Aeterna Zentaris Raises USD12 Million in Public Offering of Units 651

Table 344: Aspira Womens Health to Raise USD11 Million in Private Placement of Shares 653

Table 345: Cancer Genetics Files Registration Statement for Public Offering of Securities for up to USD100 Million 654

Table 346: SINTX Technologies to Raise USD41.3 Million in Public offering of Shares 655

Table 347: SINTX Technologies Prices Private Placement of Shares for USD5.6 Million 657

Table 348: Castle Biosciences Raises USD85.1 Million in Public Offering of Shares 658

Table 349: Akouos Raises USD244.4 Million in IPO of Shares 660

Table 350: Progenity Prices IPO of Shares for USD100 Million 662

Table 351: Constellation Pharma Prices Public Offering of Shares for USD192.5 Million 664

Table 352: Celldex Therapeutics Raises USD150 Million in Public Offering of Shares 666

Table 353: Medibio to Raise USD0.3 Million in Private Placement of Shares 668

Table 354: Medibio Raises USD0.4 Million in Rights Offering of Shares 669

Table 355: CareDx Raises USD143.8 Million in Public Offering of Shares 671

Table 356: ArcherDX Files Registration Statement for IPO of Shares for up to USD100 Million 673

Table 357: Celcuity to Raise up to USD10 Million in Public Offering of Shares 675

Table 358: Twist Bioscience Raises USD115 Million in Public Offering of Shares 677

Table 359: Aileron Therapeutics Raises USD11.2 Million in Public Offering of Shares 679

Table 360: ARCA biopharma Raises USD6.1 Million in Private Placement of Shares and Warrants 681

Table 361: Guardant Health Raises USD362.3 Million in Public Offering of Shares 683

Table 362: Cleveland BioLabs Raises USD3.2 Million in Private Placement of Shares 685

Table 363: SurModics Plans to Raise up to USD200 Millon in Public Offering of Securities 687

Table 364: Geron Raises USD150 Million in Public Offering of Shares and Warrants 688

Table 365: Cardiff Oncology Raises USD0.8 Million in Private Placement of Shares 690

Table 366: Becton Dickinson Raises USD1.5 Public Offering of Shares 691

Table 367: Becton Dickinson Raises USD1.5 Billion in Public Offering of Depositary Shares 694

Table 368: ThermoGenesis to Raise USD15 Million in Public Offering of Common Stock 697

Table 369: Turning Point Therapeutics Announces Full Exercise of Underwriters’ Option to Purchase Shares for USD373.8 Million 699

Table 370: Clovis Oncology Prices Public Offering of Shares for USD89.3 Million 701

Table 371: Moderna Prices USD1.34 Billion in Public Offering of Shares 703

Table 372: Akers Biosciences Raises USD4.8 Million in Private Placement of Shares 705

Table 373: Danaher Raises USD1.55 Billion in Public Offering of Shares 706

Table 374: Danaher Raises USD1.71 Billion in Public Offering of Series B Convertible Preferred Stock 708

Table 375: Aspirar Medical Lab Raises Funds through Equity Financing 710

Table 376: GenMark Diagnostics Raises USD80.5 Million in Public Offering of Shares 711

Table 377: Kura Oncology Raises USD143.9 Million in Public Offering of Shares 713

Table 378: Insmed Raises USD259.4 Million in Public Offering of Shares 715

Table 379: Lineage Cell Therapeutics Files Registered Statement for Public Offering of Securities up to USD75 Million 717

Table 380: Lineage Cell Therapeutics Files Registered Statement for Public Offering of Securities up to USD25 Million 719

Table 381: VistaGen Therapeutics to Raise up to USD5.75 Million in Public Offering of Shares 721

Table 382: NeoGenomics Prices Public Offering of Shares for USD125.4 Million 723

Table 383: Syndax Pharma Raises USD115 Million in Public Offering of Shares 725

Table 384: Immunomedics Raises USD483 Million in Public Offering of Shares 727

Table 385: Biocept Files Registered Statement for Public Offering of Securities up to USD100 Million 729

Table 386: Heat Biologics Plans to Raise up to USD150 Million in Public Offering of Securities 730

Table 387: Heat Biologics to Raise up to USD50 Million in Public Offering of Shares 731

Table 388: H-CYTE Raises USD2.9 Million in Equity Financing 733

Table 389: Biocept Prices Private Placement of Shares for USD10.3 Million 734

Table 390: ProtoKinetix Raises USD0.07 Million in Private Placement of Shares 735

Table 391: ProtoKinetix Raises Additional USD0.13 Million in Private Placement of Shares 736

Table 392: Entasis Therapeutics Raises USD3.3 Million in Private Placement 737

Table 393: Dascena Raises Funds through Private Placement 739

Table 394: Akers Biosciences Prices Private Placement of Shares for USD4.6 Million 740

Table 395: Invitae Raises USD184 Million in Public Offering of Shares 741

Table 396: Trovagene Raises USD2 Million in Equity Offering 743

Table 397: Celldex Therapeutics Files Registration Statement for Public Offering of Shares up to USD18 Million 744

Table 398: Precipio Files Registration Statement for Public Offering of Securities up to USD50 Million 745

Table 399: Cassava Sciences Files Registration Statement for Public Offering of Shares up to USD100 Million 747

Table 400: miRagen Therapeutics Files Registration Statement for Public Offering of Securities up to USD175 Million 749

Table 401: miRagen Therapeutics Files Registration Statement for Public Offering of Securities up to USD14.9 Million 750

Table 402: miRagen Therapeutics Files Registration Statement for Public Offering of Securities up to USD37.9 Million 752

Table 403: Novus Therapeutics Plans to Raise up to USD2.3 Million in Public Offering of Shares 754

Table 404: ThermoGenesis Holdings Raises USD3.5 Million in Registered Direct Offering 755

Table 405: Verastem Plans to Raise up to USD78.6 Million in Public Offeirng of Shares 756

Table 406: Akers Biosciences Raises USD1.2 Million in Equity Offering 757

Table 407: OncoCyte to Raise upto USD25 Million in Public Offering of Shares 758

Table 408: Biomerica Plans to Raise USD12.5 Million in Public Offering of Shares 760

Table 409: Aethlon Medical Plans to Raise up to USD25 Million in Public Offering of Securities 762

Table 410: Aethlon Medical to Raise up to USD7.5 Million in Public Offering of Shares 763

Table 411: OpGen to Raise up to USD15.7 Million in Private Placement of Common Stock 765

Table 412: CytoDyn Raises USD0.9 Million in Equity Offering 767

Table 413: Bionano Genomics to Raise USD30 Million in Public Offering of Shares 768

Table 414: Bionano Genomics Plans to Raise up to USD0.9 Million in Public Offering of Shares 770

Table 415: AIM ImmunoTech to Raise USD18 Million in Public Offering of Common Stock 771

Table 416: Seres Therapeutics Files Registration Statement for Public Offering of Securities for up to USD125 Million 773

Table 417: Corvus Pharma Files Prospectus for Public Offering of Securities for up to USD200 Million 774

Table 418: Corvus Pharma Plans to Raise up to USD50 Million in Public Offering of Shares 775

Table 419: T2 Biosystems Plans to Raise up to USD95 Million in Public Offering of Shares 776

Table 420: Titan Pharma Raises USD5.9 Million in Private Placement of Shares upon Exercise of Warrants 778

Table 421: Biocept Prices Private Placement of Shares for USD6.6 Million 779

Table 422: Fluidigm to Raise USD50 Million in Public Offering of Shares 780

Table 423: Daxor Raises USD2 Million in Private Placement of Shares 782

Table 424: AIM ImmunoTech Raises USD10.4 Million in Public Offering of Common Stock 783

Table 425: DermTech to Raise USD65 Million in Private Placement of Shares 785

Table 426: Biocept Prices Registered Direct Offering of Shares for USD9.2 Million 787

Table 427: Vaxart Prices Private Placement of Shares and Warrants for USD10 Million 789

Table 428: Tracon Pharma Plans Public Offering of Shares for up to USD2 Million 790

Table 429: iBio Files Registration Statement for Public Offering of Securities for up to USD100 Million 792

Table 430: ARCA biopharma Files Registration Statement for Public Offering of Securities for up to USD15 Million 793

Table 431: Aeterna Zentaris Raises USD4.5 Million in Private Placement of Shares and Warrants 795

Table 432: Blueprint Medicines Plans to Raise Funds through Public Offering of Securities 797

Table 433: Deciphera Pharma Raises USD175 Million in Public Offering of Shares 798

Table 434: DiaMedica Therapeutics Raises USD8.5 Million in Public Offering of Shares 800

Table 435: Atossa Therapeutics to Raise up to USD5 Million in Public Offering of Shares 802

Table 436: miRagen Therapeutics Prices Public Offering of Shares and Warrants for USD15 Million 803

Table 437: CytoDyn Plans to Raise up to USD18 Million in Public Offering of Shares 805

Table 438: CytoDyn Raises USD7.57 Million in Equity Offering 806

Table 439: Trovagene Raises USD1.5 Million in Private Placement upon Exercise of Warrants 807

Table 440: Synedgen Raises USD2.6 Million in Financing 808

Table 441: VistaGen Therapeutics to Raise USD2.8 Million in Private Placement of Shares and Warrants 809

Table 442: Adaptive Biotech Prices Public Offering of Common Stock for USD212 Million 810

Table 443: Sintx Technologies to Raise USD8.8 million in Rights Offering 812

Table 444: Regulus Therapeutics Files Registration Statement for Public Offering of Securities for up to USD82.2 Million 814

Table 445: Blueprint Medicines Prices USD324 Million Public Offering of Common Stock 816

Table 446: ImmunoGen Raises USD104.2 Million in Public Offering of Shares 818

Table 447: SI-Bone Prices USD92.45 Million Public Offeirng of Shares 820

Table 448: Aethlon Medical Raises USD3.8 Million in Private Placement of Shares and Warrants 822

Table 449: Precipio Plans to Raise up to USD1.7 Million in Public Offering of Shares 824

Table 450: Titan Pharma Prices Private Placement of Shares and Warrants for USD2.2 Million 825

Table 451: OncoCyte Prices Private Placement of Shares for USD5 Million 826

Table 452: ProtoKinetix Raises Additional USD0.05 Million in Private Placement of Units 827

Table 453: ProtoKinetix Raises Additional USD0.12 Million in Private Placement of Units 828

Table 454: Clovis Oncology Files Prospectus for Public Offering of Securities for up to USD250 Million 829

Table 455: ThermoGenesis Files Registration Statement for Public Offering of Shares for up to USD30 Million 831

Table 456: CytoDyn Raises USD0.7 Million in Private Placement of Shares 832

Table 457: Constellation Pharma Raises USD257.9 Million in Public Offering of Shares 834

Table 458: Celldex Therapeutics Files Registration Statement for Public Offering of Securities for USD150 Million 836

Table 459: Immunomedics Raises USD287.5 Million in Public Offering of Shares 837

Table 460: Akers Biosciences to Raise Funds through Public Offering of Units 839

Table 461: Seres Therapeutics Plans to Raise up to USD25 Million in Public Offering of Shares 840

Table 462: Molecular Templates Prices USD50 Million Public Offering of Shares and Series A Convertible Preferred Stock 841

Table 463: Bio-Path Holdings Raises USD8 Million in Registered Direct Offering of Shares and Warrants 843

Table 464: Molecular Templates Raises USD15 Million in Private Placement 844

Table 465: H-CYTE Raises USD6 Million in Private Placement of Preferred Shares 845

Table 466: HTG Molecular Diagnostics to Raise up to USD20 Million in Public Offering of Shares 846

Table 467: SI-Bone Plans to Raise up to USD200 Million in Public Offering of Securities 848

Table 468: Fulgent Genetics Prices Public Offering of Shares for USD26.2 Million 849

Table 469: Agios Pharma Raises USD294.09 Million in Public Offering of Shares 851

Table 470: PAVmed to Raise USD14 Million in Private Placement 853

Table 471: Akers Biosciences Raises USD8 Million in Public Offering of Shares 854

Table 472: Biocept Raises USD10 Million Public Offering of Common Stock 856

Table 473: Miragen Therapeutics Raises Additional USD0.5 Million in Private Placement of Shares 858

Table 474: VistaGen Therapeutics Raises USD0.7 Million in Financing 859

Table 475: Trovagene Raises USD5 Million in Private Placement of Shares and Warrants 860

Table 476: iBio Prices Public Offering of Shares for USD5 Million 862

Table 477: OPKO Health Raises USD75 Million in Public Offering of Shares 864

Table 478: ProtoKinetix Raises USD0.1 Million in Private Placement of Securities 866

Table 479: Natera Prices Public Offering of Shares for USD200 Million 867

Table 480: OpGen Raises USD9.4 Million in Public Offering of Units 869

Table 481: HTG Molecular Diagnostics Plans to Raise up to USD4.5 Million in Public Offering of Shares 871

Table 482: Titan Pharma Raises USD9.06 Million in Public Offering of Units 873

Table 483: Nabsys Raises USD21 Million in Equity Financing 875

Table 484: Entasis Therapeutics to Raise up to USD20 Million in Public Offering of Shares 876

Table 485: Constellation Pharma to Raise USD65 Million in Private Placement of Shares 877

Table 486: Vaxart Prices Public Offering of Shares and Warrants for USD8 Million 879

Table 487: AIM ImmunoTech Prices Public Offering of Shares for USD8 Million 881

Table 488: LexaGene Holdings Raises USD5 Million in Public Offering of Units 883

Table 489: EDP Biotech Raises USD5 Million in Equity Financing 885

Table 490: Aeterna Zentaris Raises USD5 Million in Registered Direct Offering of Shares 886

Table 491: Interpace Diagnostics Plans to Raise up to USD4.8 Million in Public Offering of Shares 888

Table 492: HTG Molecular Diagnostics Raises USD3.5 Million in Private Placement of Shares Upon Exercise of Warrants 890

Table 493: Bionano Genomics Raises USD18 Million in Public Offering of Shares and Warrants 891

Table 494: HTG Molecular Diagnostics Raises USD19 Million in Public Offering of Shares 893

Table 495: Catalyst Pharma to Raise Funds through Public Offering of Shares 895

Table 496: OncoCyte Prices Private Placement of Shares for USD6.6 Million 897

Table 497: Syndax Pharma to Raise USD50 Million in Public Offering of Shares 898

Table 498: Turning Point Therapeutics Prices Public Offering of Shares for USD202.5 Million 899

Table 499: PRA Health Sciences Raises USD650 Million in Public Offering of Shares 901

Table 500: Aridis Pharma Plans to Raise up to USD100 Million in Public Offering of Securities 903

Table 501: Aridis Pharma Decreases Size of Public Offering of Shares to Raise up to USD22 Million 905

Table 502: CytoDyn Files Registration Statement for Public Offering of Shares for up to USD7.5 Million 907

Table 503: CytoDyn Raises USD2.3 Million in Private Placement of Shares and Warrants 908

Table 504: Exagen (Exagen Diagnostics) Raises USD57.96 Million in Initial Public Offering 910

Table 505: OncoSec Medical Plans to Raise up to USD50 Million in Public Offering of Securities 912

Table 506: Trovagene Raises USD1.5 Million in Financing 913

Table 507: Accelerate Diagnostics Raises USD1 Million in Financing 914

Table 508: Quanterix Raises USD60 Million in Public Offering of Shares 915

Table 509: Titan Pharma Prices USD2.1 Million in Offering of Common Stock 917

Table 510: GenMark Diagnostics to Raise up to USD35 Million in Public Offering of Shares 918

Table 511: Constellation Pharma Plans to Raise up to USD200 Million in Public Offering of Securities 919

Table 512: Constellation Pharma Plans to Raise up to USD50 Million in Public Offering of Shares 921

Table 513: Sera Prognostics Raises USD25.77 Million in Equity Offering 923

Table 514: T2 Biosystems to Raise up to USD30 Million in Public offering of Shares 924

Table 515: OncoGenesis to Raise USD5.5 Million in Private Placement of Preferred Shares 925

Table 516: Castle Biosciences Raises USD73.6 Million in IPO of Shares 926

Table 517: Seattle Genetics Raises USD575 Million in Public Offering of Shares 928

Table 518: A Dried Blood Spot Companion Diagnostic to Measure Neuroendocrine Changes in ADHD. 930

Table 519: Analytical validation of a biochemical test for alpha-synuclein aggregates in biological fluids for the diagnosis of Parkinson’s Disease 931

Table 520: Development of Immune Mediator Based Blood Tests that Inform Concurrent and Future Clinical Disease Activity in Systemic Lupus Erythematosus (SLE) 932

Table 521: Low-Cost Instrument-free Point-of-Care Test for Chlamydia and Gonorrhea 933

Table 522: Rapid and Simple Paper Strip Test for the Multiplexed Detection of Gastrointestinal Pathogens at the Point-of-Need 934

Table 523: Low Cost, Rapid Molecular Diagnostic for Chlamydia and Gonorrhea at the Point-of-Care 935

Table 524: Development of a Highly Sensitive Quantitative Rapid Digital LSPR Diagnostic for Acute Dengue and Zika Virus Infection 936

Table 525: Diagnostics via Rapid Enrichment, Identification, and Phenotypic Antibiotic Susceptibility Testing of Pathogens from Blood. 937

Table 526: Digital Microfluidics – Minimizing Blood Volume for Pediatric Coagulation Screening 938

Table 527: A Molecular Diagnostic Assay for Accurately Differentiating Melanoma from Benign Lesions 939

Table 528: Dual Electron-Based Fragmentation with Ion Mobility to Advance Native Top-Down Proteomics 940

Table 529: Immunoassay for early diagnosis of mucormycosis 941

Table 530: Nanostructured Magnetic Disks for Wide Range Size Selection in NGS Library Preparation and PCR Purification 942

Table 531: An Innovative Unbound Bilirubin Assay to Identify Bilirubin-Induced Neurological Dysfunction (BIND) Risk as Part of a Comprehensive and Novel Point-of-Care Newborn Screening Panel 943

Table 532: Long non-coding RNA signatures to track treatment responses in multiple sclerosis 944

Table 533: Sensitive and Portable Physician Office-Based Urine Analyzer to Tackle Prescription Drug Abuse 945

Table 534: Reducing the incidence of febrile neutropenia in cancer patients treated with chemotherapy with PointCheck: a portable non-invasive neutropenia analyzer 946

Table 535: Development of Molecular Diagnostic Test for Early Onset of Lyme disease 947

Table 536: Hybrid ELISA: Simple and specific one-tier assay for Lyme disease 948

Table 537: Bloodstream infection detection directly on whole blood 949

Table 538: Multiplex nucleosome-based profiling for the development of next-generation chromatin labeling reagents 950

Table 539: Multiplex nucleosome-based profiling for the development of next-generation chromatin labeling reagents 951

Table 540: Saliva biomarkers for noninvasive diagnostics of acute mTBI in children 952

Table 541: Sinu-Test, A Multiplexed Device for Rapid Diagnosis of Acute Bacterial Sinusitis 953

Table 542: Super-sensitive detection of universal markers of allograft rejection 954

Table 543: Rapid Point-of-Care Assay for Diagnosis of Neurocysticercosis in Seizure Patients 955

Table 544: Feasibility and validation of an integrated newborn screening algorithm with targeted Next Generation Sequencing (tNGS) technology as part of a 2nd-tier test for Pompe and MPS I 956

Table 545: Feasibility and validation of an integrated newborn screening algorithm with targeted Next Generation Sequencing (tNGS) technology as part of a 2nd-tier test for Pompe and MPS I 957

Table 546: Development of a Universal Assay for Minimal Residual Disease in Acute Myeloid Leukemia using Duplex Sequencing 958

Table 547: Rapid and Simple Paper Strip Test for the Multiplexed Detection of Gastrointestinal Pathogens at the Point-of-Need 959

Table 548: Near Patient Acute Kidney Injury Biomarker Analysis in Critically Ill Neonates 960

Table 549: Multiplexed Bioassay for Checkpoint Inhibitor Autoimmunity 961

Table 550: Smokescreen Translational (TL) Analysis Platform 962

Table 551: GMP Production of a Tau Oligomer Inhibitor to Enable Clinical Development for ADRD 963

Table 552: Noninvasive biomarkers for gastrointestinal disease in preterm infants 964

Table 553: Molecular Biomarkers of Dangerous Intracranial Aneurysms 965

Table 554: A Low Blood Volume Platform for Global Newborn Screening of Common, Treatable Conditions 966

Table 555: A Rapid HIV RNA Detection without Sample Preparation 967

Table 556: Rapid, Point-of-Care Nucleic Acid Test for HCV 968

Table 557: An automated test for gestational diabetes based on glycated CD59 969

Table 558: Early Detection of Ovarian Cancer Using Uterine Lavage and Duplex Sequencing 970

Table 559: Smokescreen Translational (TL) Analysis Platform 971

Table 560: Development of a urine test for the early detection of liver cancer 972

Table 561: Improved detection of bladder cancer recurrence using a biophysical biomarker 973

Table 562: A Point of Care Test to Monitor and Improve Adherence to Dolutegravir for HIV Treatment 974

Table 563: Validation of a salivary miRNA diagnostic test for autism spectrum disorder 975

Table 564: Development of a JBS HI-LO Urine DNA Kit 976

Table 565: Project isoPTE: isothermic post-traumatic epilepsy miRNA biomarker detection 977

Table 566: Cytology-Free POC Cervical Cancer Diagnostics for Global Health 978

Table 567: Highly selective detection of tau oligomers in biological fluids for the diagnosis of Alzheimer’s Disease 979

Table 568: Seromic Mucin Signature for the Early Diagnosis of Pancreatic Cancer 980

Table 569: Lateral flow immunoassay for rapid diagnosis of tinea capitis and onychomycosis 981

Table 570: Silicon Photonic Blood Typing 982

Table 571: Multiplex Platform for Point-of-Care Newborn Screening of Hyperbilirubinemia 983

Table 572: Long non-coding RNA signatures to track treatment responses in multiple sclerosis 984

Table 573: CapioCyte circulating tumor cell assay as a biomarker for cancer immunotherapy response 985

Table 574: A Dried Blood Spot Companion Diagnostic to Measure Neuroendocrine Changes in ADHD. 986

Table 575: Comprehensive, Near Patient Assessment of Severe Hypoglycemia in Newborns Using Low Blood Volume 987

Table 576: Detecting species-specific bacterial meningitis markers with iDDS probes 988

Table 577: Development of a Clinical Screening Platform for Type 1 Diabetes 989

Table 578: Point-of-care HIV viral load system using RPA and MXR 990

Table 579: Optimization and Validation of an indicator cell assay for blood-based diagnosis of lung cancer 991

Table 580: Low-cost, portable and automated semen analysis using computational microscopy for home-based testing of male wellness and fertility 992

Table 581: Expanding thyroid testing in high risk newborns: total T3, free T4, TSH and TRAB 993

Table 582: Improving Anticoagulation Monitoring in Pediatric Patients: Use of a Microfluidic Platform to Test Low Volume Blood Samples Obtained by Heel-Stick Collection 994

Table 583: AstraZeneca Reportedly Drops Interest in Merging with Gilead Sciences 995

Table 584: Icare USA Merges with CenterVue 996

Table 585: Organovo Holdings Terminates Merger with Tarveda Therapeutics 997

Table 586: International Display Advertising to Merge with IR Med 999

Table 587: Tocagen Merges with Forte Biosciences 1000

Table 588: Qualigen Therapeutics (Ritter Pharma) Merge with Qualigen in Reverse Merger Transaction 1002

Table 589: NuProbe Merges with CarrierGene Biotech 1004

Table 590: Organovo Holdings Receives Merger Proposal from Viscient Biosciences 1005

Table 591: OpGen and Curetis Complete Merger 1006

Table 592: PointR Data to Merge with Mateon Therapeutics 1008

Table 593: Progentec Diagnostics and Karate Health Merge 1010

Table 594: 3M Company Enters into Co-Development Agreement with Massachusetts Institute of Technology 1011

Table 595: Menarini Silicon Biosystems Enters into Co-Promotion Partnership with OpGen for CELLSEARCH Platform and Other COVID-19 Related Products 1012

Table 596: Todos Medical Enters into Distribution Agreement with Meridian Health Services Network for Covid-19 Testing 1013

Table 597: Biocare Medical Enters into Partnership with Bethyl Labs 1014

Table 598: Thermo Fisher Scientific and Daiichi Sankyo Enter into Co-Development Agreement 1015

Table 599: NuProbe Global and Weigao Group Enter into Co-Development Agreement 1016

Table 600: Metabolon and DNA Genotek Enter into Agreement 1017

Table 601: Epredia and Lunaphore Technologies Enter into Distribution Agreement 1018

Table 602: Microbix Biosystems Enters into Distribution Agreement with Alpha-Tec Systems for Covid-19 Tests 1019

Table 603: Codexis Enters into Co-Marketing Agreement with Alphazyme 1020

Table 604: ArcherDX Enters into Collaboration with AstraZeneca 1021

Table 605: Inivata Enters into Collaboration with NeoGenomics 1022

Table 606: BioGX and Bosch Healthcare Solutions Enter into Co-Development Agreement 1024

Table 607: Prevencio Enters into Research Collaboration with Seattle Children’s Research Institute 1025

Table 608: Oncimmune Holdings Enters into Drug Development Agreement with US Biopharmaceutical Company 1026

Table 609: Sime Diagnostics Enters into Agreement for Commercialisation of Respiratory Diagnostic Platform 1027

Table 610: Berg Enters into Research Collaboration with Boehringer Ingelheim 1028

Table 611: Meridian Bioscience Enters into Partnership with QuantuMDx for COVID-19 Assay 1029

Table 612: Nimble Therapeutics Enters into Agreement with Roche Diagnostics for COVID-19 Diagnostics Assays 1030

Table 613: AIkido Pharma Enters into Research Agreement with Cogia Biotech (Cogia) 1031

Table 614: Roswell Biotechnologies and Imec Enter into Partnership 1032

Table 615: CareDx Enters into Agreement with Weill Cornell Medical College 1033

Table 616: Alveo Technologies Enters into Research Collaboration with Janssen Pharma 1034

Table 617: Applied BioMath Enters into Agreement with Xilio Therapeutics 1035

Table 618: Veracyte Enters into Licensing Agreement with Yale University 1036

Table 619: Elysium Health Enters into Licensing Agreement with Yale University 1038

Table 620: Mission Bio Enters into Co-Marketing Agreement with Agilent Technologies 1039

Table 621: Roswell Park Enters into Agreement with Catholic Health and University at Buffalo for Covid-19 1040

Table 622: Opentrons Labworks and Zymo Research Enter into Agreement for Covid-19 1041

Table 623: OpGen Enters into Agreement with Karolinska Institutet for Covid-19 1042

Table 624: Envisagenics Enters into Research Agreement with Lung Cancer Initiative at Johnson & Johnson 1044

Table 625: Entopsis Enters into Commercialization Agreement with Genetics Institute of America 1045

Table 626: RedHill Biopharma Enters into Agreement with National Institute of Allergy and Infectious Diseases for Covid-19 1046

Table 627: Hememics Biotechnologies Enters into Co-Development Agreement with Biomedical Advanced Research and Development Authority for Covid-19 1047

Table 628: Nimble Therapeutics and Svar Life Science Enter into Collaboration 1048

Table 629: Sino Biological Enters into Co-Development Agreement with Nanommune for COVID-19 Assay 1049

Table 630: Accelerate Diagnostics and BioCheck Enter into Collaboration Agreement to Distribute MS-FAST Chemiluminescence Immunoassay Analyzer and SARS-CoV-2 Antibody Tests 1050

Table 631: NanoMosaic Enters into Licensing Agreement with Harvard University Office for Technology Development for Infectious Disease Monitoring Including COVID-19 1051

Table 632: Q2 Solutions Enters into Co-Development Agreement with University of Texas Medical Branch to Help Accelerate Development of COVID-19 Vaccines 1052

Table 633: Todos Medical and 3DMed Enter Into Coronavirus (COVID-19) and Influenza A/B Testing Kit Distribution Agreement 1053

Table 634: NuProbe Enters into Agreement with Qiagen 1054

Table 635: Veravas Enters into Licensing Agreement with MIP Diagnostics 1055

Table 636: Invicro Enters into Research Partnership with Yale University School of Medicine 1056

Table 637: Fluidigm and Next Gen Diagnostics Enter into Agreement 1057

Table 638: Spherix Enters into Research Agreement with University of Texas Southwestern Medical Center 1058

Table 639: Pinpoint Science Enters into Collaboration with Analog Devices to Advance Novel Nanosensors for Pathogen Detection 1059

Table 640: Resolution Bioscience to Enter into Agreement with LabCorp 1060

Table 641: Thermo Fisher Scientific and NanoPin Technologies Enter into Partnership 1061

Table 642: Q-linea Enters into Commercialization Agreement with Thermo Fisher Scientific 1062

Table 643: Becton Dickinson (BD) and Babson Diagnostics Enter into Agreement 1063

Table 644: ProSciento and Nordic Bioscience Enter into Partnership 1064

Table 645: Baxter International and Spectral Medical Enter into Distribution Agreement 1065

Table 646: Predictive Technology and Atrin Pharma Enter into Co-Development Agreement 1066

Table 647: Twist Bioscience Enters into Agreement with Schrodinger 1067

Table 648: Horizon Discovery Exercises its Option with Rutgers University to License Base Editing Technology 1068

Table 649: Genomic Testing Co-Operative (GTC) and C2i Genomics Enter into Partnership 1069

Table 650: Roche Enters into Partnership with Illumina 1070

Table 651: Veravas and Tymora Analytical Enter into Partnership 1071

Table 652: Curis and DarwinHealth Enter into Research Collaboration 1072

Table 653: Horizon Discovery Enters into Licensing Agreement with Mammoth Biosciences 1073

Table 654: Personal Genome Diagnostics and Mayo Clinic Enter into Collaboration 1074

Table 655: Veracyte Enters into Partnership with Acerta Pharma 1075

Table 656: NuProbe Global Enters into Partnership with Illumina 1076

Table 657: IncellDx Enters into Distribution Agreement with Biolidics 1077

Table 658: Prescient Metabiomics and CoreBiome Enter into Collaboration 1078

Table 659: Novoheart Enters into Agreement with Harvard University 1079

Table 660: Horizon Discovery Enters into Licensing Agreement with Mammoth Biosciences 1080

Table 661: Ontera and QuantuMDx Enter into Partnership 1081

Table 662: NeuMoDx Molecular Enters into Partnership with Sentinel Diagnostics 1082

Table 663: Royal Philips and Paige Form Partnership 1083

Table 664: ArcherDX Expands Co-Development Agreement with Illumina 1084

Table 665: Cyrus Biotech and Broad Institute Enter into Partnership 1086

Table 666: LG Chem Enters into Licensing Agreement with Kryptos Biotechnologies 1087

Table 667: Asuragen Enters into Agreement with Wave Life Sciences 1088

Table 668: Navrogen Enters into Licensing Agreement with Lonza Pharma 1089

Table 669: Personalis Enters into Agreement With Merck 1090

Table 670: Ikonisys Enters into Partnership with Sheba Medical Center 1091

Table 671: Baystate Health and Life Image Enter into Development Partnership 1092

Table 672: Galectin Therapeutics Enters into Agreement with Siemens Healthineers 1093

Table 673: Abcam Enters into Partnership Agreement with BrickBio 1094

Table 674: Lexent Bio Enters into Partnership Agreement with Illumina 1095

Table 675: Owlstone Medical Enters into Partnership with Thermo Fisher Scientific 1096

Table 676: Bio Techne Enters into Licensing Agreement with C4 Therapeutics 1097

Table 677: Akoya Biosciences Enters into Agreement with Precision for Medicine 1098

Table 678: Sonic Healthcare Enters into Licensing Agreement with University of Pittsburgh Medical (UPMC) 1099

Table 679: Siemens Healthineers Enters into Licensing Agreement with Quanterix 1100

Table 680: Beam Therapeutics Enters into Licensing Agreement with Prime Medicine 1101

Table 681: Thermo Fisher Scientific and Genialis Enter into Co-Marketing Agreement 1102

Table 682: Sherlock Biosciences and Mologic Enter into Partnership 1103

Table 683: PredictImmune Enters into Partnership with KSL Biomedical 1104

Table 684: Novigenix Enters into Agreement with RadioMedix 1105

Table 685: PExA Enters into Research Agreement with Janssen and University of Gothenburg 1106

Table 686: Adaptive Biotechnologies Enters into Partnership with Illumina 1107

Table 687: CareDx and NanoString Technologies Enter into Partnership 1109

Table 688: Natera and Foundation Medicine Enter into Partnership 1110

Table 689: Thermo Fisher Scientific Enters into Agreement with Eli Lilly 1112

Table 690: Genmab and Tempus Labs Enter into Agreement 1114

Table 691: Thermo Fisher Scientific and Cedars-Sinai Medical Center Enter into Partnership 1115

Table 692: True Diagnostics and Veravas Enter into Commercialization Agreement 1117

Table 693: NanoString Technologies and Mayo Clinic Labs Enter into Development Agreement 1118

Table 694: Biodesix and Immodulon Therapeutics Enter into Research Collaboration 1119

Table 695: Bio-Techne Enters into Licensing Agreement with UmanDiagnostics 1120

Table 696: Molecular Templates Raises USD43 Million in Private Placement of Shares 1121

Table 697: Vaxart Raises USD89.4 Million in Public Offering of Common Stock 1122

Table 698: Cardiff Oncology to Raise USD13.5 Million in Private Placement of Shares and Warrants 1124

Table 699: DNAnexus Raises USD100 Million in Financing 1125

Table 700: AbbVie Recommends Shareholders to Reject Mini-Tender Offer of TRC Capital 1127

Table 701: IONIQ Sciences to Raise Funds through Private Equity Offering 1128

Table 702: Cardiff Oncology Raises USD2.5 Million in Private Placement of Shares and Warrants 1129

Table 703: iBio to Raise USD1.1 Million in Equity Financing 1130

Table 704: MaxCyte Raises USD9 Million in Private Placement of Shares 1132

Table 705: MaxCyte Raises USD22.2 Million in Private Placement of Shares 1134

Table 706: Oncocyte Raises USD10.7 Million in Registered Direct Offering of Shares 1136

Table 707: Artemis Capital Partners Acquires BioDot 1138

Table 708: VistaGen Therapeutics Raises USD0.25 Million in Private Placement of Shares 1139

Table 709: Merck Rejects Tender Offer by TRC Capital (TRC) 1141

Table 710: Verastem Oncology Raises USD100 Million in Private Placement of Shares 1142

Table 711: Biomerica Raises USD2 Million in Private Placement of Convertible Preferred Stock 1145

Table 712: Avisa Pharma to Raise up to USD39.2 Million in Financing 1146

Table 713: Syndax Pharma to Raise USD35 Million in Private Financing 1148

Table 714: Interpace Biosciences to Raise USD20 Million in Preferred Stock Financing 1150

Table 715: OncoCyte to Raise USD7.6 Million in Private Placement of Shares 1151

Table 716: Akoya Biosciences Raises USD50 Million in Private Financing 1152

Table 717: Becton Dickinson Shareholders Reject Mini Tender Offer from TRC Capital 1154

Table 718: TRACON Pharma Amends Terms of Private Placement of Shares 1155

Table 719: Interpace Diagnostics Raises USD13 Million in Second Tranche of Financing 1156

Table 720: Edgewater Capital Partners to Acquire Haematologic Technologies 1158

Table 721: Arcline Investment Management Acquires Majority Stake in Akron Biotech 1159

Table 722: Sema4 Raises Funds through Private Financing 1160

Table 723: Pattern Bioscience Raises Additional USD9 Million in Series B-1 Financing 1162

Table 724: Genobank.io Raises USD0.42 Million in Venture Financing 1163

Table 725: BioROSA Technologies Raises USD0.58 Million in Venture Financing 1164

Table 726: BioDirection (NanoDiagnosticsTM) Raises USD18 Million in Series C Financing 1165

Table 727: TARA Biosystems Raises USD10 Million in A2 Financing 1166

Table 728: Rheonix to Raise Funds through Venture Financing 1168

Table 729: Noninvasix Raises Additional USD0.4 Million in Venture Financing 1169

Table 730: Cue Health Raises USD100 Million in Series C Financing 1170

Table 731: Voltron Therapeutics Raises USD3.5 Million in Series A Financing 1172

Table 732: Adaptive Phage Therapeutics Raises USD2.8 Million in Venture Financing 1173

Table 733: AxoSim Raises USD1.96 Million in Venture Financing 1174

Table 734: Syapse Raises USD30 Million in Venture Financing 1175

Table 735: Decipher Biosciences Raises USD8 Million in Venture Financing 1177

Table 736: Genomenon Raises USD2.9 Million in Venture Financing 1178

Table 737: Luna Genetics Raises USD1.2 Million in Venture Financing 1179

Table 738: Immunai Raises USD20 Million in Seed Financing 1180

Table 739: Pillar Biosciences Raises USD29.7 Million in Series C Financing 1181

Table 740: Personal Genome Diagnostics Raises USD2.75 Million in Venture Financing 1182

Table 741: Grail Raises USD390 Million in Series D Financing 1183

Table 742: MOBILion Systems Raises USD6 Million in Venture Financing 1185

Table 743: Blaire Biomedical Raises Funds through Venture Financing 1186

Table 744: Ricovr Healthcare Raises USD1.1 Million in Seed Financing 1187

Table 745: Ischemia Care Raises USD1.1 Million in Venture Financing 1188

Table 746: Amplified Sciences Raises USD1 Million in Seed Financing 1189

Table 747: Captis Biotechnology Raises Funds through Venture Financing 1191

Table 748: QSM Diagnostics Raises Funds through Venture Financing 1192

Table 749: Efferent Labs to Raise USD3 Million in Venture Financing 1193

Table 750: SiDx Raises Additional USD0.5 Million in Venture Financing 1194

Table 751: eLum Technologies Raises USD2 Million in Venture Financing 1195

Table 752: 54gene (Stack Diagnostics) Raises USD15 Million in Series A Financing 1196

Table 753: Locus Biosciences Raises USD12.5 Million in Venture Financing 1198

Table 754: Triad Life Sciences Raises USD6.6 Million in Venture Financing 1199

Table 755: Optofluidics (Halo Labs) Raises USD12 Million in Series B1 Financing 1200

Table 756: ClickDiagnostics Raises USD70 Million in Venture Financing 1201

Table 757: Progenity Raises USD10 Million in Venture Financing 1202

Table 758: Avails Medical Raises Funds through Venture Financing 1203

Table 759: Proteowise Raises USD6.3 Million in Venture Financing 1204

Table 760: Innovaprep Raises USD0.5 Million in Venture Financing 1205

Table 761: Noninvasix Raises USD3.6 Million in Venture Financing 1206

Table 762: Savran Technologies Raises USD0.2 Million in Venture Financing 1207

Table 763: Tempus Secures USD100 Million in Series G Venture Funding 1208

Table 764: Rational Vaccines Raises USD2.8 Million in Venture Financing 1210

Table 765: BillionToOne Raises USD15 Million in Series A+ Financing 1211

Table 766: Emulate Raises USD19.3 Million in Venture Financing 1213

Table 767: Imcare Biotech Raises USD0.68 Million in Venture Financing 1214

Table 768: Akouos Raises USD105 Million in Series B Financing 1215

Table 769: Bloomer Health Tech Raises USD2.8 Million in Venture Financing 1218

Table 770: Pillar Biosciences Raises USD18 Million in Venture Financing 1219

Table 771: Arima Genomics Raises Funds through Series A Financing 1220

Table 772: Karius Raises USD165 Million in Series B Financing 1222

Table 773: Veravas Raises USD4 Million in Seed Financing 1224

Table 774: Scipher Medicine Raises Additional Funds through Series B Financing 1225

Table 775: Nuclein to Raise USD1 Million in Venture Financing 1226

Table 776: Impact Proteomics Raises USD0.2 Million in Venture Financing 1227

Table 777: Intabio Raises USD18 Million in Series B Financing 1228

Table 778: GenapSys Raises USD75 Million in Financing 1229

Table 779: mBio Diagnostics Raises USD0.55 Million in Venture Financing 1230

Table 780: Lumos Diagnostics Raises USD15 Million in Series A Financing 1231

Table 781: mBio Diagnostics Raises Additional USD1.08 Million in Venture Financing 1232

Table 782: Adarza BioSystems Raises USD25 Million in Series D Financing 1233

Table 783: Pattern Bioscience Raises USD6.4 Million in Series B Financing 1234

Table 784: Affinity Biosensors Raises Additional USD0.1 Million in Venture Financing 1235

Table 785: Mammoth Biosciences Raises USD45 Million in Series B Financing 1236

Table 786: IDbyDNA Raises USD20 Million in Series B Financing 1238

Table 787: NeuroDex Raises USD0.5 Million in Seed Financing 1240

Table 788: Ricovr Healthcare Raises USD0.3 Million in Venture Financing 1241

Table 789: Lucira Health Raises Additional USD17.5 Million in Series B Financing 1242

Table 790: Hycor Holdings Raises Additional USD12.5 Million in Venture Financing 1243

Table 791: Arpeggio Bio Raises USD3.2 Million in Seed Financing 1244

Table 792: Color Genomics Raises USD75 Million in Financing 1245

Table 793: Owl Peak Technologies to Raise USD1 Million in Venture Financing 1247

Table 794: Inflammatix Raises USD32 Million in Series C Financing 1248

Table 795: ReadCoor Raises USD27 Million in Series B Financing 1250

Table 796: IsoPlexis Raises Additional USD20 Million in Series C Financing 1251

Table 797: Element Biosciences Raises USD80.3 Million in Series B Financing 1252

Table 798: KIYATEC Raises Funds through Venture Funding 1254

Table 799: Progentec Diagnostics Raises USD5 Million in Series A Financing 1255

Table 800: BioSkryb Raises USD11.5 Million in Seed Financing 1257

Table 801: Canopy Biosciences Raises Funds through Venture Financing 1258

Table 802: Biostage Raises USD2.18 Million in Venture Financing 1259

Table 803: Prelude Raises USD10 Million in Venture Financing 1260

Table 804: Emerge Diagnostics Raises USD0.27 Million in Venture Financing 1261

Table 805: Elysium Health Raises USD40 Million in Series C Financing 1262

Table 806: GastroKlenz (CloudCath) Secures USD7.05 Million in Funding Round 1264

Table 807: RareCyte Raises USD22 Million in Venture Financing 1265

Table 808: Scipher Medicine Raises Funds through Series B Financing 1266

Table 809: J3 Bioscience Raises USD0.02 Million in Venture Financing 1267

Table 810: ChromaCode Raises USD28 Million in Series C Financing 1268

Table 811: ArcherDX Raises USD55 Million in Series C Financing 1270

Table 812: Trialjectory Raises USD2.7 Million in Seed Financing 1272

Table 813: Visiongate Raises Additional USD3 Million in Venture Financing 1273

Table 814: TwinStrand Biosciences Raises USD16 Million in Series A Financing 1274

Table 815: GRIP Molecular Technologies Raises USD0.35 Million in Venture Financing 1275

Table 816: Aurora Bio Raises USD0.2 Million in Venture Financing 1276

Table 817: S2 Genomics Raises USD2.2 Million in Venture Financing 1277

Table 818: Hememics Biotechnologies Raises USD2.5 Million in Venture Financing 1278

Table 819: NOWDiagnostics Raises USD18.9 Million in Venture Financing 1279

Table 820: Triple Endoscopy Raises USD1.95 Million in Venture Financing 1280

Table 821: Protego Biopharma Raises USD1 Million in Venture Financing 1281

Table 822: Banyan Biomarkers Raises USD2.26 Million in Venture Financing 1282

Table 823: Quadrant Biosciences Raises USD2.3 Million in Venture Financing 1283

Table 824: Omniome Raises Additional USD60 Million in Series C Financing 1284

Table 825: Durin Technologies Raises USD3.5 Million in Venture Financing 1286

Table 826: Glycotest Raises USD3 Million in Second Tranche of Series A Financing 1287

Table 827: Truvian Sciences Raises USD27.1 Million in Series B Financing 1288

Table 828: GenapSys Raises USD90 Million in Series C Financing 1289

Table 829: Sera Prognostics Raises USD36 Million in Series D Financing 1290

Table 830: Mobilion Systems Raises USD15.4 Million in Series A Venture Funding 1292

Table 831: BrickBio Raises USD5 Million in Venture Financing 1293

Table 832: Minute Molecular Diagnostics Raises USD0.8 Million in Venture Financing 1294

Table 833: Inanovate Raises USD0.4 Million in Venture Financing 1295

Table 834: Laboratory for Advanced Medicine Raises USD86 Million in Venture Funding 1296

Table 835: Kryptos Biotechnologies Raises USD2.7 Million in Pre-Series A Financing 1297

Table 836: Cytovale Raises Additional USD7.4 Million in Series B Financing 1298

Table 837: LungLife AI Raises Additional USD0.8 Million in Venture Financing 1299

Table 838: Eleven P15 Raises USD1.6 Million in Venture Financing 1300

Table 839: PierianDx Raises USD27 Million in Series B Financing 1301

Table 840: Mesa Biotech Raises USD3 Million in Venture Financing 1303

Table 841: Vigilant Biosciences Raises USD0.5 Million in Venture Financing 1304

Table 842: Biological Dynamics Raises USD12 Million in Venture Financing 1305

Table 843: Minerva Biotechnologies Raises USD1.5 Million in Venture Financing 1306

Table 844: Phitonex Secures USD2 Million in Seed Funding 1307

Table 845: Scipher Medicine Raises Additional USD5 Million in Venture Financing 1308

Table 846: SEngine Precision Medicine Raises Additional USD8 Million in Venture Financing 1309

Table 847: InnaMed Secures USD1 Million in Crowdfunding 1310

Table 848: 4D Path Raises USD1.4 Million in Venture Financing 1311

Table 849: Immunexpress Raises Funds through Financing Round 1312

Table 850: SEngine Precision Medicine Raises USD5.1 Million in Series A Financing 1313

Table 851: Selux Diagnostics Raises USD11.4 Million in Venture Financing 1314

Table 852: PROMISS Diagnostics Raises USD0.4 Million in Venture Financing 1315

Table 853: XCR Diagnostics Raises USD1.8 Million in Venture Financing 1316

Table 854: AltheaDx Raises USD1.3 Million in Venture Financing 1317